Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Achlorhydria
Deficient aldehyde dehydrogenase 2 is associated with increased risk for esophageal squamous cell carcinoma in the presence of gastric hypochlorhydria.
Acute Coronary Syndrome
Aldehyde dehydrogenase 2 Glu504Lys variant predicts a worse prognosis of acute coronary syndrome patients.
Acute Coronary Syndrome
Alpha-lipoic acid ameliorates oxidative stress by increasing aldehyde dehydrogenase-2 activity in patients with acute coronary syndrome.
Acute Coronary Syndrome
Role of Aldehyde Dehydrogenase 2 Glu504Lys Polymorphism in Acute Coronary Syndrome.
Acute Coronary Syndrome
Role of aldehyde dehydrogenase 2 Glu504lys polymorphism in acute coronary syndrome.
Acute Coronary Syndrome
The role of MTHFR C677T and ALDH2 Glu504Lys polymorphism in acute coronary syndrome in a Hakka population in southern China.
Acute Kidney Injury
Aldehyde dehydrogenase 2 protects against acute kidney injury by regulating autophagy via the Beclin-1 pathway.
Acute Kidney Injury
Inhibition of ALDH2 expression aggravates renal injury in a rat sepsis syndrome model.
Adenocarcinoma
Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations.
Adenocarcinoma
Alcohol dehydrogenase and aldehyde dehydrogenase polymorphisms and colorectal cancer: the Fukuoka Colorectal Cancer Study.
Adenocarcinoma
Aldehyde dehyderogenase (ALDH1A1) delineating the normal and cancer stem cells in spectral lung lesions: An immunohistochemical appraisal.
Adenocarcinoma
Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.
Adenocarcinoma
Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer.
Adenocarcinoma
Aldehyde Dehydrogenase 1B1 as a Modulator of Pancreatic Adenocarcinoma.
Adenocarcinoma
Aldehyde dehydrogenase 1B1 is a potential marker of colorectal tumors.
Adenocarcinoma
Aldehyde Dehydrogenase 1B1 Is Associated with Altered Cell Morphology, Proliferation, Migration and Chemosensitivity in Human Colorectal Adenocarcinoma Cells.
Adenocarcinoma
Aldehyde dehydrogenase 3A1 promotes multi-modality resistance and alters gene expression profile in human breast adenocarcinoma MCF-7 cells.
Adenocarcinoma
ALDH enzyme activity is regulated by Nodal and histamine in the A549 cell line.
Adenocarcinoma
ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data.
Adenocarcinoma
ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.
Adenocarcinoma
ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors.
Adenocarcinoma
Association of genotypes of rs671 withinALDH2 with risk for gastric cardia adenocarcinoma in the Chinese Han population in high- and low-incidence areas.
Adenocarcinoma
Bioinformatic analysis of potential hub genes in gastric adenocarcinoma.
Adenocarcinoma
Cancer stem cell markers in adenocarcinoma of the salivary glands - reliable prognostic markers?
Adenocarcinoma
Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2.
Adenocarcinoma
Cancer stem cells in Helicobacter pylori infection and aging: Implications for gastric carcinogenesis.
Adenocarcinoma
Correction to: Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis.
Adenocarcinoma
Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
Adenocarcinoma
Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma.
Adenocarcinoma
Expression of PD-L1, cancer stem cell and epithelial-mesenchymal transition phenotype in non-small cell lung cancer.
Adenocarcinoma
Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis.
Adenocarcinoma
Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Adenocarcinoma
Loss of CD44 and SOX2 Expression is Correlated with a Poor Prognosis in Esophageal Adenocarcinoma Patients.
Adenocarcinoma
Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer.
Adenocarcinoma
Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression.
Adenocarcinoma
Prognosis genes in gastric adenocarcinoma identified by cross talk genes in disease?related pathways.
Adenocarcinoma
Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma.
Adenocarcinoma
Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma.
Adenocarcinoma
Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance.
Adenocarcinoma
Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model.
Adenocarcinoma
Role of stem cells in colorectal cancer progression and prognostic and predictive characteristics of stem cells markers in colorectal cancer.
Adenocarcinoma
Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1.
Adenocarcinoma
Spectrum of ALDH1 mRNA in smokers and non-smokers with adenocarcinoma or squamous cell lung carcinoma.
Adenocarcinoma
The different pathogeneses of sporadic adenoma and adenocarcinoma in non-ampullary lesions of the proximal and distal duodenum.
Adenocarcinoma
The expression of ALDH1 in cervical carcinoma.
Adenocarcinoma
Three different stable human breast adenocarcinoma sublines that overexpress ALDH3A1 and certain other enzymes, apparently as a consequence of constitutively upregulated gene transcription mediated by transactivated EpREs (electrophile responsive elements) present in the 5'-upstream regions of these genes.
Adenocarcinoma
Transcriptional Regulation of Aldehyde Dehydrogenase 1A1 Gene by Alternative Spliced Forms of Nuclear Factor Y in Tumorigenic Population of Endometrial Adenocarcinoma.
Adenocarcinoma
Value of CagA, HER2, ALDH1, and KiSS-1 in predicting metastasis and prognosis for gastric adenocarcinoma.
Adenocarcinoma
Verification of ALDH Activity as a Biomarker in Colon Cancer Stem Cells-Derived HT-29 Cell Line.
Adenocarcinoma
[Expression and Clinical Significance of ALDH1 and Twist in Gastric Adenocarcinoma].
Adenocarcinoma
[Proliferation of cancer stem cells in colorectal adenocarcinoma].
Adenocarcinoma of Lung
?-catenin/POU5F1/SOX2 transcription factor complex mediates IGF-1 receptor signaling and predicts poor prognosis in lung adenocarcinoma.
Adenocarcinoma of Lung
?-Escin Inhibits NNK-Induced Lung Adenocarcinoma and ALDH1A1 and RhoA/Rock Expression in A/J Mice and Growth of H460 Human Lung Cancer Cells.
Adenocarcinoma of Lung
Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas.
Adenocarcinoma of Lung
ALDH1 and SALL4 Expression in Cell Block Samples from Patients with Lung Adenocarcinoma and Malignant Pleural Effusion.
Adenocarcinoma of Lung
ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data.
Adenocarcinoma of Lung
ALDH2 Repression Promotes Lung Tumor Progression via Accumulated Acetaldehyde and DNA Damage.
Adenocarcinoma of Lung
ALDH3A1 driving tumor metastasis is mediated by p53/BAG1 in lung adenocarcinoma.
Adenocarcinoma of Lung
ALDH3B1 Is an Independent Prognostic Biomarker of Lung Adenocarcinoma.
Adenocarcinoma of Lung
Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP.
Adenocarcinoma of Lung
Development of Selective Inhibitors for Human Aldehyde Dehydrogenase 3A1 (ALDH3A1) for the Enhancement of Cyclophosphamide Cytotoxicity.
Adenocarcinoma of Lung
Effect of aerobic exercise on acquired gefitinib resistance in lung adenocarcinoma.
Adenocarcinoma of Lung
Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and ?-catenin, in primary lung adenocarcinoma--their prognostic significance.
Adenocarcinoma of Lung
Inhibitory effect of PPAR? on NR0B1 in tumorigenesis of lung adenocarcinoma.
Adenocarcinoma of Lung
KANK1 regulates paclitaxel resistance in lung adenocarcinoma A549 cells.
Adenocarcinoma of Lung
Methylation-Induced Silencing of ALDH2 Facilitates Lung Adenocarcinoma Bone Metastasis by Activating the MAPK Pathway.
Adenocarcinoma of Lung
Puerarin 6?-O-xyloside suppresses growth, self-renewal and invasion of lung cancer stem-like cells derived from A549 cells via regulating Akt/c-Myc signalling.
Adenocarcinoma of Lung
Role of leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC) for anti-apoptosis and tumourigenesis in cancers.
Adenocarcinoma of Lung
Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells.
Adenocarcinoma of Lung
Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma.
Adenocarcinoma of Lung
The Clinical Significance of Cancer Stem Cell Markers ALDH1A1 and CD133 in Lung Adenocarcinoma.
Adenocarcinoma of Lung
UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells.
Adenocarcinoma of Lung
[Expression of Acetaldehyde Dehydrogenase in Gefitinib-resistant Human Lung Adenocarcinoma HCC-827/GR Cells].
Adenocarcinoma of Lung
[Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells].
Adenocarcinoma, Clear Cell
ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.
Adenocarcinoma, Clear Cell
Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression.
Adenocarcinoma, Mucinous
Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression.
Adenoma
Aldehyde dehydrogenase 1B1 is a potential marker of colorectal tumors.
Adenoma
ALDH Maintains the Stemness of Lung Adenoma Stem Cells by Suppressing the Notch/CDK2/CCNE Pathway.
Adenoma
Early gene expression differences in inbred mouse strains with susceptibility to pulmonary adenomas.
Adenoma
Genetic polymorphisms of methylenetetrahydrofolate reductase and aldehyde dehydrogenase 2, alcohol use and risk of colorectal adenomas: Self-Defense Forces Health Study.
Adenoma
Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma.
Adenoma
Lack of Influence of the ADH1B Arg47His Genetic Polymorphism on Risk of Colorectal Adenoma in Middle-aged Japanese Men.
Adenoma
Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam.
Adenoma
Temporal and spatial changes of cells positive for stem-like markers in different compartments and stages of human colorectal adenoma-carcinoma sequence.
Adenoma
The different pathogeneses of sporadic adenoma and adenocarcinoma in non-ampullary lesions of the proximal and distal duodenum.
Adenoma, Liver Cell
ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway.
Adenomatous Polyps
Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Airway Obstruction
Association between the aldehyde dehydrogenase 2*2 allele and smoking-related chronic airway obstruction in a Japanese general population: a pilot study.
alcohol dehydrogenase deficiency
Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant.
Alcohol Withdrawal Delirium
Association between personality traits and ALDH2 polymorphism in Japanese male alcoholics.
Alcohol-Related Disorders
Distribution of alcohol-metabolizing enzyme genotypes in trauma patients with excessive alcohol consumption in the emergency department.
Alcohol-Related Disorders
Genetic alcohol sensitivity regulated by ALDH2 and ADH1B polymorphisms is strongly associated with depression and anxiety in Japanese employees.
Alcohol-Related Disorders
Pharmacogenetics of alcohol metabolism and alcoholism.
Alcoholic Neuropathy
Association of aldehyde dehydrogenase-2 polymorphism with alcoholic polyneuropathy in humans.
Alcoholic Neuropathy
Influence of genetic variations of ethanol-metabolizing enzymes on phenotypes of alcohol-related disorders.
aldehyde dehydrogenase (nad+) deficiency
Acetaldehyde dehydrogenase 2 (ALDH2) deficiency exacerbates pressure overload-induced cardiac dysfunction by inhibiting Beclin-1 dependent autophagy pathway.
aldehyde dehydrogenase (nad+) deficiency
Acetaldehyde dehydrogenase 2 deficiency exacerbates cardiac fibrosis by promoting mobilization and homing of bone marrow fibroblast progenitor cells.
aldehyde dehydrogenase (nad+) deficiency
Acetaldehyde dehydrogenase 2 deficiency increases mitochondrial reactive oxygen species emission and induces mitochondrial protease Omi/HtrA2 in skeletal muscle.
aldehyde dehydrogenase (nad+) deficiency
Acetaldehyde Dehydrogenase 2 regulates HMG-CoA reductase stability and cholesterol synthesis in the liver.
aldehyde dehydrogenase (nad+) deficiency
Alcohol inhibits T-cell glucose metabolism and hepatitis in ALDH2-deficient mice and humans: roles of acetaldehyde and glucocorticoids.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenase 2 activation ameliorates CCl4 -induced chronic liver fibrosis in mice by up-regulating Nrf2/HO-1 antioxidant pathway.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer's disease related pathology.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde Dehydrogenase 2 Ameliorates Chronic Alcohol Consumption-Induced Atrial Fibrillation through Detoxification of 4-HNE.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenase 2 deficiency blunts compensatory cardiac hypertrophy through modulating Akt phosphorylation early after transverse aorta constriction in mice.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenase 2 deficiency increases resting-state glutamate and expression of the GluN1 subunit of N-methyl-D-aspartate receptor in the frontal cortex of mice.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenase 2 deficiency negates chronic low-to-moderate alcohol consumption-induced cardioprotecion possibly via ROS-dependent apoptosis and RIP1/RIP3/MLKL-mediated necroptosis.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenase 2 deficiency promotes atherosclerotic plaque instability through accelerating mitochondrial ROS-mediated vascular smooth muscle cell senescence.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenase 2 deficiency significantly exacerbates tert-butyl alcohol-induced toxicity in mice.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenase 2 knockout accentuates ethanol-induced cardiac depression: Role of protein phosphatases.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenase 2 protects against abdominal aortic aneurysm formation by reducing reactive oxygen species, vascular inflammation, and apoptosis of vascular smooth muscle cells.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenase 2 protects against sympathetic excitation-induced cardiac fibrosis.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenase-2 deficiency aggravates cardiac dysfunction elicited by endoplasmic reticulum stress induction.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenase-2 deficiency and articular collagen.
aldehyde dehydrogenase (nad+) deficiency
Aldehyde dehydrogenases are regulators of hematopoietic stem cell numbers and B-cell development.
aldehyde dehydrogenase (nad+) deficiency
ALDH-2 deficiency increases cardiovascular oxidative stress--evidence for indirect antioxidative properties.
aldehyde dehydrogenase (nad+) deficiency
ALDH1A1 Deficiency in Gorlin Syndrome Suggests a Central Role for Retinoic Acid and ATM Deficits in Radiation Carcinogenesis.
aldehyde dehydrogenase (nad+) deficiency
ALDH2 and Cardiovascular Disease.
aldehyde dehydrogenase (nad+) deficiency
ALDH2 deficiency induces atrial fibrillation through dysregulated cardiac sodium channel and mitochondrial bioenergetics: A multi-omics analysis.
aldehyde dehydrogenase (nad+) deficiency
ALDH2 deficiency inhibits Ox-LDL induced foam cell formation via suppressing CD36 expression.
aldehyde dehydrogenase (nad+) deficiency
ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
aldehyde dehydrogenase (nad+) deficiency
ALDH2 Deficiency Promotes Ethanol-Induced Gut Barrier Dysfunction and Fatty Liver in Mice.
aldehyde dehydrogenase (nad+) deficiency
ALDH2 mediates the dose-response protection of chronic ethanol against endothelial senescence through SIRT1/p53 pathway.
aldehyde dehydrogenase (nad+) deficiency
ALDH2 modulates autophagy flux to regulate acetaldehyde-mediated toxicity thresholds.
aldehyde dehydrogenase (nad+) deficiency
ALDH2 protects against stroke by clearing 4-HNE.
aldehyde dehydrogenase (nad+) deficiency
Appropriate dose of ethanol exerts anti-senescence and anti-atherosclerosis protective effects by activating ALDH2.
aldehyde dehydrogenase (nad+) deficiency
Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.
aldehyde dehydrogenase (nad+) deficiency
Deficiency of Retinaldehyde Dehydrogenase 1 Induces BMP2 and Increases Bone Mass In Vivo.
aldehyde dehydrogenase (nad+) deficiency
Deficient aldehyde dehydrogenase 2 is associated with increased risk for esophageal squamous cell carcinoma in the presence of gastric hypochlorhydria.
aldehyde dehydrogenase (nad+) deficiency
Detection of aldehyde dehydrogenase deficiency in Chachi Indians, Ecuador.
aldehyde dehydrogenase (nad+) deficiency
Dominance of the mutant ALDH2(2) allele in the expression of human stomach aldehyde dehydrogenase-2 activity.
aldehyde dehydrogenase (nad+) deficiency
Effect of Alcohol Sensitivity in Healthy Young Adults on Breath Pharmacokinetics of Acetaldehyde After Mouth Washing with Alcohol.
aldehyde dehydrogenase (nad+) deficiency
Effects of "Essential AD2" Supplement on Blood Acetaldehyde Levels in Individuals Who Have Aldehyde Dehydrogenase (ALDH2) Deficiency.
aldehyde dehydrogenase (nad+) deficiency
Effects of acetaldehyde inhalation in mitochondrial aldehyde dehydrogenase deficient mice (Aldh2-/-).
aldehyde dehydrogenase (nad+) deficiency
Effects of ALDH2 genotype, PPI treatment and L-cysteine on carcinogenic acetaldehyde in gastric juice and saliva after intragastric alcohol administration.
aldehyde dehydrogenase (nad+) deficiency
Ethanol and acetaldehyde differentially alter extracellular dopamine and serotonin in Aldh2-knockout mouse dorsal striatum: A reverse microdialysis study.
aldehyde dehydrogenase (nad+) deficiency
Ethanol induces skin hyperpigmentation in mice with aldehyde dehydrogenase 2 deficiency.
aldehyde dehydrogenase (nad+) deficiency
Ethanol metabolism, toxicity and genetic polymorphism.
aldehyde dehydrogenase (nad+) deficiency
Expression of aldehyde dehydrogenase 2 in the normal esophageal epithelium and alcohol consumption in patients with esophageal cancer.
aldehyde dehydrogenase (nad+) deficiency
Gene Therapy Correction of Aldehyde Dehydrogenase 2 Deficiency.
aldehyde dehydrogenase (nad+) deficiency
Genetic deficiency of a mitochondrial aldehyde dehydrogenase increases serum lipid peroxides in community-dwelling females.
aldehyde dehydrogenase (nad+) deficiency
Genetic Study of Fanconi Anemia in Infancy Revealed FANCI Mutations and Defective ALDH2 Variant: A Case Report.
aldehyde dehydrogenase (nad+) deficiency
Genetic testing for aldehyde dehydrogenase 2 deficiency in young adults.
aldehyde dehydrogenase (nad+) deficiency
Genotyping of the aldehyde dehydrogenase 2 (ALDH2) gene using the polymerase chain reaction: evidence for single point mutation in the ALDH2 gene of ALDH2-deficiency.
aldehyde dehydrogenase (nad+) deficiency
High ethanol and acetaldehyde impair spatial memory in mouse models: Opposite effects of aldehyde dehydrogenase 2 and apolipoprotein E on memory.
aldehyde dehydrogenase (nad+) deficiency
Human-induced pluripotent stem cell approaches to model inborn and acquired metabolic heart diseases.
aldehyde dehydrogenase (nad+) deficiency
Hypertrophic scar: a genetic hypothesis.
aldehyde dehydrogenase (nad+) deficiency
Increased formation of gastric N(2)-ethylidene-2'-deoxyguanosine DNA adducts in aldehyde dehydrogenase-2 knockout mice treated with ethanol.
aldehyde dehydrogenase (nad+) deficiency
Mendelian randomization: A novel test of the gateway hypothesis and models of gene-environment interplay.
aldehyde dehydrogenase (nad+) deficiency
Mitochondrial aldehyde dehydrogenase 2 deficiency aggravates energy metabolism disturbance and diastolic dysfunction in diabetic mice.
aldehyde dehydrogenase (nad+) deficiency
Mitochondrial Aldehyde Dehydrogenase 2 Regulates Revascularization in Chronic Ischemia: Potential Impact on the Development of Coronary Collateral Circulation.
aldehyde dehydrogenase (nad+) deficiency
Mitochondrial aldehyde dehydrogenase prevents ROS-induced vascular contraction in angiotensin-II hypertensive mice.
aldehyde dehydrogenase (nad+) deficiency
Mitochondrial aldehyde dehydrogenase-2 deficiency compromises therapeutic effect of ALDH bright cell on peripheral ischemia.
aldehyde dehydrogenase (nad+) deficiency
Mitochondrial ALDH2 deficiency as an oxidative stress.
aldehyde dehydrogenase (nad+) deficiency
Mitochondrial PKC-? deficiency promotes I/R-mediated myocardial injury via GSK3?-dependent mitochondrial permeability transition pore opening.
aldehyde dehydrogenase (nad+) deficiency
Moderate vitamin A supplementation in obese mice regulates tissue factor and cytokine production in a sex-specific manner.
aldehyde dehydrogenase (nad+) deficiency
Pharmacogenetics of alcohol sensitivity.
aldehyde dehydrogenase (nad+) deficiency
Polymorphism of aldehyde dehydrogenase and its application to alcoholism.
aldehyde dehydrogenase (nad+) deficiency
Population genetic and family studies on aldehyde dehydrogenase deficiency and alcohol sensitivity.
aldehyde dehydrogenase (nad+) deficiency
Population genetic studies on aldehyde dehydrogenase isozyme deficiency and alcohol sensitivity.
aldehyde dehydrogenase (nad+) deficiency
Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype.
aldehyde dehydrogenase (nad+) deficiency
Primum Non Nocere: Should Gene Therapy Be Used to Prevent Potentially Fatal Disease but Enable Potentially Destructive Behavior?
aldehyde dehydrogenase (nad+) deficiency
Retinaldehyde dehydrogenase 1 coordinates hepatic gluconeogenesis and lipid metabolism.
aldehyde dehydrogenase (nad+) deficiency
Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region.
aldehyde dehydrogenase (nad+) deficiency
Role of the aldehyde dehydrogenase-1 isozyme in the metabolism of acetaldehyde.
aldehyde dehydrogenase (nad+) deficiency
Spinal astrocyte aldehyde dehydrogenase-2 mediates ethanol metabolism and analgesia in mice.
aldehyde dehydrogenase (nad+) deficiency
Steady-state metabolism of ethanol in perfused rat livers treated with cyanamide: quantitative analysis of acetaldehyde effects on the metabolic flux rates.
aldehyde dehydrogenase (nad+) deficiency
Susceptibility to inhalation toxicity of acetaldehyde in Aldh2 knockout mice.
aldehyde dehydrogenase (nad+) deficiency
Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol Ingestion.
aldehyde dehydrogenase (nad+) deficiency
Targeting liver aldehyde dehydrogenase-2 prevents heavy but not moderate alcohol drinking.
aldehyde dehydrogenase (nad+) deficiency
The aldehyde dehydrogenase ALDH2*2 allele exhibits dominance over ALDH2*1 in transduced HeLa cells.
aldehyde dehydrogenase (nad+) deficiency
The role of alcohol dehydrogenase and aldehyde dehydrogenase isozymes in alcohol metabolism, alcohol sensitivity, and alcoholism.
aldehyde dehydrogenase (nad+) deficiency
The Role of Mitochondrial Aldehyde Dehydrogenase 2 (ALDH2) in Neuropathology and Neurodegeneration.
aldehyde dehydrogenase (nad+) deficiency
Transformed ALDH2-/- hepatocytes by ethanol could serve as a useful tool for studying alcoholic hepatocarcinogenesis.
aldehyde dehydrogenase (nad+) deficiency
Validation of Alcohol Flushing Questionnaire to Identify ALDH2 Status in a Case-Control Study of Head and Neck Cancer.
aldehyde dehydrogenase (nad+) deficiency
Why can't Chinese Han drink alcohol? Hepatitis B virus infection and the evolution of acetaldehyde dehydrogenase deficiency.
aldehyde dehydrogenase (nad+) deficiency
[Roles of mitochondrial dysfunctions in Alzheimer's disease--contribution of deficiency of ALDH 2]
Alzheimer Disease
Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer's disease related pathology.
Alzheimer Disease
Aldehyde dehydrogenase 2 protects against acute kidney injury by regulating autophagy via the Beclin-1 pathway.
Alzheimer Disease
Assessment of association between mitochondrial aldehyde dehydrogenase polymorphism and Alzheimer's disease in an older Korean population.
Alzheimer Disease
Association Between Aldehyde dehydrogenase-2 Polymorphisms and Risk of Alzheimer's Disease and Parkinson's Disease: A Meta-Analysis Based on 5,315 Individuals.
Alzheimer Disease
Association between ALDH2 Gene Polymorphism and Late-onset Alzheimer Disease: An Up-to-date Meta-analysis.
Alzheimer Disease
Characterization of Aldh2 (-/-) mice as an age-related model of cognitive impairment and Alzheimer's disease.
Alzheimer Disease
Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.
Alzheimer Disease
Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification.
Alzheimer Disease
Effects of "Essential AD2" Supplement on Blood Acetaldehyde Levels in Individuals Who Have Aldehyde Dehydrogenase (ALDH2) Deficiency.
Alzheimer Disease
Effects of the common polymorphism in the human aldehyde dehydrogenase 2 (ALDH2) gene on the lung.
Alzheimer Disease
Endogenous formaldehyde is a memory-related molecule in mice and humans.
Alzheimer Disease
Glu504Lys Single Nucleotide Polymorphism of Aldehyde Dehydrogenase 2 Gene and the Risk of Human Diseases.
Alzheimer Disease
Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) in the putamen of individuals with Alzheimer's disease: a human postmortem study.
Alzheimer Disease
Meta-analysis of aldehyde dehydrogenase 2 gene polymorphism and Alzheimer's disease in East Asians.
Alzheimer Disease
Mitochondrial aldehyde dehydrogenase (ALDH2) rescues cardiac contractile dysfunction in an APP/PS1 murine model of Alzheimer's disease via inhibition of ACSL4-dependent ferroptosis.
Alzheimer Disease
Mitochondrial aldehyde dehydrogenase polymorphism is not associated with incidence of Alzheimer's disease.
Alzheimer Disease
Multifaceted Regulation of ALDH1A1 by Cdk5 in Alzheimer's Disease Pathogenesis.
Alzheimer Disease
Neuronal Calcium Imaging, Excitability, and Plasticity Changes in the Aldh2-/- Mouse Model of Sporadic Alzheimer's Disease.
Alzheimer Disease
Oxadiazon affects the expression and activity of aldehyde dehydrogenase and acylphosphatase in human striatal precursor cells: A possible role in neurotoxicity.
Alzheimer Disease
Polymorphisms in the aldehyde dehydrogenase 2 and dopamine ? hydroxylase genes are not associated with Alzheimer's disease.
Alzheimer Disease
Role of ADH1B rs1229984 and ALDH2 rs671 gene polymorphisms in the development of Alzheimer's disease.
Alzheimer Disease
The association of mitochondrial aldehyde dehydrogenase gene (ALDH2) polymorphism with susceptibility to late-onset Alzheimer's disease in Chinese.
Alzheimer Disease
[Roles of mitochondrial dysfunctions in Alzheimer's disease--contribution of deficiency of ALDH 2]
Androgen-Insensitivity Syndrome
Biological role of human cytosolic aldehyde dehydrogenase 1: hormonal response, retinal oxidation and implication in testicular feminization.
Androgen-Insensitivity Syndrome
The cytosolic aldehyde dehydrogenase gene (Aldh1) is developmentally expressed in Leydig cells.
Anemia
Recovery from anemia and leukocytopenia after abstinence in Japanese alcoholic men and their genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2.
Anemia, Aplastic
Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells.
Anemia, Aplastic
Aldehyde dehydrogenase-2 polymorphism contributes to the progression of bone marrow failure in children with idiopathic aplastic anaemia.
Anemia, Diamond-Blackfan
ALDH2 polymorphism in patients with Diamond-Blackfan anemia in Japan.
Anemia, Macrocytic
Macrocytosis, Macrocytic Anemia, and Genetic Polymorphisms of Alcohol Dehydrogenase-1B and Aldehyde Dehydrogenase-2 in Japanese Alcoholic Men.
Angina Pectoris
Efficient expression of codon-adapted human acetaldehyde dehydrogenase 2 cDNA with 6xHis tag in Pichia pastoris.
Angina, Stable
Combined effects of current-smoking and the aldehyde dehydrogenase 2*2 allele on the risk of myocardial infarction in Japanese patients.
Aniridia
Expression of retinoic acid signaling components ADH7 and ALDH1A1 is reduced in aniridia limbal epithelial cells and a siRNA primary cell based aniridia model.
Anophthalmos
A Novel Missense Mutation in the ALDH13 Gene Causes Anophthalmia in Two Unrelated Iranian Consanguineous Families.
Anophthalmos
ALDH1A3 loss of function causes bilateral anophthalmia/microphthalmia and hypoplasia of the optic nerve and optic chiasm.
Anophthalmos
ALDH1A3 mutations cause recessive anophthalmia and microphthalmia.
Anophthalmos
Novel compound heterozygous mutations of ALDH1A3 contribute to anophthalmia in a non-consanguineous Chinese family.
Anophthalmos
Novel mutations in ALDH1A3 associated with autosomal recessive anophthalmia/microphthalmia, and review of the literature.
Aortic Aneurysm, Abdominal
Aldehyde dehydrogenase 2 protects against abdominal aortic aneurysm formation by reducing reactive oxygen species, vascular inflammation, and apoptosis of vascular smooth muscle cells.
Arrhythmias, Cardiac
Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells.
Asthma
A rare case of Sjogren-Larsson syndrome with recurrent pneumonia and asthma.
Asthma
Acute severe alcohol-induced bronchial asthma.
Asthma
Correlation between alcohol-induced asthma and acetaldehyde dehydrogenase-2 genotype.
Asthma
Genotypes of ALDH2 related to liver and pulmonary diseases and other genetic factors related to alcoholic liver disease.
Asthma
Linking endotypes to omics profiles in difficult-to-control asthma using the diagnostic Chinese medicine syndrome differentiation algorithm.
Asthma
Screening for acetaldehyde dehydrogenase 2 genotype in alcohol-induced asthma by using the ethanol patch test.
Asthma
The Identification of Childhood Asthma Progression-Related lncRNAs and mRNAs Suitable as Biomarkers Using Weighted Gene Coexpression Network Analysis.
Astrocytoma
ALDH1 expression is correlated with pathologic grade and poor clinical outcome in patients with astrocytoma.
Astrocytoma
Expression and prognostic value of the aldehyde dehydrogenase 1 (ALDH1) and N-myc downstream regulated gene 2 (NDRG2) as potential markers in human astrocytomas.
Astrocytoma
Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes.
Astrocytoma
Prognostic Value of ALDH1, EZH2 and Ki-67 in Astrocytic Gliomas.
Astrocytoma
Retraction Note to: Expression and prognostic value of the aldehyde dehydrogenase 1 (ALDH1) and N-myc downstream regulated gene 2 (NDRG2) as potential markers in human astrocytomas.
Ataxia
A histochemical study of the distribution of aldehyde dehydrogenase activity in brain structures of rats with genetically different alcohol-related behaviour.
Ataxia Telangiectasia
ALDH1A1 Deficiency in Gorlin Syndrome Suggests a Central Role for Retinoic Acid and ATM Deficits in Radiation Carcinogenesis.
Ataxia Telangiectasia
Novel composite drug delivery system as a novel radio sensitizer for the local treatment of cervical carcinoma.
Atherosclerosis
Acetaldehyde dehydrogenase 2 interactions with LDLR and AMPK regulate foam cell formation.
Atherosclerosis
Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells.
Atherosclerosis
Appropriate dose of ethanol exerts anti-senescence and anti-atherosclerosis protective effects by activating ALDH2.
Atherosclerosis
Association between Carotid Intima-media Thickness and Aldehyde Dehydrogenase 2 Glu504Lys Polymorphism in Chinese Han with Essential Hypertension.
Atherosclerosis
Effects of aldehyde dehydrogenase genotypes on carotid atherosclerosis.
Atherosclerosis
Homozygous ALDH2*2 Is an Independent Risk Factor for Ischemic Stroke in Taiwanese Men.
Atherosclerosis
Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice.
Atherosclerosis
Not just correlative: a new pathway defines how an ALDH2 SNP contributes to atherosclerosis.
Atherosclerosis
Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype.
Atherosclerosis
Targeting ALDH2 in Atherosclerosis: Molecular Mechanisms and Therapeutic Opportunities.
Atrial Fibrillation
Aldehyde Dehydrogenase 2 Ameliorates Chronic Alcohol Consumption-Induced Atrial Fibrillation through Detoxification of 4-HNE.
Atrial Fibrillation
ALDH2 deficiency induces atrial fibrillation through dysregulated cardiac sodium channel and mitochondrial bioenergetics: A multi-omics analysis.
Atrial Fibrillation
Genetic variations of aldehyde dehydrogenase 2 and alcohol dehydrogenase 1B are associated with the etiology of atrial fibrillation in Japanese.
Basal Cell Nevus Syndrome
ALDH1A1 Deficiency in Gorlin Syndrome Suggests a Central Role for Retinoic Acid and ATM Deficits in Radiation Carcinogenesis.
Basal Cell Nevus Syndrome
Deficient expression of aldehyde dehydrogenase 1A1 is consistent with increased sensitivity of Gorlin syndrome patients to radiation carcinogenesis.
Bone Diseases, Metabolic
A critical assessment of the potential of pharmacological modulation of aldehyde dehydrogenases to treat the diseases of bone loss.
Bone Diseases, Metabolic
Astaxanthin improves osteopenia caused by aldehyde-stress resulting from Aldh2 mutation due to impaired osteoblastogenesis.
Bone Diseases, Metabolic
The Thiocarbamate Disulphide Drug, Disulfiram Induces Osteopenia in Rats by Inhibition of Osteoblast Function Due to Suppression of Acetaldehyde Dehydrogenase Activity.
Bone Marrow Failure Disorders
Aldehyde dehydrogenase-2 polymorphism contributes to the progression of bone marrow failure in children with idiopathic aplastic anaemia.
Bone Marrow Failure Disorders
Maternal aldehyde elimination during pregnancy preserves the fetal genome.
Bone Marrow Failure Disorders
The phenotype and clinical course of Japanese Fanconi Anaemia infants is influenced by patient, but not maternal ALDH2 genotype.
Bone Marrow Failure Disorders
Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients.
Bowen's Disease
Aldehyde dehydrogenase 1 expression in basal cell carcinoma, actinic keratosis and Bowen's disease.
Brain Diseases, Metabolic
Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors.
Brain Edema
ALDH2 Protects Against Ischemic Stroke in Rats by Facilitating 4-HNE Clearance and AQP4 Down-Regulation.
Brain Injuries
Alda-1 reduces cerebral ischemia/reperfusion injury in rat through clearance of reactive aldehydes.
Brain Ischemia
ALDH 2 conferred neuroprotection on cerebral ischemic injury by alleviating mitochondria-related apoptosis through JNK/caspase-3 signing pathway.
Brain Neoplasms
Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity.
Brain Neoplasms
Deubiquitinating ALDH1A3 key to maintaining the culprit of aggressive brain cancer.
Brain Neoplasms
FOXD1-ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells.
Brain Neoplasms
Synthesis and Preliminary Evaluation of n.c.a. Iodoquine: A Novel Radiotracer with High Uptake in Cells with High ALDH1 Expression.
Breast Diseases
Aldehyde dehydrogenase 1 expression correlates with the invasion of breast cancer.
Breast Neoplasms
A Novel Approach for Overcoming Drug Resistance in Breast Cancer Chemotherapy by Targeting new Synthetic Curcumin Analogues Against Aldehyde Dehydrogenase 1 (ALDH1A1) and Glycogen Synthase Kinase-3 ? (GSK-3?).
Breast Neoplasms
A positive cross-regulation of HER2 and ER-?36 controls ALDH1 positive breast cancer cells.
Breast Neoplasms
A review of the racial heterogeneity of breast cancer stem cells.
Breast Neoplasms
A triple negative breast cancer: what it is not!
Breast Neoplasms
ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
Breast Neoplasms
Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over-express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species.
Breast Neoplasms
Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC).
Breast Neoplasms
Aldehyde dehydrogenase 1 as a predictor of the neoadjuvant chemotherapy response in breast cancer: A meta-analysis.
Breast Neoplasms
Aldehyde dehydrogenase 1 expression correlates with clinicopathologic features of patients with breast cancer: a meta-analysis.
Breast Neoplasms
Aldehyde dehydrogenase 1 expression correlates with the invasion of breast cancer.
Breast Neoplasms
Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.
Breast Neoplasms
Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
Breast Neoplasms
Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.
Breast Neoplasms
Aldehyde dehydrogenase 1-positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with lymph node-positive breast cancer.
Breast Neoplasms
Aldehyde Dehydrogenase 1-related Genes in Triple-negative Breast Cancer Investigated Using Network Analysis.
Breast Neoplasms
Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy.
Breast Neoplasms
Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.
Breast Neoplasms
Aldehyde dehydrogenase 2 genotype in tolerability of alcohol contained in paclitaxel in Japanese breast cancer patients.
Breast Neoplasms
Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells is Primarily Due to Isoform ALDH1A3 and Its Expression is Predictive of Metastasis.
Breast Neoplasms
Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Breast Neoplasms
Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells.
Breast Neoplasms
ALDH(+)/CD44(+)/CD24(-) expression in cells from body cavity fluids.
Breast Neoplasms
ALDH1 and tumor infiltrating lymphocytes as predictors for neoadjuvant chemotherapy response in breast cancer.
Breast Neoplasms
ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells.
Breast Neoplasms
ALDH1 Cancer Stem Cell Marker as a Prognostic Factor in Triple-Negative Breast Cancer.
Breast Neoplasms
ALDH1 Expression and Vasculogenic Mimicry Are Positively Associated with Poor Prognosis in Patients with Breast Cancer.
Breast Neoplasms
ALDH1 expression correlates with favorable prognosis in ovarian cancers.
Breast Neoplasms
ALDH1 expression is enriched in breast cancers arising in young women but does not predict outcome.
Breast Neoplasms
ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype.
Breast Neoplasms
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
Breast Neoplasms
ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis.
Breast Neoplasms
ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer.
Breast Neoplasms
Androgen Receptor and ALDH1 Expression Among Internationally Diverse Patient Populations.
Breast Neoplasms
Association between ALDH1+/CD133+ stem-like cells and tumor angiogenesis in invasive ductal breast carcinoma.
Breast Neoplasms
Association of aldehyde dehydrogenase 1 expression and biologically aggressive features in breast cancer.
Breast Neoplasms
Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Breast Neoplasms
Associations between ALDH1A1 polymorphisms, alcohol consumption, and mortality among Hispanic and non-Hispanic white women diagnosed with breast cancer: the Breast Cancer Health Disparities Study.
Breast Neoplasms
Associations of mammographic breast density with breast stem cell marker-defined breast cancer subtypes.
Breast Neoplasms
BCMA (TNFRSF17) Induces APRIL and BAFF Mediated Breast Cancer Cell Stemness.
Breast Neoplasms
Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer.
Breast Neoplasms
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Breast Neoplasms
Breast cancer stem cells and intrinsic subtypes: controversies rage on.
Breast Neoplasms
Breast cancer stem cells.
Breast Neoplasms
Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinoma.
Breast Neoplasms
Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
Breast Neoplasms
Carboxypeptidase A4 negatively correlates with p53 expression and regulates the stemness of breast cancer cells.
Breast Neoplasms
Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients.
Breast Neoplasms
Causal Bayesian gene networks associated with bone, brain and lung metastasis of breast cancer.
Breast Neoplasms
CD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancer.
Breast Neoplasms
CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator.
Breast Neoplasms
Cellular level classification of breast cancer through proteomic markers using nanochannel array sensors.
Breast Neoplasms
Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens.
Breast Neoplasms
Characteristic Genes in Luminal Subtype Breast Tumors with CD44+CD24-/Low Gene Expression Signature.
Breast Neoplasms
Characterizing Breast Cancer in a Population with Increased Prevalence of Triple-Negative Breast Cancer: Androgen Receptor and ALDH1 Expression in Ghanaian Women.
Breast Neoplasms
Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.
Breast Neoplasms
Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
Breast Neoplasms
Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.
Breast Neoplasms
Clinicopathologic characteristics of breast cancer stem cells identified on the basis of aldehyde dehydrogenase 1 expression.
Breast Neoplasms
Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis.
Breast Neoplasms
Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer.
Breast Neoplasms
Clinicopathological Significance of CD133 and ALDH1 Cancer Stem Cell Marker Expression in Invasive Ductal Breast Carcinoma.
Breast Neoplasms
Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer.
Breast Neoplasms
Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases.
Breast Neoplasms
Combination Twist1 and CA15-3 in axillary lymph nodes for breast cancer prognosis.
Breast Neoplasms
Combined expression of aldehyde dehydrogenase 1A1 and ?-catenin is associated with lymph node metastasis and poor survival in breast cancer patients following cyclophosphamide treatment.
Breast Neoplasms
Correction to: Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1?/VEGF signalling in MCF-7 breast cancer cells.
Breast Neoplasms
Correlation between c-Met and ALDH1 contributes to the survival and tumor-sphere formation of ALDH1 positive breast cancer stem cells and predicts poor clinical outcome in breast cancer.
Breast Neoplasms
Correlations of aldehyde dehydrogenase-1 (ALDH1) expression with traditional prognostic parameters and different molecular subtypes of breast carcinoma.
Breast Neoplasms
Correlations of ALDH1 expression with molecular subtypes and ABCG2 in breast cancer.
Breast Neoplasms
Crosstalk between miR-203 and PKC? regulates breast cancer stem cell markers.
Breast Neoplasms
Cytokeratin 19 (KRT19) has a Role in the Reprogramming of Cancer Stem Cell-Like Cells to Less Aggressive and More Drug-Sensitive Cells.
Breast Neoplasms
Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133.
Breast Neoplasms
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Breast Neoplasms
Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells.
Breast Neoplasms
Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.
Breast Neoplasms
Distinct prognostic values of ALDH1 isoenzymes in breast cancer.
Breast Neoplasms
Distribution of aldehyde dehydrogenase 1-positive stem cells in benign mammary tissue from women with and without breast cancer.
Breast Neoplasms
Doxorubicin and ?-Mangostin oppositely affect luminal breast cancer cell stemness evaluated by a new retinaldehyde-dependent ALDH assay in MCF-7 tumor spheroids.
Breast Neoplasms
Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study.
Breast Neoplasms
DUSP9-mediated reduction of pERK1/2 supports cancer stem cell-like traits and promotes triple negative breast cancer.
Breast Neoplasms
Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype.
Breast Neoplasms
Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism.
Breast Neoplasms
Erratum: Clinicopathologic Characteristics of Breast Cancer Stem Cells Identified on the Basis of Aldehyde Dehydrogenase 1 Expression.
Breast Neoplasms
Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor.
Breast Neoplasms
Evaluation of ALDH1 expression in ipsilateral breast cancer recurrence.
Breast Neoplasms
Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer.
Breast Neoplasms
Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women.
Breast Neoplasms
Expression of ALDH1 and TGF?2 in benign and malignant breast tumors and their prognostic implications.
Breast Neoplasms
Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases.
Breast Neoplasms
Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse.
Breast Neoplasms
Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer.
Breast Neoplasms
Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
Breast Neoplasms
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells.
Breast Neoplasms
Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer.
Breast Neoplasms
EZH2 and ALDH1 expression in ductal carcinoma in situ: complex association with recurrence and progression to invasive breast cancer.
Breast Neoplasms
Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.
Breast Neoplasms
Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer.
Breast Neoplasms
Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.
Breast Neoplasms
High Expression of c-Met, PKC? and ALDH1A3 Predicts a Poor Prognosis in Late-stage Breast Cancer.
Breast Neoplasms
High Expression of Stem Cell Marker ALDH1 is Associated with Reduced BRCA1 in Invasive Breast Carcinomas.
Breast Neoplasms
High PKC? expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients.
Breast Neoplasms
Identification of ALDH1A3 as a viable therapeutic target in breast cancer metastasis-initiating cells.
Breast Neoplasms
Identification of new cancer stem cell markers and signaling pathways in HER?2?positive breast cancer by transcriptome sequencing.
Breast Neoplasms
IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties.
Breast Neoplasms
Immunocytochemical stem cell markers can predict clinical stage of breast cancer.
Breast Neoplasms
In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.
Breast Neoplasms
Increased aldehyde dehydrogenase 1 (ALDH1) levels are associated with chemo-responsiveness in breast cancer patients treated with taxane-adriamycin-cyclophosphamide regimen.
Breast Neoplasms
Induced Expression of Cancer Stem Cell Markers ALDH1A3 and Sox-2 in Hierarchical Reconstitution of Apoptosis-resistant Human Breast Cancer Cells.
Breast Neoplasms
Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines.
Breast Neoplasms
Inhibition of breast cancer growth via miR-7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation.
Breast Neoplasms
Inhibitor of DNA-binding 4 contributes to the maintenance and expansion of cancer stem cells in 4T1 mouse mammary cancer cell line.
Breast Neoplasms
Interaction of the effects of alcohol drinking and polymorphisms in alcohol-metabolizing enzymes on the risk of female breast cancer in Japan.
Breast Neoplasms
Is ALDH1 a good method for definition of breast cancer stem cells?
Breast Neoplasms
Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR-7-TGFBR2-Smad3-CD44 regulatory axis.
Breast Neoplasms
Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion.
Breast Neoplasms
Limonin attenuates the stemness of breast cancer cells via suppressing MIR216A methylation.
Breast Neoplasms
Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness.
Breast Neoplasms
Long-term PM2.5 exposure increases the risk of non-small cell lung cancer (NSCLC) progression by enhancing interleukin-17a (IL-17a)-regulated proliferation and metastasis.
Breast Neoplasms
Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.
Breast Neoplasms
Measurement of Aldehyde Dehydrogenase 1 Expression Defines a Group with Better Prognosis in Patients with Non-Small Cell Lung Cancer.
Breast Neoplasms
miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitro.
Breast Neoplasms
miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
Breast Neoplasms
Molecular markers of therapeutic resistance in breast cancer.
Breast Neoplasms
Moving Forward in Human Mammary Stem Cell Biology and Breast Cancer Prognostication Using ALDH1.
Breast Neoplasms
Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1.
Breast Neoplasms
MUC1-C Oncoprotein Activates ERK->C/EBP? Signaling and Induction of Aldehyde Dehydrogenase 1A1 in Breast Cancer Cells.
Breast Neoplasms
MYC dysfunction modulates stemness and tumorigenesis in breast cancer.
Breast Neoplasms
Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo.
Breast Neoplasms
Nodal signaling activates the Smad2/3 pathway to regulate stem cell-like properties in breast cancer cells.
Breast Neoplasms
NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells.
Breast Neoplasms
Novel prognostic markers for patients with triple-negative breast cancer.
Breast Neoplasms
Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells.
Breast Neoplasms
P-Cadherin is Co-Expressed with Cd44 and Cd49f and Mediates Stem Cell Properties in Basal-Like Breast Cancer.
Breast Neoplasms
P2Y2R has a significant correlation with Notch-4 in patients with breast cancer.
Breast Neoplasms
Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance.
Breast Neoplasms
Preventive medical services not covered by public health insurance at Daiko Medical Center in Japan, 2004-2011.
Breast Neoplasms
Primary breast tumor levels of suspected molecular determinants of cellular sensitivity to cyclophosphamide, ifosfamide, and certain other anticancer agents as predictors of paired metastatic tumor levels of these determinants. Rational individualization of cancer chemotherapeutic regimens.
Breast Neoplasms
Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression.
Breast Neoplasms
Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer.
Breast Neoplasms
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.
Breast Neoplasms
Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients.
Breast Neoplasms
Prognostic value of aldehyde dehydrogenase 1 (ALDH1) in invasive breast carcinomas.
Breast Neoplasms
Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer.
Breast Neoplasms
Proliferation rate and breast cancer subtype, but not ALDH1 expression, predict pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.
Breast Neoplasms
Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1A1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM).
Breast Neoplasms
Radioresistant breast cancer cells exhibit increased resistance to chemotherapy and enhanced invasive properties due to cancer stem cells.
Breast Neoplasms
Relationship between alcohol metabolism and chemotherapy-induced emetic events in breast cancer patients.
Breast Neoplasms
RhoC Impacts the Metastatic Potential and Abundance of Breast Cancer Stem Cells.
Breast Neoplasms
RNA binding protein PUM2 promotes the stemness of breast cancer cells via competitively binding to neuropilin-1 (NRP-1) mRNA with miR-376a.
Breast Neoplasms
Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development.
Breast Neoplasms
Role of aldehyde dehydrogenases, alcohol dehydrogenase 1B genotype, alcohol consumption, and their combination in breast cancer in East-Asian women.
Breast Neoplasms
Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell growth and invasion.
Breast Neoplasms
Role of the CXCR4-LASP1 Axis in the Stabilization of Snail1 in Triple-Negative Breast Cancer.
Breast Neoplasms
Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Breast Neoplasms
SOX2 and ALDH1 as Predictors of Operable Breast Cancer.
Breast Neoplasms
Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients.
Breast Neoplasms
Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.
Breast Neoplasms
Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study.
Breast Neoplasms
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.
Breast Neoplasms
Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.
Breast Neoplasms
Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancer.
Breast Neoplasms
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1?/VEGF signalling in MCF-7 breast cancer cells.
Breast Neoplasms
Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.
Breast Neoplasms
Tamoxifen enhances stemness and promotes metastasis of ER?36
Breast Neoplasms
Tamoxifen induces a pluripotency signature in breast cancer cells and human tumors.
Breast Neoplasms
Tamoxifen, an anticancer drug, is an activator of human aldehyde dehydrogenase 1A1.
Breast Neoplasms
Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer.
Breast Neoplasms
The absence of aldehyde dehydrogenase 1 A1-positive cells in benign mammary stroma is associated with risk factors for breast cancer.
Breast Neoplasms
The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
Breast Neoplasms
The discordance between primary breast cancer lesions and pulmonary metastatic lesions in expression of aldehyde dehydrogenase 1-positive cancer cells.
Breast Neoplasms
The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.
Breast Neoplasms
The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association Consortium.
Breast Neoplasms
The functional role of the EZH2 gene in controlling breast cancer stem cells.
Breast Neoplasms
The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
Breast Neoplasms
The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population.
Breast Neoplasms
The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.
Breast Neoplasms
Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.
Breast Neoplasms
Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Breast Neoplasms
ZFHX3 Promotes the Proliferation and Tumor Growth of ER-Positive Breast Cancer Cells Likely by Enhancing Stem-Like Features and MYC and TBX3 Transcription.
Breast Neoplasms
[Advancement of studies on ALDH1 as a universal marker of stem cells].
Carcinogenesis
Across-site differences in the mechanism of alcohol-induced digestive tract carcinogenesis: an evaluation by mediation analysis.
Carcinogenesis
ADP-Ribosylation Factor Like GTPase 4C (ARL4C) augments stem-like traits of glioblastoma cells by upregulating ALDH1A3.
Carcinogenesis
Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics.
Carcinogenesis
Alcohol and aldehyde dehydrogenase gene polymorphisms influence susceptibility to esophageal cancer in Japanese alcoholics.
Carcinogenesis
Alcohol and cancer.
Carcinogenesis
Alcohol intake and folate antagonism via CYP2E1 and ALDH1: effects on oral carcinogenesis.
Carcinogenesis
Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.
Carcinogenesis
Aldehyde dehydrogenase 1 expression has prognostic significance in patients with glioma.
Carcinogenesis
Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.
Carcinogenesis
Aldehyde dehydrogenase 1A1 up-regulates stem cell markers in benzo[a]pyrene-induced malignant transformation of BEAS-2B cells.
Carcinogenesis
Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.
Carcinogenesis
Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancer.
Carcinogenesis
Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis.
Carcinogenesis
Aldehyde dehydrogenase 3A1 is robustly upregulated in gastric cancer stem-like cells and associated with tumorigenesis.
Carcinogenesis
ALDH1A1 Deficiency in Gorlin Syndrome Suggests a Central Role for Retinoic Acid and ATM Deficits in Radiation Carcinogenesis.
Carcinogenesis
ALDH1A1 positive cells are a unique component of the tonsillar crypt niche and are lost along with NGFR positive stem cells during tumourigenesis.
Carcinogenesis
Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer.
Carcinogenesis
ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/?-Catenin, Notch and PI3K/Akt Signaling Pathways.
Carcinogenesis
ALDH2 and Cancer Therapy.
Carcinogenesis
ALDH2 modulates autophagy flux to regulate acetaldehyde-mediated toxicity thresholds.
Carcinogenesis
ALDH2 Polymorphism and Ethanol Consumption: A Genetic-Environmental Interaction in Carcinogenesis.
Carcinogenesis
ALDH2 polymorphism for the risk of cervical carcinogenesis.
Carcinogenesis
All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells.
Carcinogenesis
Association Between ALDH2 Polymorphism and Gastric Cancer Risk in Terms of Alcohol Consumption: A Meta-Analysis.
Carcinogenesis
Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Carcinogenesis
Deficient expression of aldehyde dehydrogenase 1A1 is consistent with increased sensitivity of Gorlin syndrome patients to radiation carcinogenesis.
Carcinogenesis
Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133.
Carcinogenesis
DNA polymorphism and risk of esophageal squamous cell carcinoma in a population of North Xinjiang, China.
Carcinogenesis
Downregulation of ALDH1A1 expression in non-small cell lung carcinomas--its clinicopathologic and biological significance.
Carcinogenesis
Effects of long-term ethanol consumption and Aldh1b1 depletion on intestinal tumourigenesis in mice.
Carcinogenesis
Epigenetic therapy regulates the expression of ALDH1 and immunologic response: Relevance to the prognosis of oral cancer.
Carcinogenesis
Expression of ALDH1A1 and CD44 in primary head and neck squamous cell carcinoma and their value for carcinogenesis, tumor progression and cancer stem cell identification.
Carcinogenesis
Expression of cancer stem cell marker during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
Carcinogenesis
Gene expression profiling signatures for the diagnosis and prevention of oral cavity carcinogenesis-genome-wide analysis using RNA-seq technology.
Carcinogenesis
Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility.
Carcinogenesis
Grape pomace inhibits colon carcinogenesis by suppressing cell proliferation and inducing epigenetic modifications.
Carcinogenesis
High PKC? expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients.
Carcinogenesis
Human papillomavirus 16 (HPV16) enhances tumor growth and cancer stemness of HPV-negative oral/oropharyngeal squamous cell carcinoma cells via miR-181 regulation.
Carcinogenesis
Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Carcinogenesis
IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties.
Carcinogenesis
Increased expression of aldehyde dehydrogenase 1 A1 in nasopharyngeal carcinoma is associated with enhanced invasiveness.
Carcinogenesis
Increased Expression of ALDH1A1 in Prostate Cancer is Correlated With Tumor Aggressiveness: A Tissue Microarray Study of Iranian Patients.
Carcinogenesis
Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans.
Carcinogenesis
Integrated analysis reveals candidate mRNA and their potential roles in uterine leiomyomas.
Carcinogenesis
Mutation of the gene encoding the circadian clock component PERIOD2 in oncogenic cells confers chemoresistance by up-regulating the Aldh3a1 gene.
Carcinogenesis
NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells.
Carcinogenesis
p53 Protein accumulation, cancer multiplicity, and aldehyde dehydrogenase-2 genotype in Japanese alcoholic men with early esophageal squamous cell carcinoma.
Carcinogenesis
p53 protein accumulation, iodine-unstained lesions, and alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 genotypes in Japanese alcoholic men with esophageal dysplasia.
Carcinogenesis
Phosphorylation-dependent regulation of ALDH1A1 by Aurora kinase A: insights on their synergistic relationship in pancreatic cancer.
Carcinogenesis
Protective effects of Alda-1, an ALDH2 activator, on alcohol-derived DNA damage in the esophagus of human ALDH2*2 (Glu504Lys) knock-in mice.
Carcinogenesis
Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1A1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM).
Carcinogenesis
Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma.
Carcinogenesis
Relation of stem cell markers ALDH1 and CD44 with clinicopathological factors in urothelial carcinomas of urinary bladder.
Carcinogenesis
Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment.
Carcinogenesis
Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
Carcinogenesis
Single-PanIN-seq unveils that ARID1A deficiency promotes pancreatic tumorigenesis by attenuating KRAS-induced senescence.
Carcinogenesis
TAZ induces lung cancer stem cell properties and tumorigenesis by up-regulating ALDH1A1.
Carcinogenesis
The aldehyde dehydrogenase 2 (ALDH2) Glu504Lys polymorphism interacts with alcohol drinking in the risk of stomach cancer.
Carcinogenesis
The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment.
Carcinogenesis
Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Carcinogenesis
[Alcohol and oropharyngolaryngeal and digestive tract cancer]
Carcinoma
A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells.
Carcinoma
A perspective on challenges and opportunities in characterizing oral cancer stem cells.
Carcinoma
A prospective study of association of cancer stem cell marker aldehyde dehydrogenase 1 with clinicopathological profile in lung carcinoma patients.
Carcinoma
A retrospective review of the prognostic value of ALDH-1, Bmi-1 and Nanog stem cell markers in esophageal squamous cell carcinoma.
Carcinoma
ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
Carcinoma
ADH1B and ALDH2 polymorphisms and their associations with increased risk of squamous cell carcinoma of the head and neck in the Korean population.
Carcinoma
Alcohol abstinence and risk assessment for second esophageal cancer in Japanese men after mucosectomy for early esophageal cancer.
Carcinoma
Alcohol and aldehyde dehydrogenase polymorphisms and a new strategy for prevention and screening for cancer in the upper aerodigestive tract in East Asians.
Carcinoma
Aldehyde dehyderogenase (ALDH1A1) delineating the normal and cancer stem cells in spectral lung lesions: An immunohistochemical appraisal.
Carcinoma
Aldehyde dehydrogenase 1 (ALDH1) positivity correlates with poor prognosis in cervical cancer.
Carcinoma
Aldehyde dehydrogenase 1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma.
Carcinoma
Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.
Carcinoma
Aldehyde dehydrogenase 1 expression in basal cell carcinoma, actinic keratosis and Bowen's disease.
Carcinoma
Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study.
Carcinoma
Aldehyde Dehydrogenase 1 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
Carcinoma
Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.
Carcinoma
Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.
Carcinoma
Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
Carcinoma
Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
Carcinoma
Aldehyde Dehydrogenase-1 Expression Predicts Unfavorable Outcomes in Patients with Esophageal Squamous Cell Carcinoma.
Carcinoma
Aldehyde dehydrogenase-1 predicts favorable prognosis in patients with vulvar squamous cell carcinoma.
Carcinoma
ALDH1 expression correlates with favorable prognosis in ovarian cancers.
Carcinoma
ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinoma.
Carcinoma
ALDH1 in Combination with CD44 as Putative Cancer Stem Cell Markers are Correlated with Poor Prognosis in Urothelial Carcinoma of the Urinary Bladder.
Carcinoma
ALDH1 might influence the metastatic capability of HeLa cells.
Carcinoma
ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Carcinoma
ALDH1A1 maintains the cancer stem-like cells properties of esophageal squamous cell carcinoma by activating the AKT signal pathway and interacting with ?-catenin.
Carcinoma
ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer.
Carcinoma
ALDH2 1510 G/A (Glu487Lys) polymorphism interaction with age in head and neck squamous cell carcinoma.
Carcinoma
ALDH3A1 acts as a prognostic biomarker and inhibits the epithelial mesenchymal transition of oral squamous cell carcinoma through IL-6/STAT3 signaling pathway.
Carcinoma
Anticancer Activities of Thymus vulgaris L. in Experimental Breast Carcinoma in Vivo and in Vitro.
Carcinoma
Antineoplastic effects of clove buds (Syzygium aromaticum L.) in the model of breast carcinoma.
Carcinoma
Association of Genetic Polymorphisms of Aldehyde Dehydrogenase-2 and Cytochrome P450 2E1-RsaI and Alcohol Consumption with Oral Squamous Cell Carcinoma.
Carcinoma
Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
Carcinoma
BMI1, ALDH1A1, and CD133 Transcripts Connect Epithelial-Mesenchymal Transition to Cancer Stem Cells in Lung Carcinoma.
Carcinoma
Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
Carcinoma
Cancer stem cell markers ALDH1 and Bmi1 expression in oral erythroplakia revisited: Implication for driving the process of field cancerization.
Carcinoma
Cancer stem cell markers in eyelid sebaceous gland carcinoma: high expression of ALDH1, CD133, and ABCG2 correlates with poor prognosis.
Carcinoma
Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
Carcinoma
Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid.
Carcinoma
Casticin suppresses self-renewal and invasion of lung cancer stem-like cells from A549 cells through down-regulation of pAkt.
Carcinoma
CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
Carcinoma
Clinical significance of ALDH1 combined with DAPI expression in patients with esophageal carcinoma.
Carcinoma
Clinicopathological correlation of stem cell markers expression in oral squamous cell carcinoma; relation to patients` outcome.
Carcinoma
Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.
Carcinoma
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
Carcinoma
Comprehensive in situ analysis of ALDH1 and SOX2 reveals increased expression of stem cell markers in high-grade serous carcinomas compared to low-grade serous carcinomas and atypical proliferative serous tumors.
Carcinoma
Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.
Carcinoma
Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-?
Carcinoma
Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
Carcinoma
Correlations of ALDH2 rs671 and C12orf30 rs4767364 polymorphisms with increased risk and prognosis of esophageal squamous cell carcinoma in the Kazak and Han populations in Xinjiang province.
Carcinoma
Deficient aldehyde dehydrogenase 2 is associated with increased risk for esophageal squamous cell carcinoma in the presence of gastric hypochlorhydria.
Carcinoma
Dietary selenium intake, aldehyde dehydrogenase-2 and X-ray repair cross-complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma.
Carcinoma
Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
Carcinoma
Downregulation of ALDH1A1 expression in non-small cell lung carcinomas--its clinicopathologic and biological significance.
Carcinoma
Epigenetic therapy regulates the expression of ALDH1 and immunologic response: Relevance to the prognosis of oral cancer.
Carcinoma
Esophageal squamous cell carcinoma and aldehyde dehydrogenase-2 genotypes in Japanese females.
Carcinoma
Esophageal squamous cell carcinoma and ALDH2 and ADH1B polymorphisms in Chinese females.
Carcinoma
Evaluation of ALDH1 expression in ipsilateral breast cancer recurrence.
Carcinoma
Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma.
Carcinoma
Evaluation of the risk of metachronous multiple squamous cell carcinoma of the head and neck after transoral surgery based on the genetic polymorphisms of alcohol dehydrogenase 1B and aldehyde dehydrogenase 2.
Carcinoma
Expression and associations of TRAF1, BMI-1, ALDH1, and Lin28B in oral squamous cell carcinoma.
Carcinoma
Expression and functional role of ALDH1 in cervical carcinoma cells.
Carcinoma
Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma.
Carcinoma
Expression of ALDH1A1 and CD44 in primary head and neck squamous cell carcinoma and their value for carcinogenesis, tumor progression and cancer stem cell identification.
Carcinoma
Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer.
Carcinoma
Expression of CD44, CD44v9, ABCG2, CD24, Bmi-1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological factors.
Carcinoma
Expression of stem cell markers in oral cavity and oropharynx squamous cell carcinoma.
Carcinoma
Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy.
Carcinoma
Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity.
Carcinoma
Genetic modulation of ADH1B and ALDH2 polymorphisms with regard to alcohol and tobacco consumption for younger aged esophageal squamous cell carcinoma diagnosis.
Carcinoma
Genetic polymorphisms in cytochrome P4502E1, alcohol and aldehyde dehydrogenases and the risk of esophageal squamous cell carcinoma in Gansu Chinese males.
Carcinoma
Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma.
Carcinoma
Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility.
Carcinoma
Genomic characterization of early-stage esophageal squamous cell carcinoma in a Japanese population.
Carcinoma
Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma.
Carcinoma
GnRH participates in the self-renewal of A549-derived lung cancer stem-like cells through upregulation of the JNK signaling pathway.
Carcinoma
GRIK2 has a role in the maintenance of urothelial carcinoma stem-like cells, and its expression is associated with poorer prognosis.
Carcinoma
Heavy alcohol drinking downregulates ALDH2 gene expression but heavy smoking up-regulates SOD2 gene expression in head and neck squamous cell carcinoma.
Carcinoma
Helicobacter pylori, chronic atrophic gastritis, inactive aldehyde dehydrogenase-2, macrocytosis and multiple upper aerodigestive tract cancers and the risk for gastric cancer in alcoholic Japanese men.
Carcinoma
High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis.
Carcinoma
Identification of cytosolic aldehyde dehydrogenase 1 from non-small cell lung carcinomas as a flavopiridol-binding protein.
Carcinoma
Identification of Human Aldehyde Dehydrogenase 1 Family Member A1 as a Novel CD8+ T-Cell Defined Tumor Antigen in Squamous Cell Carcinoma of the Head and Neck.
Carcinoma
Immunolocalization of Cancer Stem Cells Marker ALDH1 and its Association with Tumor Budding in Oral Squamous Cell Carcinoma.
Carcinoma
Impact of alcohol dehydrogenase-aldehyde dehydrogenase polymorphism on clinical outcome in patients with hypopharyngeal cancer.
Carcinoma
Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma.
Carcinoma
Impairment of aldehyde dehydrogenase 2 increases accumulation of acetaldehyde-derived DNA damage in the esophagus after ethanol ingestion.
Carcinoma
In vitro and in vivo expression of aldehyde dehydrogenase 1 in oral squamous cell carcinoma.
Carcinoma
Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Carcinoma
Limitations of lymphoblastoid cell lines for functional analysis of SNPs.
Carcinoma
Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma.
Carcinoma
Macrocytosis, a new predictor for esophageal squamous cell carcinoma in Japanese alcoholic men.
Carcinoma
Meta-analysis of ADH1B and ALDH2 polymorphisms and esophageal cancer risk in China.
Carcinoma
Molecular Mechanisms of Acetaldehyde-Mediated Carcinogenesis in Squamous Epithelium.
Carcinoma
Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen.
Carcinoma
Multiple cancers associated with esophageal and oropharyngolaryngeal squamous cell carcinoma and the aldehyde dehydrogenase-2 genotype in male Japanese drinkers.
Carcinoma
Multiple primary esophageal and concurrent upper aerodigestive tract cancer and the aldehyde dehydrogenase-2 genotype of Japanese alcoholics.
Carcinoma
Neuregulin-1-?1 and ?-secretase play a critical role in sphere-formation and cell survival of urothelial carcinoma cancer stem-like cells.
Carcinoma
Normal and neoplastic urothelial stem cells: getting to the root of the problem.
Carcinoma
Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma.
Carcinoma
Overexpression of ALDH1 and EMT marker profile are linked with unfavorable outcome in head and neck cancer.
Carcinoma
p53 Protein accumulation, cancer multiplicity, and aldehyde dehydrogenase-2 genotype in Japanese alcoholic men with early esophageal squamous cell carcinoma.
Carcinoma
Predictive Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma.
Carcinoma
Prognostic Impact of ALDH1 Expression in Transitional Cell Carcinoma of the Renal Pelvis.
Carcinoma
Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract.
Carcinoma
Prognostic Implications of ALDH1 and Notch1 in Different Subtypes of Oral Cancer.
Carcinoma
Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Carcinoma
Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
Carcinoma
Prognostic Value of Drinking Status and Aldehyde Dehydrogenase 2 Polymorphism in Patients With Head and Neck Squamous Cell Carcinoma.
Carcinoma
Protein expression of CYP1A1, CYP1B1, ALDH1A1, and ALDH2 in young patients with oral squamous cell carcinoma.
Carcinoma
Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.
Carcinoma
Relation of stem cell markers ALDH1 and CD44 with clinicopathological factors in urothelial carcinomas of urinary bladder.
Carcinoma
Relationships of early esophageal cancer with human papillomavirus and alcohol metabolism.
Carcinoma
Rhus coriaria L. (Sumac) Demonstrates Oncostatic Activity in the Therapeutic and Preventive Model of Breast Carcinoma.
Carcinoma
Risk assessment of metachronous squamous cell carcinoma after endoscopic resection for esophageal carcinoma based on the genetic polymorphisms of alcoholdehydrogense-1B aldehyde dehydrogenase-2: temperance reduces the risk.
Carcinoma
Risk of metachronous squamous cell carcinoma in the upper aerodigestive tract of Japanese alcoholic men with esophageal squamous cell carcinoma: a long-term endoscopic follow-up study.
Carcinoma
Risk of squamous cell carcinoma of the upper aerodigestive tract in cancer-free alcoholic Japanese men: an endoscopic follow-up study.
Carcinoma
Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment.
Carcinoma
Spatial distribution of cancer stem cells in head and neck squamous cell carcinomas.
Carcinoma
Spectrum of ALDH1 mRNA in smokers and non-smokers with adenocarcinoma or squamous cell lung carcinoma.
Carcinoma
ST6Gal-I Protein Expression Is Upregulated in Human Epithelial Tumors and Correlates with Stem Cell Markers in Normal Tissues and Colon Cancer Cell Lines.
Carcinoma
Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles.
Carcinoma
Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells.
Carcinoma
The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study.
Carcinoma
The expression of ALDH1 in cervical carcinoma.
Carcinoma
The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
Carcinoma
Upregulation of stem cell markers ALDH1A1 and OCT4 as potential biomarkers for the early detection of cervical carcinoma.
Carcinoma
Vasculogenic mimicry and expression of ALDH1, Beclin1, and p16 correlate with metastasis and prognosis in oral squamous cell carcinoma.
Carcinoma
VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2.
Carcinoma
[Correlation between drinking behavior and polymorphisms of extracellular superoxide dismutase, aldehyde dehydrogenase 2 genes, and oral squamous cell carcinoma].
Carcinoma
[Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship with Ovarian Cancer Stem Cell Markers CD117, CD133, ALDH1.]
Carcinoma
[Expression of ALDH1, CXCR4 and E-cadherin in castric carcinoma and their roles in lymphatic metastasis].
Carcinoma
[Markers of stem cells and their prognostic values for urothelial carcinomas of the urinary tract].
Carcinoma in Situ
Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma.
Carcinoma in Situ
[Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
Carcinoma, Adenoid Cystic
ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinoma.
Carcinoma, Basal Cell
Aldehyde dehydrogenase 1 expression in basal cell carcinoma, actinic keratosis and Bowen's disease.
Carcinoma, Basal Cell
Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.
Carcinoma, Ductal
ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
Carcinoma, Ductal
Aberrant expression of ALDH1, MMP9, Integrin ?v?3, and KiSS-1 in invasive ductal carcinoma and their clinical significance.
Carcinoma, Ductal
Aldehyde dehydrogenase 1 expression correlates with the invasion of breast cancer.
Carcinoma, Ductal
Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinoma.
Carcinoma, Ductal
Clinicopathologic characteristics of breast cancer stem cells identified on the basis of aldehyde dehydrogenase 1 expression.
Carcinoma, Ductal
Clinicopathological analysis of breast ductal carcinoma in situ with ALDH1-positive cancer stem cells.
Carcinoma, Ductal
Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse.
Carcinoma, Ductal
EZH2 and ALDH1 expression in ductal carcinoma in situ: complex association with recurrence and progression to invasive breast cancer.
Carcinoma, Ductal
Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.
Carcinoma, Ductal
The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
Carcinoma, Embryonal
Expression of RALDHs (ALDH1As) and CYP26s in human tissues and during the neural differentiation of P19 embryonal carcinoma stem cell.
Carcinoma, Endometrioid
ALDH1 expression correlates with favorable prognosis in ovarian cancers.
Carcinoma, Endometrioid
Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications.
Carcinoma, Endometrioid
Inhibitory effect of Nodal on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma of uterus.
Carcinoma, Endometrioid
Roles of histamine on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma cell line.
Carcinoma, Endometrioid
Serum deprivation-response protein regulates aldehyde dehydrogenase 1 through integrin-linked kinase signaling in endometrioid carcinoma cells.
Carcinoma, Hepatocellular
A multiple mediator analysis approach to quantify the effects of the ADH1B and ALDH2 genes on hepatocellular carcinoma risk.
Carcinoma, Hepatocellular
AAV Gene Therapy for Alcoholism: Inhibition of Mitochondrial Aldehyde Dehydrogenase Enzyme Expression in Hepatoma Cells.
Carcinoma, Hepatocellular
Alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes, alcohol drinking and the risk of primary hepatocellular carcinoma in a chinese population.
Carcinoma, Hepatocellular
Alcohol Drinking Mediates the Association between Polymorphisms of ADH1B and ALDH2 and Hepatitis B-Related Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Aldehyde dehydrogenase (ALDH2) activity in hepatoma cells is reduced by an adenoviral vector coding for an ALDH2 antisense mRNA.
Carcinoma, Hepatocellular
Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Aldehyde dehydrogenase 1 is associated with recurrence-free survival but not stem cell-like properties in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis.
Carcinoma, Hepatocellular
Aldehyde dehydrogenase 3 expression is decreased by clofibrate via PPAR gamma induction in JM2 rat hepatoma cell line.
Carcinoma, Hepatocellular
Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice.
Carcinoma, Hepatocellular
ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
Carcinoma, Hepatocellular
ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway.
Carcinoma, Hepatocellular
Arachidonic acid suppresses growth of human lung tumor A549 cells through down-regulation of ALDH3A1 expression.
Carcinoma, Hepatocellular
Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Effects of hepatocarcinogenic initiators on aldehyde dehydrogenase gene expression in cultured rat hepatic cells.
Carcinoma, Hepatocellular
Eliciting the low-activity aldehyde dehydrogenase Asian phenotype by an antisense mechanism results in an aversion to ethanol.
Carcinoma, Hepatocellular
Evaluation of the selective toxic effect of the charge switchable diethyldithiocarbamate-loaded nanoparticles between hepatic normal and cancerous cells.
Carcinoma, Hepatocellular
Feedback inhibition of the retinaldehyde dehydrogenase gene ALDH1 by retinoic acid through retinoic acid receptor alpha and CCAAT/enhancer-binding protein beta.
Carcinoma, Hepatocellular
Genetic polymorphisms of ALDH2 and ADH2 are not associated with risk of hepatocellular carcinoma among East Asians.
Carcinoma, Hepatocellular
Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Hepatitis B and C viruses infection, lifestyle and genetic polymorphisms as risk factors for hepatocellular carcinoma in Haimen, China.
Carcinoma, Hepatocellular
Hepatocellular carcinoma associated with alcoholic liver disease: a clinicopathological study and genetic polymorphism of aldehyde dehydrogenase 2.
Carcinoma, Hepatocellular
High FOXK1 expression correlates with poor outcomes in hepatocellular carcinoma and regulates stemness of hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Increase in class 2 aldehyde dehydrogenase expression by arachidonic acid in rat hepatoma cells.
Carcinoma, Hepatocellular
Influence of alcohol consumption and gene polymorphisms of ADH2 and ALDH2 on hepatocellular carcinoma in a Japanese population.
Carcinoma, Hepatocellular
Inhibition of mitochondrial aldehyde dehydrogenase by nitric oxide-mediated S-nitrosylation.
Carcinoma, Hepatocellular
Mouse cytosolic class 3 aldehyde dehydrogenase (Aldh3a1): gene structure and regulation of constitutive and dioxin-inducible expression.
Carcinoma, Hepatocellular
mTOR/HDAC1 Crosstalk Mediated Suppression of ADH1A and ALDH2 Links Alcohol Metabolism to Hepatocellular Carcinoma Onset and Progression in silico.
Carcinoma, Hepatocellular
Preferential transcription of rabbit Aldh1a1 in the cornea: implication of hypoxia-related pathways.
Carcinoma, Hepatocellular
Quantitative histochemistry of benzaldehyde dehydrogenase in hepatocellular carcinomas of vinyl chloride-treated rats.
Carcinoma, Hepatocellular
Relationship between alcohol drinking, ADH2 and ALDH2 genotypes, and risk for hepatocellular carcinoma in Japanese.
Carcinoma, Hepatocellular
Relationship of ALDH2 rs671 and CYP2E1 rs2031920 with hepatocellular carcinoma susceptibility in East Asians: a meta-analysis.
Carcinoma, Hepatocellular
The Defective Allele of Aldehyde Dehydrogenase 2 Gene is Associated with Favorable Postoperative Prognosis in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
The effect of a novel irreversible inhibitor of aldehyde dehydrogenases 1 and 3 on tumour cell growth and death.
Carcinoma, Hepatocellular
The novel aldehyde dehydrogenase gene, ALDH5, encodes an active aldehyde dehydrogenase enzyme.
Carcinoma, Hepatocellular
The transcriptional regulation of human aldehyde dehydrogenase I gene. The structural and functional analysis of the promoter.
Carcinoma, Hepatocellular
Use of an "acetaldehyde clamp" in the determination of low-KM aldehyde dehydrogenase activity in H4-II-E-C3 rat hepatoma cells.
Carcinoma, Intraductal, Noninfiltrating
Aldehyde dehydrogenase 1 expression correlates with the invasion of breast cancer.
Carcinoma, Intraductal, Noninfiltrating
Characterization of a stem-like subpopulation in basal-like ductal carcinoma in situ (DCIS) lesions.
Carcinoma, Intraductal, Noninfiltrating
Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer.
Carcinoma, Intraductal, Noninfiltrating
EZH2 and ALDH1 expression in ductal carcinoma in situ: complex association with recurrence and progression to invasive breast cancer.
Carcinoma, Intraductal, Noninfiltrating
Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.
Carcinoma, Neuroendocrine
High ALDH1A1 expression indicates a poor prognosis in gastric neuroendocrine carcinoma.
Carcinoma, Non-Small-Cell Lung
A prospective study of association of cancer stem cell marker aldehyde dehydrogenase 1 with clinicopathological profile in lung carcinoma patients.
Carcinoma, Non-Small-Cell Lung
Aldehyde Dehydrogenase 1 (ALDH1) Promotes the Toxicity of TRAIL in Non-Small Cell Lung Cancer Cells via Post-Transcriptional Regulation of MEK-1 Expression.
Carcinoma, Non-Small-Cell Lung
Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: identification of prognostic microenvironmental factors after chemoradiation.
Carcinoma, Non-Small-Cell Lung
Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
Carcinoma, Non-Small-Cell Lung
Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
Carcinoma, Non-Small-Cell Lung
Aldehyde dehydrogenases in early stage lung cancer: nuclear expression.
Carcinoma, Non-Small-Cell Lung
ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors.
Carcinoma, Non-Small-Cell Lung
Casticin suppresses self-renewal and invasion of lung cancer stem-like cells from A549 cells through down-regulation of pAkt.
Carcinoma, Non-Small-Cell Lung
Downregulation of ALDH1A1 expression in non-small cell lung carcinomas--its clinicopathologic and biological significance.
Carcinoma, Non-Small-Cell Lung
Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.
Carcinoma, Non-Small-Cell Lung
Garcinol from Garcinia indica Downregulates Cancer Stem-like Cell Biomarker ALDH1A1 in Nonsmall Cell Lung Cancer A549 Cells through DDIT3 Activation.
Carcinoma, Non-Small-Cell Lung
Ginsenoside Rg3 attenuates the osimertinib resistance by reducing the stemness of non-small cell lung cancer cells.
Carcinoma, Non-Small-Cell Lung
GnRH participates in the self-renewal of A549-derived lung cancer stem-like cells through upregulation of the JNK signaling pathway.
Carcinoma, Non-Small-Cell Lung
Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Measurement of Aldehyde Dehydrogenase 1 Expression Defines a Group with Better Prognosis in Patients with Non-Small Cell Lung Cancer.
Carcinoma, Non-Small-Cell Lung
Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
Carcinoma, Non-Small-Cell Lung
Serum ALDH1A1 is a tumor marker for the diagnosis of non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
Carcinoma, Non-Small-Cell Lung
The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
Carcinoma, Ovarian Epithelial
ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome.
Carcinoma, Ovarian Epithelial
ALDH1A1 contributes to PARP inhibitor resistance via enhancing DNA repair in BRCA2-/- ovarian cancer cells.
Carcinoma, Ovarian Epithelial
ALDH1A1 Is a Novel EZH2 Target Gene in Epithelial Ovarian Cancer Identified by Genome-Wide Approaches.
Carcinoma, Ovarian Epithelial
ALDH1A2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating STAT3.
Carcinoma, Ovarian Epithelial
High Expressions of Lgr5 and ALDH1 in Primary Epithelial Ovarian Cancer Correlate with Advanced Tumor Stage and Grade as well as Poor Prognosis of the Patients.
Carcinoma, Ovarian Epithelial
[Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship with Ovarian Cancer Stem Cell Markers CD117, CD133, ALDH1.]
Carcinoma, Pancreatic Ductal
Aldehyde Dehydrogenase 1B1 as a Modulator of Pancreatic Adenocarcinoma.
Carcinoma, Renal Cell
Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study.
Carcinoma, Renal Cell
Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.
Carcinoma, Renal Cell
Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Carcinoma, Renal Cell
VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2.
Carcinoma, Squamous Cell
ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
Carcinoma, Squamous Cell
ADH1B and ALDH2 polymorphisms and their associations with increased risk of squamous cell carcinoma of the head and neck in the Korean population.
Carcinoma, Squamous Cell
Alcohol and aldehyde dehydrogenase polymorphisms and a new strategy for prevention and screening for cancer in the upper aerodigestive tract in East Asians.
Carcinoma, Squamous Cell
Aldehyde dehyderogenase (ALDH1A1) delineating the normal and cancer stem cells in spectral lung lesions: An immunohistochemical appraisal.
Carcinoma, Squamous Cell
Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.
Carcinoma, Squamous Cell
Aldehyde dehydrogenase-1 predicts favorable prognosis in patients with vulvar squamous cell carcinoma.
Carcinoma, Squamous Cell
ALDH2 1510 G/A (Glu487Lys) polymorphism interaction with age in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid.
Carcinoma, Squamous Cell
Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.
Carcinoma, Squamous Cell
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
Carcinoma, Squamous Cell
Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.
Carcinoma, Squamous Cell
Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
Carcinoma, Squamous Cell
Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
Carcinoma, Squamous Cell
Evaluation of the risk of metachronous multiple squamous cell carcinoma of the head and neck after transoral surgery based on the genetic polymorphisms of alcohol dehydrogenase 1B and aldehyde dehydrogenase 2.
Carcinoma, Squamous Cell
Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Expression of ALDH1A1 and CD44 in primary head and neck squamous cell carcinoma and their value for carcinogenesis, tumor progression and cancer stem cell identification.
Carcinoma, Squamous Cell
Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer.
Carcinoma, Squamous Cell
Expression of stem cell markers in oral cavity and oropharynx squamous cell carcinoma.
Carcinoma, Squamous Cell
Genetic polymorphisms in cytochrome P4502E1, alcohol and aldehyde dehydrogenases and the risk of esophageal squamous cell carcinoma in Gansu Chinese males.
Carcinoma, Squamous Cell
Heavy alcohol drinking downregulates ALDH2 gene expression but heavy smoking up-regulates SOD2 gene expression in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Identification of Human Aldehyde Dehydrogenase 1 Family Member A1 as a Novel CD8+ T-Cell Defined Tumor Antigen in Squamous Cell Carcinoma of the Head and Neck.
Carcinoma, Squamous Cell
Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Macrocytosis, a new predictor for esophageal squamous cell carcinoma in Japanese alcoholic men.
Carcinoma, Squamous Cell
Molecular Mechanisms of Acetaldehyde-Mediated Carcinogenesis in Squamous Epithelium.
Carcinoma, Squamous Cell
Multiple cancers associated with esophageal and oropharyngolaryngeal squamous cell carcinoma and the aldehyde dehydrogenase-2 genotype in male Japanese drinkers.
Carcinoma, Squamous Cell
Overexpression of ALDH1 and EMT marker profile are linked with unfavorable outcome in head and neck cancer.
Carcinoma, Squamous Cell
p53 Protein accumulation, cancer multiplicity, and aldehyde dehydrogenase-2 genotype in Japanese alcoholic men with early esophageal squamous cell carcinoma.
Carcinoma, Squamous Cell
Predictive Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Prognostic Implications of ALDH1 and Notch1 in Different Subtypes of Oral Cancer.
Carcinoma, Squamous Cell
Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Prognostic Value of Drinking Status and Aldehyde Dehydrogenase 2 Polymorphism in Patients With Head and Neck Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.
Carcinoma, Squamous Cell
Risk assessment of metachronous squamous cell carcinoma after endoscopic resection for esophageal carcinoma based on the genetic polymorphisms of alcoholdehydrogense-1B aldehyde dehydrogenase-2: temperance reduces the risk.
Carcinoma, Squamous Cell
Risk of metachronous squamous cell carcinoma in the upper aerodigestive tract of Japanese alcoholic men with esophageal squamous cell carcinoma: a long-term endoscopic follow-up study.
Carcinoma, Squamous Cell
Risk of squamous cell carcinoma of the upper aerodigestive tract in cancer-free alcoholic Japanese men: an endoscopic follow-up study.
Carcinoma, Squamous Cell
Spatial distribution of cancer stem cells in head and neck squamous cell carcinomas.
Carcinoma, Squamous Cell
Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells.
Carcinoma, Squamous Cell
The expression of ALDH1 in cervical carcinoma.
Carcinoma, Squamous Cell
The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
Carcinoma, Transitional Cell
Prognostic Impact of ALDH1 Expression in Transitional Cell Carcinoma of the Renal Pelvis.
Carcinoma, Verrucous
Prognostic Implications of ALDH1 and Notch1 in Different Subtypes of Oral Cancer.
Cardiomegaly
A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: Role of AMPK-regulated autophagy.
Cardiomegaly
Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells.
Cardiomegaly
Aldehyde dehydrogenase 2 deficiency blunts compensatory cardiac hypertrophy through modulating Akt phosphorylation early after transverse aorta constriction in mice.
Cardiomegaly
Aldehyde dehydrogenase-2 (ALDH2) ameliorates chronic alcohol ingestion-induced myocardial insulin resistance and endoplasmic reticulum stress.
Cardiomegaly
Complex Inhibition of Autophagy by Mitochondrial Aldehyde Dehydrogenase Shortens Lifespan and Exacerbates Cardiac Aging.
Cardiomegaly
Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin.
Cardiomegaly
Increased clearance of reactive aldehydes and damaged proteins in hypertension-induced compensated cardiac hypertrophy: impact of exercise training.
Cardiomegaly
Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function.
Cardiomegaly
Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction.
Cardiomyopathies
Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
Cardiomyopathies
Aldehyde dehydrogenase 2 protects cardiomyocytes against lipotoxicity via the AKT/glycogen synthase kinase 3 beta pathways.
Cardiomyopathies
Aldehyde Dehydrogenase-2 Attenuates Myocardial Remodeling and Contractile Dysfunction Induced by a High-Fat Diet.
Cardiomyopathies
Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1.
Cardiomyopathies
ALDH2 protects against high fat diet-induced obesity cardiomyopathy and defective autophagy: role of CaM kinase II, histone H3K9 methyltransferase SUV39H, Sirt1, and PGC-1? deacetylation.
Cardiomyopathies
Correction to: ALDH2 protects against high fat diet-induced obesity cardiomyopathy and defective autophagy: role of CaM kinase II, histone H3K9 methyltransferase SUV39H, Sirt1, and PGC-1? deacetylation.
Cardiomyopathies
Mitochondrial aldehyde dehydrogenase obliterates insulin resistance-induced cardiac dysfunction through deacetylation of PGC-1?.
Cardiomyopathy, Alcoholic
Acetaldehyde and alcoholic cardiomyopathy: lessons from the ADH and ALDH2 transgenic models.
Cardiomyopathy, Alcoholic
Aldehyde dehydrogenase 2 knockout accentuates ethanol-induced cardiac depression: Role of protein phosphatases.
Cardiomyopathy, Alcoholic
ALDH2 in alcoholic heart diseases: Molecular mechanism and clinical implications.
Cardiomyopathy, Alcoholic
ALDH2 protects against alcoholic cardiomyopathy through a mechanism involving the p38 MAPK/CREB pathway and local renin-angiotensin system inhibition in cardiomyocytes.
Cardiomyopathy, Alcoholic
Attenuation of acetaldehyde-induced cell injury by overexpression of aldehyde dehydrogenase-2 (ALDH2) transgene in human cardiac myocytes: role of MAP kinase signaling.
Cardiomyopathy, Alcoholic
Deficiency of insulin-like growth factor 1 reduces vulnerability to chronic alcohol intake-induced cardiomyocyte mechanical dysfunction: Role of AMPK.
Cardiomyopathy, Dilated
Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
Cardiotoxicity
Aldehyde dehydrogenase 2 activation ameliorates cyclophosphamide-induced acute cardiotoxicity via detoxification of toxic aldehydes and suppression of cardiac cell death.
Cardiotoxicity
Aldehyde dehydrogenase 2 ameliorates acute cardiac toxicity of ethanol: role of protein phosphatase and forkhead transcription factor.
Cardiotoxicity
ALDH2 attenuates Dox-induced cardiotoxicity by inhibiting cardiac apoptosis and oxidative stress.
Cardiotoxicity
ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation.
Cardiotoxicity
Cardioprotection induced by a brief exposure to acetaldehyde:role of aldehyde dehydrogenase 2.
Cardiotoxicity
Mitochondrial aldehyde dehydrogenase protects against doxorubicin cardiotoxicity through a transient receptor potential channel vanilloid 1-mediated mechanism.
Cardiovascular Diseases
Acetaldehyde dehydrogenase 2 (ALDH2) deficiency exacerbates pressure overload-induced cardiac dysfunction by inhibiting Beclin-1 dependent autophagy pathway.
Cardiovascular Diseases
Acetaldehyde dehydrogenase 2 interactions with LDLR and AMPK regulate foam cell formation.
Cardiovascular Diseases
Acetaldehyde Dehydrogenase 2 regulates HMG-CoA reductase stability and cholesterol synthesis in the liver.
Cardiovascular Diseases
Alda-1, an Aldehyde Dehydrogenase 2 Agonist, Improves Cutaneous Wound Healing by Activating Epidermal Keratinocytes via Akt/GSK-3?/?-Catenin Pathway.
Cardiovascular Diseases
Aldehyde dehydrogenase 2 protects against acute kidney injury by regulating autophagy via the Beclin-1 pathway.
Cardiovascular Diseases
Aldehyde Dehydrogenase-2 Roles in Ischemic Cardiovascular Disease.
Cardiovascular Diseases
ALDH2 activation inhibited cardiac fibroblast-to-myofibroblast transformation via TGF-?1/Smad signaling pathway.
Cardiovascular Diseases
ALDH2 and Cardiovascular Disease.
Cardiovascular Diseases
ALDH2 in alcoholic heart diseases: Molecular mechanism and clinical implications.
Cardiovascular Diseases
ALDH2 protects against high fat diet-induced obesity cardiomyopathy and defective autophagy: role of CaM kinase II, histone H3K9 methyltransferase SUV39H, Sirt1, and PGC-1? deacetylation.
Cardiovascular Diseases
ALDH2 rs671 polymorphism and the risk of heart failure with preserved ejection fraction (HFpEF) in patients with cardiovascular diseases.
Cardiovascular Diseases
ALDH2*2 Allele is a Negative Risk Factor for Cerebral Infarction in Chinese Women.
Cardiovascular Diseases
Association between Carotid Intima-media Thickness and Aldehyde Dehydrogenase 2 Glu504Lys Polymorphism in Chinese Han with Essential Hypertension.
Cardiovascular Diseases
Association of an aldehyde dehydrogenase 2 (ALDH2) gene polymorphism with hyper-low-density lipoprotein cholesterolemia in a Japanese population.
Cardiovascular Diseases
Confirmation of ALDH2 as a Major Locus of Drinking Behavior and of Its Variants Regulating Multiple Metabolic Phenotypes in a Japanese Population.
Cardiovascular Diseases
Epidemiologic study of the association of low-Km mitochondrial acetaldehyde dehydrogenase genotypes with blood pressure level and the prevalence of hypertension in a general population.
Cardiovascular Diseases
Glu504Lys Single Nucleotide Polymorphism of Aldehyde Dehydrogenase 2 Gene and the Risk of Human Diseases.
Cardiovascular Diseases
Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3? and mitochondrial function.
Cardiovascular Diseases
Mitochondrial aldehyde dehydrogenase and cardiac diseases.
Cardiovascular Diseases
Not just correlative: a new pathway defines how an ALDH2 SNP contributes to atherosclerosis.
Cardiovascular Diseases
Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: An update.
Cardiovascular Diseases
Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.
Cardiovascular Diseases
The ALDH2 rs671 polymorphism affects post-stroke epilepsy susceptibility and plasma 4-HNE levels.
Cardiovascular Diseases
The effect of ALDH2 rs671 gene mutation on clustering of cardiovascular risk factors in a big data study of Chinese population: associations differ between the sexes.
Cardiovascular Diseases
The potential of aldehyde dehydrogenase 2 as a therapeutic target in cardiovascular disease.
Carotid Artery Diseases
Effects of aldehyde dehydrogenase genotypes on carotid atherosclerosis.
Carotid Artery Diseases
The polymorphism in acetaldehyde dehydrogenase 2 gene, causing a substitution of Glu > Lys(504), is not associated with coronary atherosclerosis severity in Han Chinese.
Cataract
Characterization of Two Distinct Structural Classes of Selective Aldehyde Dehydrogenase 1A1 Inhibitors.
Cataract
Corneal haze phenotype in Aldh3a1-null mice: In vivo confocal microscopy and tissue imaging mass spectrometry.
Cataract
Molecular characterization of the human lens epithelium-derived cell line SRA01/04.
Cataract
Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice.
Cerebral Amyloid Angiopathy
Mitochondrial aldehyde dehydrogenase-2 activation prevents ? amyloids induced endothelial cell dysfunction and restores angiogenesis.
Cerebral Infarction
Aldehyde Dehydrogenase 2 (ALDH2) Glu504Lys Polymorphism Affects Collateral Circulation and Short-Term Prognosis of Acute Cerebral Infarction Patients.
Cerebral Infarction
ALDH2 and Stroke: A Systematic Review of the Evidence.
Cerebral Infarction
ALDH2*2 Allele is a Negative Risk Factor for Cerebral Infarction in Chinese Women.
Cerebral Infarction
Association Between the Polymorphism of Aldehyde Dehydrogenase 2 Gene and Cerebral Infarction in a Hakka Population in Southern China.
Cheilitis
Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer.
Chemical and Drug Induced Liver Injury
Identification of Serum Biomarkers to Distinguish Hazardous and Benign Aminotransferase Elevations.
Chemical and Drug Induced Liver Injury
Prospective study of ALDH1A1 gene polymorphisms associated with antituberculosis drug-induced liver injury in Western Chinese Han population.
Cholangiocarcinoma
ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma Patients.
Cholangiocarcinoma
Loss of ARID1A induces a stemness gene ALDH1A1 expression with histone acetylation in the malignant subtype of cholangiocarcinoma.
Cholangiocarcinoma
Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway.
Cholecystitis
Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Cholestasis
Identification of Serum Biomarkers to Distinguish Hazardous and Benign Aminotransferase Elevations.
Chondrosarcoma
Proline?rich polypeptide?1 decreases cancer stem cell population by targeting BAFF chromatin?remodeling complexes in human chondrosarcoma JJ012 cells.
Colitis
Notch Balances Th17 and Induced Regulatory T Cell Functions in Dendritic Cells by Regulating Aldh1a2 Expression.
Colitis
Taraxacum officinale extract ameliorates dextran sodium sulphate-induced colitis by regulating fatty acid degradation and microbial dysbiosis.
Coloboma
A homozygous mutation in a consanguineous family consolidates the role of ALDH1A3 in autosomal recessive microphthalmia.
Colonic Neoplasms
Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer.
Colonic Neoplasms
Aldehyde Dehydrogenase 1B1 Is Associated with Altered Cell Morphology, Proliferation, Migration and Chemosensitivity in Human Colorectal Adenocarcinoma Cells.
Colonic Neoplasms
ALDH1A3 affects colon cancer in vitro proliferation and invasion depending on CXCR4 status.
Colonic Neoplasms
ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/?-Catenin, Notch and PI3K/Akt Signaling Pathways.
Colonic Neoplasms
Association of aldehyde dehydrogenase 2 gene polymorphism with pancreatic cancer but not colon cancer.
Colonic Neoplasms
Colon cancer stem cells: implications in carcinogenesis.
Colonic Neoplasms
Colon cancer: cancer stem cells markers, drug resistance and treatment.
Colonic Neoplasms
Combination of aging and dimethylhydrazine treatment causes an increase in cancer-stem cell population of rat colonic crypts.
Colonic Neoplasms
Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.
Colonic Neoplasms
Eugenia jambolana (Java Plum) Fruit Extract Exhibits Anti-Cancer Activity against Early Stage Human HCT-116 Colon Cancer Cells and Colon Cancer Stem Cells.
Colonic Neoplasms
Expression Analysis of Aldehyde Dehydrogenase 1A1 (ALDH1A1) in Colon and Rectal Cancer in Association with Prognosis and Response to Chemotherapy.
Colonic Neoplasms
Expression of Aldehyde Dehydrogenase (ALDH1) and ATP Binding Cassette Transporter G2 (ABCG2) in Iraqi Patients with Colon Cancer and the Relation with Clinicopathological Features.
Colonic Neoplasms
Expression of aldehyde dehydrogenase 1 in colon cancer.
Colonic Neoplasms
Expression pattern of ALDH1, E-cadherin, Vimentin and Twist in early and late onset sporadic colorectal cancer.
Colonic Neoplasms
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells.
Colonic Neoplasms
Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer.
Colonic Neoplasms
Objective analysis of cancer stem cell marker expression using immunohistochemistry.
Colonic Neoplasms
The heparan sulfate proteoglycan syndecan-1 regulates colon cancer stem cell function via a focal adhesion kinase-Wnt signaling axis.
Colonic Neoplasms
The impact of Aldehyde dehydrogenase 1 expression on prognosis for metastatic colon cancer.
Colonic Neoplasms
[Prognostic values of the clinical, morphological and molecular biological characteristics of colon adenocarcinoma].
Colorectal Neoplasms
A gene-gene interaction between ALDH2 Glu487Lys and ADH2 His47Arg polymorphisms regarding the risk of colorectal cancer in Japan.
Colorectal Neoplasms
A novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern Chinese population.
Colorectal Neoplasms
A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro.
Colorectal Neoplasms
ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.
Colorectal Neoplasms
Across-site differences in the mechanism of alcohol-induced digestive tract carcinogenesis: an evaluation by mediation analysis.
Colorectal Neoplasms
Alcohol and cancer.
Colorectal Neoplasms
Alcohol dehydrogenase and aldehyde dehydrogenase polymorphisms and colorectal cancer: the Fukuoka Colorectal Cancer Study.
Colorectal Neoplasms
Aldehyde Dehydragenase 1 and Nodal as Significant Prognostic Markers in Colorectal Cancer.
Colorectal Neoplasms
Aldehyde dehydrogenase 1: A specific cancer stem cell marker for human colorectal carcinoma.
Colorectal Neoplasms
Aldehyde dehydrogenase 1B1 is a potential marker of colorectal tumors.
Colorectal Neoplasms
Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancer.
Colorectal Neoplasms
Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced Colorectal Cancer Immune Escape through Stabilizing PD-L1 Expression.
Colorectal Neoplasms
ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
Colorectal Neoplasms
ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells.
Colorectal Neoplasms
ALDH2 gene polymorphism in different types of cancers and its clinical significance.
Colorectal Neoplasms
Association between aldehyde dehydrogenase 2 (ALDH2) Glu504Lys polymorphism and susceptibility to colorectal cancer: a meta-analysis.
Colorectal Neoplasms
Association between ALDH2 and ADH1B Polymorphisms and the Risk for Colorectal Cancer in Koreans.
Colorectal Neoplasms
Association of ADH1B Arg47His and ALDH2 Glu487Lys polymorphisms with risk of colorectal cancer and their interaction with environmental factors in a Chinese population.
Colorectal Neoplasms
CEACAM1 is associated with recurrence after hepatectomy for colorectal liver metastasis.
Colorectal Neoplasms
Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer.
Colorectal Neoplasms
Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas.
Colorectal Neoplasms
Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis.
Colorectal Neoplasms
Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma.
Colorectal Neoplasms
Colorectal cancer stem cell: a potential therapeutic target.
Colorectal Neoplasms
Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer.
Colorectal Neoplasms
Cross-talk between YAP and RAR-RXR Drives Expression of Stemness Genes to Promote 5-FU Resistance and Self-Renewal in Colorectal Cancer Cells.
Colorectal Neoplasms
Distinct patterns of ALDH1A1 expression predict metastasis and poor outcome of colorectal carcinoma.
Colorectal Neoplasms
Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.
Colorectal Neoplasms
Evaluation of the Role of ALDH1 as Cancer Stem Cell Marker in Colorectal Carcinoma: An Immunohistochemical Study.
Colorectal Neoplasms
Expression Analysis of Aldehyde Dehydrogenase 1A1 (ALDH1A1) in Colon and Rectal Cancer in Association with Prognosis and Response to Chemotherapy.
Colorectal Neoplasms
Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma.
Colorectal Neoplasms
Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
Colorectal Neoplasms
Expression pattern of ALDH1, E-cadherin, Vimentin and Twist in early and late onset sporadic colorectal cancer.
Colorectal Neoplasms
Folate, alcohol, ADH1B and ALDH2 and colorectal cancer risk.
Colorectal Neoplasms
Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer.
Colorectal Neoplasms
Genotype difference of aldehyde dehydrogenase 2 gene in alcohol drinkers influences the incidence of Japanese colorectal cancer patients.
Colorectal Neoplasms
Interplay between APC and ALDH1B1 in a newly developed mouse model of colorectal cancer.
Colorectal Neoplasms
L1CAM, CA9, KLK6, HPN, and ALDH1A1 as Potential Serum Markers in Primary and Metastatic Colorectal Cancer Screening.
Colorectal Neoplasms
Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer.
Colorectal Neoplasms
Meta-analysis of the ADH1B and ALDH2 polymorphisms and the risk of colorectal cancer in East Asians.
Colorectal Neoplasms
Meta-analysis of the aldehyde dehydrogenases-2 (ALDH2) Glu487Lys polymorphism and colorectal cancer risk.
Colorectal Neoplasms
MIR600HG suppresses metastasis and enhances oxaliplatin chemosensitivity by targeting ALDH1A3 in colorectal cancer.
Colorectal Neoplasms
Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
Colorectal Neoplasms
Polymorphisms in alcohol metabolism genes ADH1B and ALDH2, alcohol consumption and colorectal cancer.
Colorectal Neoplasms
Polymorphisms of alcohol dehydrogenase 2 and aldehyde dehydrogenase 2 and colorectal cancer risk in Chinese males.
Colorectal Neoplasms
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
Colorectal Neoplasms
Prognostic value of ALDH1 and Nestin in advanced cancer: a systematic meta-analysis with trial sequential analysis.
Colorectal Neoplasms
Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Colorectal Neoplasms
Protein Markers Associated with an ALDH Sub-Population in Colorectal Cancer.
Colorectal Neoplasms
Reduction of NANOG Mediates the Inhibitory Effect of Aspirin on Tumor Growth and Stemness in Colorectal Cancer.
Colorectal Neoplasms
Relation of the CD36 gene A52C polymorphism to the risk of colorectal cancer among Japanese, with reference to with the aldehyde dehydrogenase 2 gene Glu487Lys polymorphism and drinking habit.
Colorectal Neoplasms
The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
Colorectal Neoplasms
The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer.
Colorectal Neoplasms
The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Colorectal Neoplasms
TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-?1.
Colorectal Neoplasms
Verification of ALDH Activity as a Biomarker in Colon Cancer Stem Cells-Derived HT-29 Cell Line.
Colorectal Neoplasms
[CD133(+) Colo205 colorectal cancer cells express high levels of ALDH1 in serum-free culture].
Colorectal Neoplasms
[Role of alcohol-metabolizing enzymes gene polymorphisms and environmental exposure on colorectal cancer: a case-only study].
Congenital Abnormalities
Maternal aldehyde elimination during pregnancy preserves the fetal genome.
Congenital Abnormalities
The Bidirectional Effect of Defective ALDH2 Polymorphism and Disease Prevention.
Contracture
Robotic-assisted latissimus dorsi harvest in delayed-immediate breast reconstruction.
Corneal Edema
Protective effect of aldehyde dehydrogenase 2 against rat corneal dysfunction caused by streptozotocin-induced type I diabetes.
Coronary Artery Disease
Aldehyde dehydrogenase 2 (ALDH2) polymorphism gene and coronary artery disease risk: a meta-analysis.
Coronary Artery Disease
Aldehyde dehydrogenase 2 polymorphism as a protective factor for intracranial vascular stenosis in ischemic stroke in Han Chinese.
Coronary Artery Disease
ALDH2 deficiency inhibits Ox-LDL induced foam cell formation via suppressing CD36 expression.
Coronary Artery Disease
ALDH2 gene G487A polymorphism and coronary artery disease: a meta-analysis including 5644 participants.
Coronary Artery Disease
ALDH2 Glu504Lys polymorphism and susceptibility to coronary artery disease and myocardial infarction in East Asians: a meta-analysis.
Coronary Artery Disease
Association between ALDH2 Glu504Lys Polymorphism and Susceptibility to Coronary Artery Disease and Myocardial Infarction: Need for Clarification of Data in a Recent Meta-analysis.
Coronary Artery Disease
Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardial infarction: a meta-analysis.
Coronary Artery Disease
Associations of common variants at ALDH2 gene and the risk of stroke in patients with coronary artery diseases undergoing percutaneous coronary intervention.
Coronary Artery Disease
Combined effects of current-smoking and the aldehyde dehydrogenase 2*2 allele on the risk of myocardial infarction in Japanese patients.
Coronary Artery Disease
East Asians Variant Mitochondrial Aldehyde Dehydrogenase 2 Genotype Exacerbates Nitrate Tolerance in Patients With Coronary Spastic Angina.
Coronary Artery Disease
Genetic risk score (GRS) constructed from polymorphisms in the PON1, IL-6, ITGB3, and ALDH2 genes is associated with the risk of coronary artery disease in Pakistani subjects.
Coronary Artery Disease
Impact of Genetic Variation in Aldehyde Dehydrogenase 2 and Alcohol Consumption on Coronary Artery Lesions in Chinese Patients with Stable Coronary Artery Disease.
Coronary Artery Disease
Impacts of common variants in ALDH2 on coronary artery disease patients.
Coronary Artery Disease
Interactions between ALDH2 rs671 polymorphism and lifestyle behaviors on coronary artery disease risk in a Chinese Han population with dyslipidemia: A guide to targeted heart health management.
Coronary Artery Disease
Mitochondrial aldehyde dehydrogenase in myocardial ischemia-reperfusion injury: from bench to bedside.
Coronary Artery Disease
Relationship between ALDH2 genotype and in-stent restenosis in Chinese Han patients after percutaneous coronary intervention.
Coronary Artery Disease
Reply to: ALDH2 Glu504Lys Polymorphism and Susceptibility to Coronary Artery Disease and Myocardial Infarction in East Asians: A Meta-analysis.
Coronary Artery Disease
The ALDH2 Glu504Lys polymorphism is associated with coronary artery disease in Han Chinese: Relation with endothelial ADMA levels.
Coronary Artery Disease
The Glu504Lys polymorphism of aldehyde dehydrogenase 2 contributes to development of coronary artery disease.
Coronary Artery Disease
The polymorphism in acetaldehyde dehydrogenase 2 gene, causing a substitution of Glu > Lys(504), is not associated with coronary atherosclerosis severity in Han Chinese.
Coronary Disease
Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells.
Coronary Disease
Aldehyde dehydrogenase 2 inhibits inflammatory response and regulates atherosclerotic plaque.
Coronary Disease
ALDH2 rs671 Polymorphism and coronary heart disease risk among Asian populations: a meta-analysis and meta-regression.
Coronary Disease
ALDH2 rs671 polymorphism and the risk of heart failure with preserved ejection fraction (HFpEF) in patients with cardiovascular diseases.
Coronary Disease
Associations of common variants at ALDH2 gene and the risk of stroke in patients with coronary artery diseases undergoing percutaneous coronary intervention.
Coronary Disease
Genotyping on ALDH2: comparison of four different technologies.
Coronary Disease
Mitochondrial aldehyde dehydrogenase in myocardial ischemia-reperfusion injury: from bench to bedside.
Coronary Disease
The impact of ALDH2 activation by Alda-1 on the expression of VEGF in the hippocampus of a rat model of post-MI depression.
Coronary Disease
[Correlation of aldehyde dehydrogenase-2 gene polymorphism with hypertension in patients with coronary heart disease complicated by diabetes mellitus].
Coronary Disease
[The relationship between aldehyde dehydrogenase-2 gene polymorphisms and efficacy of nitroglycerin]
Coronary Stenosis
Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells.
Cryptorchidism
[Expression changes of aldehyde dehydrogenase 1A1 in rat cryptorchidism and normal testis].
Cystadenoma
Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression.
Cystitis
Aldh2 gene reduces oxidative stress in the bladder by regulating the NF-?B pathway in a mouse model of ketamine-induced cystitis.
Cysts
A homozygous mutation in a consanguineous family consolidates the role of ALDH1A3 in autosomal recessive microphthalmia.
Cysts
The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae.
Dehydration
Cloning of the black seabream (Acanthopagrus schlegeli) antiquitin gene and functional characterization of its promoter region.
Dehydration
Ethylene Glycol Metabolism in the Acetogen Acetobacterium woodii.
Dehydration
Sequence and functional analyses of the aldehyde dehydrogenase 7B4 gene promoter in Arabidopsis thaliana and selected Brassicaceae: regulation patterns in response to wounding and osmotic stress.
Dementia
Assessment of association between mitochondrial aldehyde dehydrogenase polymorphism and Alzheimer's disease in an older Korean population.
Dementia
Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment.
Dementia
Formaldehyde induces diabetes-associated cognitive impairments.
Dementia
Preventive effects of Chlorella on cognitive decline in age-dependent dementia model mice.
Dermatitis
[Polymorphisms of aldehyde and alcohol dehydrogenase genes associated with susceptibility to trichloroethylene-induced medicamentosa-like dermatitis]
Dermatitis, Atopic
Functional study of acetaldehyde dehydrogenase 1 (ALDH1) in keratinocytes: Microarray integrating bioinformatics approaches.
Diabetes Complications
Association of Genetically Determined Aldehyde Dehydrogenase 2 Activity with Diabetic Complications in Relation to Alcohol Consumption in Japanese Patients with Type 2 Diabetes Mellitus: The Fukuoka Diabetes Registry.
Diabetes Complications
Diabetic Aldehyde Dehydrogenase 2 Mutant (ALDH2*2) Mice Are More Susceptible to Cardiac Ischemic-Reperfusion Injury Due to 4-Hydroxy-2-Nonenal Induced Coronary Endothelial Cell Damage.
Diabetes Complications
Inactive aldehyde dehydrogenase 2 worsens glycemic control in patients with type 2 diabetes mellitus who drink low to moderate amounts of alcohol.
Diabetes Mellitus
A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: Role of AMPK-regulated autophagy.
Diabetes Mellitus
Activation of ALDH2 with Low Concentration of Ethanol Attenuates Myocardial Ischemia/Reperfusion Injury in Diabetes Rat Model.
Diabetes Mellitus
Aldehyde dehydrogenase 2 genotype in type 1 diabetes mellitus.
Diabetes Mellitus
ALDH2 genetic polymorphism and the risk of type II diabetes mellitus in CAD patients.
Diabetes Mellitus
ALDH2 rs671 polymorphism and the risk of heart failure with preserved ejection fraction (HFpEF) in patients with cardiovascular diseases.
Diabetes Mellitus
Association between aldehyde dehydrogenase 2 polymorphisms and the incidence of diabetic retinopathy among Japanese subjects with type 2 diabetes mellitus.
Diabetes Mellitus
Association of Genetically Determined Aldehyde Dehydrogenase 2 Activity with Diabetic Complications in Relation to Alcohol Consumption in Japanese Patients with Type 2 Diabetes Mellitus: The Fukuoka Diabetes Registry.
Diabetes Mellitus
Changes in cardiac mitochondrial aldehyde dehydrogenase 2 activity in relation to oxidative stress and inflammatory injury in diabetic rats.
Diabetes Mellitus
Genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 and liver cirrhosis, chronic calcific pancreatitis, diabetes mellitus, and hypertension among Japanese alcoholic men.
Diabetes Mellitus
Human-induced pluripotent stem cell approaches to model inborn and acquired metabolic heart diseases.
Diabetes Mellitus
Inactive aldehyde dehydrogenase 2 worsens glycemic control in patients with type 2 diabetes mellitus who drink low to moderate amounts of alcohol.
Diabetes Mellitus
Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: An update.
Diabetes Mellitus
Targeting acetaldehyde dehydrogenase 2 (ALDH2) in heart failure-Recent insights and perspectives.
Diabetes Mellitus
The Glu504Lys polymorphism of aldehyde dehydrogenase 2 contributes to development of coronary artery disease.
Diabetes Mellitus
ULK1-regulated autophagy: A mechanism in cellular protection for ALDH2 against hyperglycemia.
Diabetes Mellitus
[Aldehyde dehydrogenase 2(ALDH2) gene polymorphism in NIDDM patients with chronic renal failure]
Diabetes Mellitus, Type 1
Aldehyde dehydrogenase 2 genotype in type 1 diabetes mellitus.
Diabetes Mellitus, Type 2
ALDH2 rs671 Is Associated With Elevated FPG, Reduced Glucose Clearance and Hepatic Insulin Resistance in Japanese Men.
Diabetes Mellitus, Type 2
ALDH2/ADH2 polymorphism associated with vasculopathy and neuropathy in type 2 diabetes.
Diabetes Mellitus, Type 2
Association between aldehyde dehydrogenase 2 polymorphisms and the incidence of diabetic retinopathy among Japanese subjects with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Association of aldehyde dehydrogenase with inheritance of NIDDM.
Diabetes Mellitus, Type 2
Association of Genetically Determined Aldehyde Dehydrogenase 2 Activity with Diabetic Complications in Relation to Alcohol Consumption in Japanese Patients with Type 2 Diabetes Mellitus: The Fukuoka Diabetes Registry.
Diabetes Mellitus, Type 2
Deficiency of mitochondrial aldehyde dehydrogenase increases type 2 diabetes risk in males via autophagy dysregulation.
Diabetes Mellitus, Type 2
Downregulation of the acetyl-CoA metabolic network in adipose tissue of obese diabetic individuals and recovery after weight loss.
Diabetes Mellitus, Type 2
Inactive aldehyde dehydrogenase 2 worsens glycemic control in patients with type 2 diabetes mellitus who drink low to moderate amounts of alcohol.
Diabetes Mellitus, Type 2
Mitochondrial aldehyde dehydrogenase in diabetes associated with mitochondrial tRNA(Leu(UUR)) mutation at position 3243.
Diabetes Mellitus, Type 2
[Aldehyde dehydrogenase 2(ALDH2) gene polymorphism in NIDDM patients with chronic renal failure]
Diabetes Mellitus, Type 2
[Correlation of aldehyde dehydrogenase-2 gene polymorphism with hypertension in patients with coronary heart disease complicated by diabetes mellitus].
Diabetic Cardiomyopathies
A Novel ALDH2 Activator AD-9308 Improves Diastolic and Systolic Myocardial Functions in Streptozotocin-Induced Diabetic Mice.
Diabetic Cardiomyopathies
A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: Role of AMPK-regulated autophagy.
Diabetic Cardiomyopathies
Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3? and mitochondrial function.
Diabetic Nephropathies
ALDH2/ADH2 polymorphism associated with vasculopathy and neuropathy in type 2 diabetes.
Diabetic Retinopathy
ALDH2 attenuates early-stage STZ-induced aged diabetic rats retinas damage via Sirt1/Nrf2 pathway.
Diabetic Retinopathy
Association between aldehyde dehydrogenase 2 polymorphisms and the incidence of diabetic retinopathy among Japanese subjects with type 2 diabetes mellitus.
Diabetic Retinopathy
Association of aldehyde dehydrogenase with inheritance of NIDDM.
Diabetic Retinopathy
Meta-Analysis on the Association of ALDH2 Polymorphisms and Type 2 Diabetic Mellitus, Diabetic Retinopathy.
Drug-Related Side Effects and Adverse Reactions
Aldehyde dehydrogenases and cell proliferation.
Dupuytren Contracture
Common Variants of the ALDH2 and DHDH Genes and the Risk of Dupuytren's Disease.
Dupuytren Contracture
[A coexistence of the Dupuytren's disease and malignant neoplasms: a review].
Dyskinesias
ALDH1A1 regulates postsynaptic ?-opioid receptor expression in dorsal striatal projection neurons and mitigates dyskinesia through transsynaptic retinoic acid signaling.
Dyslipidemias
Acetaldehyde Dehydrogenase 2 rs671 Polymorphism Affects Hypertension Susceptibility and Lipid Profiles in a Chinese Population.
Dyslipidemias
Interactions between ALDH2 rs671 polymorphism and lifestyle behaviors on coronary artery disease risk in a Chinese Han population with dyslipidemia: A guide to targeted heart health management.
Dyslipidemias
The Glu504Lys polymorphism of aldehyde dehydrogenase 2 contributes to development of coronary artery disease.
Encephalitis
Systems Pharmacology-Based Approach to Comparatively Study the Independent and Synergistic Mechanisms of Danhong Injection and Naoxintong Capsule in Ischemic Stroke Treatment.
Endometrial Hyperplasia
ALDH1 expression predicts progression of premalignant lesions to cancer in Type I endometrial carcinomas.
Endometrial Neoplasms
ALDH1 expression predicts progression of premalignant lesions to cancer in Type I endometrial carcinomas.
Endometrial Neoplasms
Bioinformatic analysis of four miRNAs relevant to metastasis-regulated processes in endometrial carcinoma.
Endometrial Neoplasms
The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer.
Endometriosis
Aberrant reactive aldehyde detoxification by ALDH2 influences endometriosis development and pain-associated behaviors.
Endometriosis
CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis.
Endometriosis
Expression Levels of the Oxidative Stress Response Gene ALDH3A2 in Granulosa-Lutein Cells Are Related to Female Age and Infertility Diagnosis.
Endometriosis
Expression of ALDH1A Isozymes in Human Endometrium with and without Endometriosis and in Ovarian Endometrioma.
Epilepsy
Quantitative Proteomic Analysis To Identify Differentially Expressed Proteins in Myocardium of Epilepsy Using iTRAQ Coupled with Nano-LC-MS/MS.
Epilepsy
The ALDH2 rs671 polymorphism affects post-stroke epilepsy susceptibility and plasma 4-HNE levels.
Erythema
[Associations between ALDH2 and ADH1B Genotypes and Ethanol-Induced Cutaneous Erythema in Young Japanese Women].
Esophageal Neoplasms
A health-risk appraisal model and endoscopic mass screening for esophageal cancer in Japanese men.
Esophageal Neoplasms
A variant allele of ADH1B and ALDH2, is associated with the risk of esophageal cancer.
Esophageal Neoplasms
Acetaldehyde inhibits the formation of retinoic acid from retinal in the rat esophagus.
Esophageal Neoplasms
Advances in cancer epidemiology in Japan.
Esophageal Neoplasms
Alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes, alcohol drinking and the risk for esophageal cancer in a Chinese population.
Esophageal Neoplasms
Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men.
Esophageal Neoplasms
Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach.
Esophageal Neoplasms
Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics.
Esophageal Neoplasms
Aldehyde dehydrogenase-2 genotypes and HLA haplotypes in Japanese patients with esophageal cancer.
Esophageal Neoplasms
ALDH2 gene polymorphism in different types of cancers and its clinical significance.
Esophageal Neoplasms
Analysis of risk factors for post-operative complications and prognostic predictors of disease recurrence following definitive treatment of patients with esophageal cancer from two medical centers in Northwest China.
Esophageal Neoplasms
Association between ALDH2 Glu487Lys polymorphism and the risk of esophageal cancer.
Esophageal Neoplasms
Association between ALDH2 polymorphism and esophageal cancer risk in South Koreans: a case-control study.
Esophageal Neoplasms
Association of aldehyde dehydrogenase 2 gene polymorphism with pancreatic cancer but not colon cancer.
Esophageal Neoplasms
Association of genetic polymorphisms of aldehyde dehydrogenase-2 with esophageal squamous cell dysplasia.
Esophageal Neoplasms
Association of low-activity ALDH2 and alcohol consumption with risk of esophageal cancer in Chinese adults: A population-based cohort study.
Esophageal Neoplasms
Cancer screening of upper aerodigestive tract in Japanese alcoholics with reference to drinking and smoking habits and aldehyde dehydrogenase-2 genotype.
Esophageal Neoplasms
CD14 promoter polymorphism in Chinese alcoholic patients with cirrhosis of liver and acute pancreatitis.
Esophageal Neoplasms
Chinese alcoholic patients with esophageal cancer are genetically different from alcoholics with acute pancreatitis and liver cirrhosis.
Esophageal Neoplasms
Clinical significance of ALDH2 rs671 polymorphism in esophageal cancer: evidence from 31 case-control studies.
Esophageal Neoplasms
Combination of ADH1B*2/ALDH2*2 polymorphisms alters acetaldehyde-derived DNA damage in the blood of Japanese alcoholics.
Esophageal Neoplasms
Correlations of ALDH2 rs671 and C12orf30 rs4767364 polymorphisms with increased risk and prognosis of esophageal squamous cell carcinoma in the Kazak and Han populations in Xinjiang province.
Esophageal Neoplasms
Effect of ALDH2 polymorphism on cancer risk in Asians: A meta-analysis.
Esophageal Neoplasms
Esophageal cancer and aldehyde dehydrogenase-2 genotypes in Japanese males.
Esophageal Neoplasms
Esophageal cancer risk by ALDH2 and ADH2 polymorphisms and alcohol consumption: exploration of gene-environment and gene-gene interactions.
Esophageal Neoplasms
Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract.
Esophageal Neoplasms
Expression of aldehyde dehydrogenase 2 in the normal esophageal epithelium and alcohol consumption in patients with esophageal cancer.
Esophageal Neoplasms
Facial flushing after alcohol intake as a predictor for a high risk of synchronous or metachronous cancer of the upper gastrointestinal tract.
Esophageal Neoplasms
Functional Variants in ADH1B and ALDH2 Coupled With Alcohol and Smoking Synergistically Enhance Esophageal Cancer Risk.
Esophageal Neoplasms
Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer.
Esophageal Neoplasms
Gene-environment Interactions and Polymorphism Studies of Cancer Risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II).
Esophageal Neoplasms
Genetic polymorphism of aldehyde dehydrogenase 2 in patients with upper aerodigestive tract cancer.
Esophageal Neoplasms
Genetic Polymorphism of Aldehyde Dehydrogenase 2 in Patients With Upper Aerodigestive Tract Cancer.
Esophageal Neoplasms
Genetic polymorphisms and esophageal cancer risk.
Esophageal Neoplasms
Genetic polymorphisms of ADH2 and ALDH2 association with esophageal cancer risk in southwest China.
Esophageal Neoplasms
Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma.
Esophageal Neoplasms
Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers.
Esophageal Neoplasms
Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility.
Esophageal Neoplasms
Hepatocellular carcinoma in heavy drinkers with negative markers for viral hepatitis.
Esophageal Neoplasms
Identifying genetic variation for alcohol dependence.
Esophageal Neoplasms
Interactive effects of lifetime alcohol consumption and alcohol and aldehyde dehydrogenase polymorphisms on esophageal cancer risks.
Esophageal Neoplasms
Lifestyle habits and genetic susceptibility and the risk of esophageal cancer in the Thai population.
Esophageal Neoplasms
Mean corpuscular volume and the aldehyde dehydrogenase-2 genotype in male Japanese workers.
Esophageal Neoplasms
Meta-analysis of ADH1B and ALDH2 polymorphisms and esophageal cancer risk in China.
Esophageal Neoplasms
Meta-analysis of ALDH2 variants and esophageal cancer in Asians.
Esophageal Neoplasms
Multifocal accumulation of p53 protein in esophageal carcinoma: evidence for field cancerization.
Esophageal Neoplasms
p53 protein accumulation, iodine-unstained lesions, and alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 genotypes in Japanese alcoholic men with esophageal dysplasia.
Esophageal Neoplasms
Polymorphisms of alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 and esophageal cancer risk in Southeast Chinese males.
Esophageal Neoplasms
Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance.
Esophageal Neoplasms
Relationship between alcohol drinking, ADH2 and ALDH2 genotypes, and risk for hepatocellular carcinoma in Japanese.
Esophageal Neoplasms
Relationship between genetic polymorphisms of alcohol and aldehyde dehydrogenases and esophageal squamous cell carcinoma risk in males.
Esophageal Neoplasms
Relationship between genetic polymorphisms of ALDH2 and ADH1B and esophageal cancer risk: a meta-analysis.
Esophageal Neoplasms
Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment.
Esophageal Neoplasms
Short-term follow-up after endoscopic mucosectomy of early esophageal cancer and aldehyde dehydrogenase-2 genotype in Japanese alcoholics.
Esophageal Neoplasms
Single nucleotide polymorphisms of ADH1B, ADH1C and ALDH2 genes and esophageal cancer: A population-based case-control study in china.
Esophageal Neoplasms
Specific Smad2/3 Linker Phosphorylation Indicates Esophageal Non-neoplastic and Neoplastic Stem-Like Cells and Neoplastic Development.
Esophageal Neoplasms
Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol Ingestion.
Esophageal Neoplasms
The effect of ethanol on the formation of N?((2))-ethylidene-dG adducts in mice: implications for alcohol-related carcinogenicity of the oral cavity and esophagus.
Esophageal Neoplasms
[Alcohol and oropharyngolaryngeal and digestive tract cancer]
Esophageal Neoplasms
[Field cancerization and field therapy - the therapy of actinic keratosis by imiquimod].
Esophageal Neoplasms
[Genetic polymorphisms of ADH1B and ALDH-2 associated with risk of esophageal cancer: a meta-analysis].
Esophageal Neoplasms
[Genetic polymorphisms of alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 associated with the susceptibility on esophageal cancer]
Esophageal Squamous Cell Carcinoma
A retrospective review of the prognostic value of ALDH-1, Bmi-1 and Nanog stem cell markers in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Alcohol abstinence and risk assessment for second esophageal cancer in Japanese men after mucosectomy for early esophageal cancer.
Esophageal Squamous Cell Carcinoma
Aldehyde Dehydrogenase 1 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
Esophageal Squamous Cell Carcinoma
Aldehyde Dehydrogenase-1 Expression Predicts Unfavorable Outcomes in Patients with Esophageal Squamous Cell Carcinoma.
Esophageal Squamous Cell Carcinoma
ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
ALDH1A1 maintains the cancer stem-like cells properties of esophageal squamous cell carcinoma by activating the AKT signal pathway and interacting with ?-catenin.
Esophageal Squamous Cell Carcinoma
Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
Esophageal Squamous Cell Carcinoma
Correlations of ALDH2 rs671 and C12orf30 rs4767364 polymorphisms with increased risk and prognosis of esophageal squamous cell carcinoma in the Kazak and Han populations in Xinjiang province.
Esophageal Squamous Cell Carcinoma
Deficient aldehyde dehydrogenase 2 is associated with increased risk for esophageal squamous cell carcinoma in the presence of gastric hypochlorhydria.
Esophageal Squamous Cell Carcinoma
Dietary selenium intake, aldehyde dehydrogenase-2 and X-ray repair cross-complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Esophageal squamous cell carcinoma and aldehyde dehydrogenase-2 genotypes in Japanese females.
Esophageal Squamous Cell Carcinoma
Esophageal squamous cell carcinoma and ALDH2 and ADH1B polymorphisms in Chinese females.
Esophageal Squamous Cell Carcinoma
Genetic modulation of ADH1B and ALDH2 polymorphisms with regard to alcohol and tobacco consumption for younger aged esophageal squamous cell carcinoma diagnosis.
Esophageal Squamous Cell Carcinoma
Genetic polymorphisms in cytochrome P4502E1, alcohol and aldehyde dehydrogenases and the risk of esophageal squamous cell carcinoma in Gansu Chinese males.
Esophageal Squamous Cell Carcinoma
Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility.
Esophageal Squamous Cell Carcinoma
Genomic characterization of early-stage esophageal squamous cell carcinoma in a Japanese population.
Esophageal Squamous Cell Carcinoma
Impairment of aldehyde dehydrogenase 2 increases accumulation of acetaldehyde-derived DNA damage in the esophagus after ethanol ingestion.
Esophageal Squamous Cell Carcinoma
Macrocytosis, a new predictor for esophageal squamous cell carcinoma in Japanese alcoholic men.
Esophageal Squamous Cell Carcinoma
Meta-analysis of ADH1B and ALDH2 polymorphisms and esophageal cancer risk in China.
Esophageal Squamous Cell Carcinoma
p53 Protein accumulation, cancer multiplicity, and aldehyde dehydrogenase-2 genotype in Japanese alcoholic men with early esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Relationships of early esophageal cancer with human papillomavirus and alcohol metabolism.
Esophageal Squamous Cell Carcinoma
Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment.
Esophageal Squamous Cell Carcinoma
Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles.
Essential Hypertension
Acetaldehyde dehydrogenase 2 SNP rs671 and susceptibility to essential hypertension in Mongolians: a case control study.
Essential Hypertension
ALDH2 Gene rs671 Polymorphism May Decrease the Risk of Essential Hypertension.
Essential Hypertension
Association Between ALDH-2 rs671 and Essential Hypertension Risk or Blood Pressure Levels: A Systematic Review and Meta-Analysis.
Essential Hypertension
Association between Carotid Intima-media Thickness and Aldehyde Dehydrogenase 2 Glu504Lys Polymorphism in Chinese Han with Essential Hypertension.
Essential Hypertension
Association of a functional single-nucleotide polymorphism in the ALDH2 gene with essential hypertension depends on drinking behavior in a Chinese Han population.
Essential Hypertension
Association of the Glu504Lys polymorphism in the aldehyde dehydrogenase 2 gene with endothelium-dependent dilation disorder in Chinese Han patients with essential hypertension.
Essential Hypertension
Common single nucleotide polymorphisms in Japanese patients with essential hypertension: aldehyde dehydrogenase 2 gene as a risk factor independent of alcohol consumption.
Essential Hypertension
Meta-analysis of association between ALDH2 rs671 polymorphism and essential hypertension in Asian populations.
Essential Hypertension
Positive association between ALDH2 rs671 polymorphism and essential hypertension: A case-control study and meta-analysis.
Essential Hypertension
The ALDH2 gene rs671 polymorphism is not associated with essential hypertension.
Exfoliation Syndrome
Quantitative analysis of SOD2, ALDH1A1 and MGST1 messenger ribonucleic acid in anterior lens epithelium of patients with pseudoexfoliation syndrome.
Eye Diseases
Aldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring.
Fanconi Anemia
Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells.
Fanconi Anemia
Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.
Fanconi Anemia
Digenic mutations in ALDH2 and ADH5 impair formaldehyde clearance and cause a multisystem disorder, AMeD syndrome.
Fanconi Anemia
Genetic Study of Fanconi Anemia in Infancy Revealed FANCI Mutations and Defective ALDH2 Variant: A Case Report.
Fanconi Anemia
Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function.
Fanconi Anemia
Maternal aldehyde elimination during pregnancy preserves the fetal genome.
Fanconi Anemia
Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.
Fanconi Anemia
The phenotype and clinical course of Japanese Fanconi Anaemia infants is influenced by patient, but not maternal ALDH2 genotype.
Fanconi Anemia
Transcriptional Silencing of ALDH2 Confers a Dependency on Fanconi Anemia Proteins in Acute Myeloid Leukemia.
Fanconi Anemia
Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients.
Fatty Liver
Aldehyde Dehydrogenase 2 (ALDH2) in Rat Fatty Liver Cold Ischemia Injury.
Fatty Liver
Aldehyde dehydrogenase 2 and beta3-adrenergic receptor gene polymorphisms: their association with elevated liver enzymes and metabolic syndrome.
Fatty Liver
ALDH2 Deficiency Promotes Ethanol-Induced Gut Barrier Dysfunction and Fatty Liver in Mice.
Fatty Liver
Associations among liver disease, serum lipid profile, body mass index, ketonuria, meal skipping, and the alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 genotypes in Japanese men with alcohol dependence.
Fatty Liver
Bioinformatic and biochemical findings disclosed anti-hepatic steatosis mechanism of calycosin.
Fatty Liver
Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice.
Fatty Liver
Role of PEG35, Mitochondrial ALDH2, and Glutathione in Cold Fatty Liver Graft Preservation: An IGL-2 Approach.
Fatty Liver
Slow-metabolizing ADH1B and inactive heterozygous ALDH2 increase vulnerability to fatty liver in Japanese men with alcohol dependence.
Fatty Liver
SREBP1c mediates the effect of acetaldehyde on Cidea expression in Alcoholic fatty liver Mice.
Fatty Liver
The Association and Interaction of Aldehyde Dehydrogenase 2 Polymorphisms with Food Group Intake and Probability of Having Non-Alcoholic Fatty Liver Disease.
Fatty Liver
Vinyl chloride-induced interaction of nonalcoholic and toxicant-associated steatohepatitis: Protection by the ALDH2 activator Alda-1.
Fatty Liver, Alcoholic
Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice.
Fetal Alcohol Spectrum Disorders
Loss of the TGF-? Effector ?2SP Promotes Genomic Instability.
Fetal Alcohol Spectrum Disorders
Loss of the transforming growth factor-? effector ?2-Spectrin promotes genomic instability.
Fetal Alcohol Spectrum Disorders
The fetal alcohol syndrome: symptoms and pathogenesis.
Fibroadenoma
Expression of ALDH1 and TGF?2 in benign and malignant breast tumors and their prognostic implications.
Food Hypersensitivity
Ginger Increases ALDH1A1 Expression and Enhances Retinoic Acid Signaling in a Human Colonic Epithelial Cell Line.
Gallbladder Neoplasms
Positive ALDH1A3 and negative GPX3 expressions are biomarkers for poor prognosis of gallbladder cancer.
Gastritis
Cancer stem cells in Helicobacter pylori infection and aging: Implications for gastric carcinogenesis.
Gastritis, Atrophic
Acetaldehyde and gastric cancer.
Gastritis, Atrophic
Acetaldehyde as a common denominator and cumulative carcinogen in digestive tract cancers.
Gastritis, Atrophic
Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population.
Gastritis, Atrophic
Helicobacter pylori, chronic atrophic gastritis, inactive aldehyde dehydrogenase-2, macrocytosis and multiple upper aerodigestive tract cancers and the risk for gastric cancer in alcoholic Japanese men.
Gastritis, Atrophic
Risk factors for esophageal iodine-unstained lesions and changing trends among Japanese alcohol-dependent men (2003-2018).
Genetic Diseases, Inborn
Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.
Glaucoma
Alcohol consumption is associated with glaucoma severity regardless of ALDH2 polymorphism.
Glioblastoma
A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro.
Glioblastoma
ADP-Ribosylation Factor Like GTPase 4C (ARL4C) augments stem-like traits of glioblastoma cells by upregulating ALDH1A3.
Glioblastoma
Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity.
Glioblastoma
Aldehyde dehydrogenase 1A3 (ALDH1A3) is regulated by autophagy in human glioblastoma cells.
Glioblastoma
ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients.
Glioblastoma
ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma.
Glioblastoma
Development of Selective Inhibitors for Human Aldehyde Dehydrogenase 3A1 (ALDH3A1) for the Enhancement of Cyclophosphamide Cytotoxicity.
Glioblastoma
Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma.
Glioblastoma
Genome-wide methylation profiling reveals new biomarkers for prognosis prediction of glioblastoma.
Glioblastoma
Hypoxia upregulates aldehyde dehydrogenase isoform 1 (ALDH1) expression and induces functional stem cell characteristics in human glioblastoma cells.
Glioblastoma
Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro.
Glioblastoma
Prognostic Value of ALDH1A3 Promoter Methylation in Gliob;astoma: A Single Center Experience in Western China.
Glioblastoma
Retinoid resistance and multifaceted impairment of retinoic acid synthesis in glioblastoma.
Glioblastoma
Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells.
Glioblastoma
The predominant expression of cancer stem cell marker ALDH1A3 in tumor infiltrative area is associated with shorter overall survival of human glioblastoma.
Glioblastoma
USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.
Glioma
Aldehyde dehydrogenase 1 expression has prognostic significance in patients with glioma.
Glioma
Aldehyde dehydrogenase 1A1 circumscribes high invasive glioma cells and predicts poor prognosis.
Glioma
ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients.
Glioma
ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma.
Glioma
ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion.
Glioma
BRD4 promotes glioma cell stemness via enhancing miR-142-5p-mediated activation of Wnt/?-catenin signaling.
Glioma
CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2.
Glioma
Crystal structure of human aldehyde dehydrogenase 1A3 complexed with NAD(+) and retinoic acid.
Glioma
FOXD1-ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells.
Glioma
High expression of ALDH1A3 might independently influence poor progression-free and overall survival in patients with glioma via maintaining glucose uptake and lactate production.
Glioma
KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.
Glioma
Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
Glioma
Regulation of gliomagenesis and stemness through acid sensor ASIC1a.
Glioma
Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential.
Glioma
The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
Glioma
TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways.
Glioma
TRPM7 Induces Tumorigenesis and Stemness Through Notch Activation in Glioma.
Glucose Intolerance
Aldehyde dehydrogenase 2 and beta3-adrenergic receptor gene polymorphisms: their association with elevated liver enzymes and metabolic syndrome.
Glucose Intolerance
Aldehyde dehydrogenase-2 (ALDH2) ameliorates chronic alcohol ingestion-induced myocardial insulin resistance and endoplasmic reticulum stress.
Glycogen Storage Disease
Detection of single nucleotide substitution by competitive allele-specific short oligonucleotide hybridization (CASSOH) with immunochromatographic strip.
Gout
Analysis of the genotypes for aldehyde dehydrogenase 2 in Japanese patients with primary gout.
Gout
Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout.
Gout
Identification of rs671, a common variant of ALDH2, as a gout susceptibility locus.
Gout
Independent effects of ADH1B and ALDH2 common dysfunctional variants on gout risk.
Gout
Multiple Membrane Transporters and Some Immune Regulatory Genes are Major Genetic Factors to Gout.
Gout
Replication of Gout/Urate Concentrations GWAS Susceptibility Loci Associated with Gout in a Han Chinese Population.
Gout
Risk of gout among Taiwanese adults with ALDH-2 rs671 polymorphism according to BMI and alcohol intake.
Gout
Subtype-specific gout susceptibility loci and enrichment of selection pressure on ABCG2 and ALDH2 identified by subtype genome-wide meta-analyses of clinically defined gout patients.
Graft vs Host Disease
Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality.
Hallucinations
Evidence of Epistasis Between the Catechol-O-Methyltransferase and Aldehyde Dehydrogenase 3B1 Genes in Paranoid Schizophrenia.
Head and Neck Neoplasms
Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis.
Head and Neck Neoplasms
Aldehyde dehydrogenase 2 and head and neck cancer: a meta-analysis implementing a Mendelian randomization approach.
Head and Neck Neoplasms
Association Between the Aldehyde Dehydrogenase-2 rs671 G>A Polymorphism and Head and Neck Cancer Susceptibility: A Meta-Analysis in East Asians.
Head and Neck Neoplasms
Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients.
Head and Neck Neoplasms
Association of aldehyde dehydrogenase 2 gene polymorphism with pancreatic cancer but not colon cancer.
Head and Neck Neoplasms
Cancer stem cell markers ALDH1 and Bmi1 expression in oral erythroplakia revisited: Implication for driving the process of field cancerization.
Head and Neck Neoplasms
Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
Head and Neck Neoplasms
Clinical features and treatment outcomes of Japanese head and neck cancer patients with a second primary cancer.
Head and Neck Neoplasms
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
Head and Neck Neoplasms
Different Expression of Aldehyde Dehydrogenases 1A1 and 2 in Oral Leukoplakia With Epithelial Dysplasia and in Oral Squamous Cell Carcinoma.
Head and Neck Neoplasms
Genetic polymorphism of aldehyde dehydrogenase 2 in patients with upper aerodigestive tract cancer.
Head and Neck Neoplasms
Genetic Polymorphism of Aldehyde Dehydrogenase 2 in Patients With Upper Aerodigestive Tract Cancer.
Head and Neck Neoplasms
Inactive aldehyde dehydrogenase-2 increased the risk of pancreatic cancer among smokers in a Japanese male population.
Head and Neck Neoplasms
Overexpression of ALDH1 and EMT marker profile are linked with unfavorable outcome in head and neck cancer.
Head and Neck Neoplasms
Prognostic value of ALDH1 and Nestin in advanced cancer: a systematic meta-analysis with trial sequential analysis.
Head and Neck Neoplasms
Quercetin in elimination of tumor initiating stem-like and mesenchymal transformation property in head and neck cancer.
Head and Neck Neoplasms
The interplay between alcohol consumption, oral hygiene, ALDH2, and ADH1B in the risk of head and neck cancer.
Head and Neck Neoplasms
Validation of Alcohol Flushing Questionnaire to Identify ALDH2 Status in a Case-Control Study of Head and Neck Cancer.
Heart Arrest
Aldehyde Dehydrogenase 2 Protects Against Post-Cardiac Arrest Myocardial Dysfunction Through a Novel Mechanism of Suppressing Mitochondrial Reactive Oxygen Species Production.
Heart Defects, Congenital
ALDH1A2 (RALDH2) genetic variation in human congenital heart disease.
Heart Defects, Congenital
Effect of mitochondrial aldehyde dehydrogenase-2 genotype on cardioprotection in patients with congenital heart disease.
Heart Defects, Congenital
Influence of the aldehyde dehydrogenase 2 polymorphism on the vasodilatory effect of nitroglycerin in infants with congenital heart disease and pulmonary arterial hypertension.
Heart Diseases
(13) C magnetic resonance spectroscopic imaging of hyperpolarized [1-(13) C, U-(2) H5 ] ethanol oxidation can be used to assess aldehyde dehydrogenase activity in vivo.
Heart Diseases
Aldehyde Dehydrogenase (ALDH) 2 in Diabetic Heart Diseases.
Heart Diseases
Aldehyde Dehydrogenase 2 Ameliorates Chronic Alcohol Consumption-Induced Atrial Fibrillation through Detoxification of 4-HNE.
Heart Diseases
Aldehyde dehydrogenase-2 deficiency aggravates cardiac dysfunction elicited by endoplasmic reticulum stress induction.
Heart Diseases
ALDH2 in alcoholic heart diseases: Molecular mechanism and clinical implications.
Heart Diseases
Mitochondrial aldehyde dehydrogenase and cardiac diseases.
Heart Diseases
The Role of Cariporide in Protecting Saphenous Vein among Different Aldehyde Dehydrogenase Genotypes.
Heart Diseases
VISIONET: intuitive visualisation of overlapping transcription factor networks, with applications in cardiogenic gene discovery.
Heart Failure
Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells.
Heart Failure
Aldehyde dehydrogenase 2 activation in heart failure restores mitochondrial function and improves ventricular function and remodelling.
Heart Failure
Aldehyde Dehydrogenase 2 and Heart Failure.
Heart Failure
Aldehyde dehydrogenase 2 as a potential protective factor for renal insufficiency in Japanese subjects with heart failure: a pilot study.
Heart Failure
Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1.
Heart Failure
ALDH2 rs671 polymorphism and the risk of heart failure with preserved ejection fraction (HFpEF) in patients with cardiovascular diseases.
Heart Failure
Cardiac-specific overexpression of aldehyde dehydrogenase 2 exacerbates cardiac remodeling in response to pressure overload.
Heart Failure
Correction: Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography.
Heart Failure
Efficient expression of codon-adapted human acetaldehyde dehydrogenase 2 cDNA with 6xHis tag in Pichia pastoris.
Heart Failure
Influence of ALDH2 Glu504Lys polymorphism on nitroglycerin response in chronic heart failure and involvement of Calcitonin Gene Related Peptide (CGRP).
Heart Failure
Mitochondrial aldehyde dehydrogenase 2 plays protective roles in heart failure after myocardial infarction via suppression of the cytosolic JNK/p53 pathway in mice.
Heart Failure
Molecular Mechanism of HSF1-Upregulated ALDH2 by PKC in Ameliorating Pressure Overload-Induced Heart Failure in Mice.
Heart Failure
Potentiating mitochondrial aldehyde dehydrogenase 2 to treat post-infarction heart failure.
Heart Failure
Salvaging the ischemic heart: Gi-coupled receptors in mast cells activate a PKC?/ALDH2 pathway providing anti-RAS cardioprotection.
Heart Failure
Targeting acetaldehyde dehydrogenase 2 (ALDH2) in heart failure-Recent insights and perspectives.
Heart Failure
Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography.
Hemangioendothelioma
Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors.
Hemangioma
Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors.
Hemangioma, Capillary
Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors.
Hemangiosarcoma
Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors.
Hematologic Neoplasms
Markers and Reporters to Reveal the Hierarchy in Heterogeneous Cancer Stem Cells.
Hepatitis
Alcohol Drinking Mediates the Association between Polymorphisms of ADH1B and ALDH2 and Hepatitis B-Related Hepatocellular Carcinoma.
Hepatitis
Alcohol inhibits T-cell glucose metabolism and hepatitis in ALDH2-deficient mice and humans: roles of acetaldehyde and glucocorticoids.
Hepatitis
Blockade of Retinol Metabolism Protects T Cell-Induced Hepatitis by Increasing Migration of Regulatory T Cells.
Hepatitis B
Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma.
Hepatitis B
ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
Hepatitis B
Association between smoking, acetaldehyde dehydrogenase-2 1-1 status, and alcohol drinking among Taiwanese polyvinyl chloride workers.
Hepatitis B, Chronic
Alcohol Drinking Mediates the Association between Polymorphisms of ADH1B and ALDH2 and Hepatitis B-Related Hepatocellular Carcinoma.
Hepatitis B, Chronic
Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis.
Hepatitis B, Chronic
Risk and Predictors of Hepatocellular Carcinoma for Chronic Hepatitis b Patients With Newly Developed Cirrhosis.
Hepatitis C
Multi?layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/??catenin signaling activation (Review).
HIV Infections
RALDH Activity Induced by Bacterial/Fungal Pathogens in CD16+ Monocyte-Derived Dendritic Cells Boosts HIV Infection and Outgrowth in CD4+ T Cells.
Hyperaldosteronism
Modulating ALDH2 reveals a differential dependence on ROS for hypertrophy and SR Ca2+ release in aldosterone-treated cardiac myocytes.
Hyperalgesia
TRPA1/NOX in the soma of trigeminal ganglion neurons mediates migraine-related pain of glyceryl trinitrate in mice.
Hypercholesterolemia
The response of hepatic transcriptome to dietary cholesterol in Prague hereditary hypercholesterolemic (PHHC) rat.
Hyperglycemia
Cardiac Mitochondrial Respiratory Dysfunction and Tissue Damage in Chronic Hyperglycemia Correlate with Reduced Aldehyde Dehydrogenase-2 Activity.
Hyperglycemia
Formaldehyde induces diabetes-associated cognitive impairments.
Hyperglycemia
Inhibition of aldehyde dehydrogenase 2 by oxidative stress is associated with cardiac dysfunction in diabetic rats.
Hyperglycemia
Inhibition of ALDH2 by O-GlcNAcylation contributes to the hyperglycemic exacerbation of myocardial ischemia/reperfusion injury.
Hyperglycemia
The Glu504Lys polymorphism of aldehyde dehydrogenase 2 contributes to development of coronary artery disease.
Hyperglycemia
ULK1-regulated autophagy: A mechanism in cellular protection for ALDH2 against hyperglycemia.
Hyperglycinemia, Nonketotic
Detection of single nucleotide substitution by competitive allele-specific short oligonucleotide hybridization (CASSOH) with immunochromatographic strip.
Hyperinsulinism
Inactive aldehyde dehydrogenase 2 worsens glycemic control in patients with type 2 diabetes mellitus who drink low to moderate amounts of alcohol.
Hyperlipidemias
Aldehyde dehydrogenase 2 and beta3-adrenergic receptor gene polymorphisms: their association with elevated liver enzymes and metabolic syndrome.
Hyperlipidemias
Sex differences in environmental and genetic factors for hypertension.
Hyperpigmentation
Ethanol induces skin hyperpigmentation in mice with aldehyde dehydrogenase 2 deficiency.
Hyperpigmentation
Targeting ALDH1A1 to treat pigmentary disorders.
Hypersensitivity
Aldehyde Dehydrogenase Inhibition Ameliorates Cardiac Dysfunction and Exacerbates Hypotension Caused by Alcohol in Female Rats.
Hypersensitivity
Dihydromyricetin attenuates neuropathic pain via enhancing the transition from M1 to M2 phenotype polarization by potentially elevating ALDH2 activity in vitro and vivo.
Hypersensitivity
Effect of Tongxieyaofang decoction on colonic mucosal protein expression profiles in rats with visceral hypersensitivity.
Hypersensitivity
Genetic determinants of both ethanol and acetaldehyde metabolism influence alcohol hypersensitivity and drinking behaviour among Scandinavians.
Hypersensitivity
Relationship between alcohol drinking, ADH2 and ALDH2 genotypes, and risk for hepatocellular carcinoma in Japanese.
Hypertension
A case-control study on male hepatocellular carcinoma based on hospital and community controls.
Hypertension
Acetaldehyde Dehydrogenase 2 rs671 Polymorphism Affects Hypertension Susceptibility and Lipid Profiles in a Chinese Population.
Hypertension
Alcohol intake and blood pressure: a systematic review implementing a mendelian randomization approach.
Hypertension
Aldehyde dehydrogenase 2 (ALDH2) Glu504Lys polymorphism is associated with hypertension risk in Asians: a meta-analysis.
Hypertension
Aldehyde dehydrogenase 2 and beta3-adrenergic receptor gene polymorphisms: their association with elevated liver enzymes and metabolic syndrome.
Hypertension
Aldehyde dehydrogenase 2 partly mediates hypotensive effect of nitrite on l-NAME-induced hypertension in normoxic rat.
Hypertension
Aldehyde dehydrogenase 2 protects against oxidative stress associated with pulmonary arterial hypertension.
Hypertension
ALDH1A3 Coordinates Metabolism With Gene Regulation in Pulmonary Arterial Hypertension.
Hypertension
ALDH2 improved irbesartan treatment efficacy among rats with hypertension.
Hypertension
ALDH2 rs671 polymorphism and the risk of heart failure with preserved ejection fraction (HFpEF) in patients with cardiovascular diseases.
Hypertension
ALDH2 rs671 polymorphisms and the risk of cerebral microbleeds in Chinese elderly: the Taizhou Imaging Study.
Hypertension
Association Between ALDH-2 rs671 and Essential Hypertension Risk or Blood Pressure Levels: A Systematic Review and Meta-Analysis.
Hypertension
Association between Carotid Intima-media Thickness and Aldehyde Dehydrogenase 2 Glu504Lys Polymorphism in Chinese Han with Essential Hypertension.
Hypertension
Association of Aldehyde Dehydrogenase 2 Gene Polymorphism with Myocardial Infarction.
Hypertension
Associations between aldehyde dehydrogenase 2 (ALDH2) genetic polymorphisms, drinking status, and hypertension risk in Japanese adult male workers: a case-control study.
Hypertension
Associations between aldehyde dehydrogenase 2 (ALDH2) rs671 genetic polymorphisms, lifestyles and hypertension risk in Chinese Han people.
Hypertension
Common ALDH2 genetic variants predict development of hypertension in the SAPPHIRe prospective cohort: Gene-environmental interaction with alcohol consumption.
Hypertension
Contribution of ALDH2 polymorphism to alcoholism-associated hypertension.
Hypertension
Effect Modification of Acetaldehyde Dehydrogenase 2 rs671 Polymorphism on the Association between Alcohol Intake and Blood Pressure: the Dong-gu Study.
Hypertension
Effect of alcohol and aldehyde dehydrogenase gene polymorphisms on alcohol-associated hypertension: the Guangzhou Biobank Cohort Study.
Hypertension
Epidemiologic study of the association of low-Km mitochondrial acetaldehyde dehydrogenase genotypes with blood pressure level and the prevalence of hypertension in a general population.
Hypertension
Genetic deficiency of a mitochondrial aldehyde dehydrogenase increases serum lipid peroxides in community-dwelling females.
Hypertension
Genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 and liver cirrhosis, chronic calcific pancreatitis, diabetes mellitus, and hypertension among Japanese alcoholic men.
Hypertension
Homozygous ALDH2*2 Is an Independent Risk Factor for Ischemic Stroke in Taiwanese Men.
Hypertension
Influence of the aldehyde dehydrogenase 2 polymorphism on the vasodilatory effect of nitroglycerin in infants with congenital heart disease and pulmonary arterial hypertension.
Hypertension
Interaction between ALDH2 rs671 and life habits affects the risk of hypertension in Koreans: A STROBE observational study.
Hypertension
Low-Km aldehyde dehydrogenase deficiency does not influence the elevation of blood pressure by alcohol.
Hypertension
Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype.
Hypertension
Sex differences in environmental and genetic factors for hypertension.
Hypertension
Targeting acetaldehyde dehydrogenase 2 (ALDH2) in heart failure-Recent insights and perspectives.
Hypertension
The aldehyde dehydrogenase 2 gene is a risk factor for hypertension in Japanese but does not alter the sensitivity to pressor effects of alcohol: the Suita study.
Hypertension
The combination of mitochondrial low enzyme-activity aldehyde dehydrogenase 2 allele and superoxide dismutase 2 genotypes increases the risk of hypertension in relation to alcohol consumption.
Hypertension
The effect of ALDH2 rs671 gene mutation on clustering of cardiovascular risk factors in a big data study of Chinese population: associations differ between the sexes.
Hypertension
The Glu504Lys polymorphism of aldehyde dehydrogenase 2 contributes to development of coronary artery disease.
Hypertension
[Correlation of aldehyde dehydrogenase-2 gene polymorphism with hypertension in patients with coronary heart disease complicated by diabetes mellitus].
Hypertension, Pulmonary
ALDH1A3 Coordinates Metabolism With Gene Regulation in Pulmonary Arterial Hypertension.
Hypertension, Pulmonary
ALDH2 (Aldehyde Dehydrogenase 2) Protects Against Hypoxia-Induced Pulmonary Hypertension.
Hypoadrenocorticism, Familial
The combination of whole-exome sequencing and clinical analysis allows better diagnosis of rare syndromic retinal dystrophies.
Hypokinesia
Interactions of COMT and ALDH2 Genetic Polymorphisms on Symptoms of Parkinson's Disease.
Hypopharyngeal Neoplasms
Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma.
Hypotension
Aldehyde Dehydrogenase Inhibition Ameliorates Cardiac Dysfunction and Exacerbates Hypotension Caused by Alcohol in Female Rats.
Hypotension
Tetrahydrobiopterin paradoxically mediates cardiac oxidative stress and mitigates ethanol-evoked cardiac dysfunction in conscious female rats.
Hypothyroidism
Adult-onset hypothyroidism increases ethanol consumption.
Ichthyosis
A Neurodegenerative Phenotype Associated With Sjögren-Larsson Syndrome.
Ichthyosis
Genetic assessment of ten Egyptian patients with Sjögren-Larsson syndrome: expanding the clinical spectrum and reporting a novel ALDH3A2 mutation.
Ichthyosis
Genotype and phenotype variability in Sjögren-Larsson syndrome.
Ichthyosis
Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.
Ichthyosis
Large contiguous gene deletions in Sjögren-Larsson syndrome.
Ichthyosis
Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.
Ichthyosis
Novel Mutation in Sjogren-Larsson Syndrome Is Associated With Divergent Neurologic Phenotypes.
Ichthyosis
Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
Ichthyosis
Sjögren-Larsson syndrome: Novel mutations in the ALDH3A2 gene in a French cohort.
Ichthyosis
The combination of whole-exome sequencing and clinical analysis allows better diagnosis of rare syndromic retinal dystrophies.
Infarction, Middle Cerebral Artery
ALDH2 Protects Against Ischemic Stroke in Rats by Facilitating 4-HNE Clearance and AQP4 Down-Regulation.
Infections
AAV Gene Therapy for Alcoholism: Inhibition of Mitochondrial Aldehyde Dehydrogenase Enzyme Expression in Hepatoma Cells.
Infections
Acetaldehyde and gastric cancer.
Infections
ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
Infections
Effects of alcohol consumption, ALDH2 rs671 polymorphism, and Helicobacter pylori infection on the gastric cancer risk in a Korean population.
Infections
Effects of the common polymorphism in the human aldehyde dehydrogenase 2 (ALDH2) gene on the lung.
Infections
Gene-environment Interactions and Polymorphism Studies of Cancer Risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II).
Infections
HBV/HCV Infection, Alcohol, Tobacco and Genetic Polymorphisms for Hepatocellular Carcinoma in Nagoya, Japan.
Infections
Hepatitis B and C viruses infection, lifestyle and genetic polymorphisms as risk factors for hepatocellular carcinoma in Haimen, China.
Infections
HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target.
Infections
Multi?layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/??catenin signaling activation (Review).
Infections
Oxidative-stress-related proteome changes in Helicobacter pylori-infected human gastric mucosa.
Infections
Robotic-assisted latissimus dorsi harvest in delayed-immediate breast reconstruction.
Infections
The aldehyde dehydrogenase 2 (ALDH2) Glu504Lys polymorphism interacts with alcohol drinking in the risk of stomach cancer.
Infections
Upregulation of Retinal Dehydrogenase 2 in Alternatively Activated Macrophages during Retinoid-dependent Type-2 Immunity to Helminth Infection in Mice.
Infertility
Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure.
Infertility
Expression Levels of the Oxidative Stress Response Gene ALDH3A2 in Granulosa-Lutein Cells Are Related to Female Age and Infertility Diagnosis.
Inflammatory Breast Neoplasms
Aldehyde Dehydrogenase 1 Expression in Inflammatory Breast Cancer as Measured by Immunohistochemical Staining.
Influenza, Human
Effects of the common polymorphism in the human aldehyde dehydrogenase 2 (ALDH2) gene on the lung.
Insulin Resistance
Aldehyde dehydrogenase-2 (ALDH2) ameliorates chronic alcohol ingestion-induced myocardial insulin resistance and endoplasmic reticulum stress.
Insulin Resistance
Aldehyde Dehydrogenase-2 Attenuates Myocardial Remodeling and Contractile Dysfunction Induced by a High-Fat Diet.
Insulin Resistance
ALDH2 rs671 Is Associated With Elevated FPG, Reduced Glucose Clearance and Hepatic Insulin Resistance in Japanese Men.
Insulin Resistance
Common ALDH2 genetic variants predict development of hypertension in the SAPPHIRe prospective cohort: Gene-environmental interaction with alcohol consumption.
Insulin Resistance
Contribution of Hepatic Retinaldehyde Dehydrogenase Induction to Impairment of Glucose Metabolism by High-Fat-Diet Feeding in C57BL/6J Mice.
Insulin Resistance
Discovery of coumarin-based selective aldehyde dehydrogenase 1A1 inhibitors with glucose metabolism improving activity.
Insulin Resistance
L-carnitine exerts a nutrigenomic effect via direct modulation of nuclear receptor signaling in adipocytes, hepatocytes and SKMC, demonstrating its nutritional impact.
Insulin Resistance
Mitochondrial aldehyde dehydrogenase obliterates insulin resistance-induced cardiac dysfunction through deacetylation of PGC-1?.
Insulin Resistance
Moderate vitamin A supplementation in obese mice regulates tissue factor and cytokine production in a sex-specific manner.
Insulin Resistance
Resveratrol attenuates excessive ethanol exposure induced insulin resistance in rats via improving NAD(+) /NADH ratio.
Insulin Resistance
Retinaldehyde represses adipogenesis and diet-induced obesity.
Insulinoma
Novel prognostic markers revealed by a proteomic approach separating benign from malignant insulinomas.
Intellectual Disability
A Neurodegenerative Phenotype Associated With Sjögren-Larsson Syndrome.
Intellectual Disability
Genetic assessment of ten Egyptian patients with Sjögren-Larsson syndrome: expanding the clinical spectrum and reporting a novel ALDH3A2 mutation.
Intellectual Disability
Genotype and phenotype variability in Sjögren-Larsson syndrome.
Intellectual Disability
Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.
Intellectual Disability
Large contiguous gene deletions in Sjögren-Larsson syndrome.
Intellectual Disability
Novel Mutation in Sjogren-Larsson Syndrome Is Associated With Divergent Neurologic Phenotypes.
Intellectual Disability
Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
Intellectual Disability
Sjögren-Larsson syndrome: Novel mutations in the ALDH3A2 gene in a French cohort.
Intervertebral Disc Displacement
Genetic polymorphisms of ALDH2 are associated with lumbar disc herniation in a Chinese Han population.
Ischemic Stroke
Aldehyde dehydrogenase 2 polymorphism as a protective factor for intracranial vascular stenosis in ischemic stroke in Han Chinese.
Ischemic Stroke
Aldehyde dehydrogenase 2 rs671G>A polymorphism and ischemic stroke risk in Chinese population: a meta-analysis.
Ischemic Stroke
ALDH2 Protects Against Ischemic Stroke in Rats by Facilitating 4-HNE Clearance and AQP4 Down-Regulation.
Ischemic Stroke
Association between ALDH2 rs671 polymorphism and risk of ischemic stroke: A protocol for systematic review and meta analysis.
Ischemic Stroke
Association Between the Polymorphism of Aldehyde Dehydrogenase 2 Gene and Cerebral Infarction in a Hakka Population in Southern China.
Ischemic Stroke
Association of ADH1B polymorphism and alcohol consumption with increased risk of intracerebral hemorrhagic stroke.
Ischemic Stroke
Genetic variants in ALDH2 predict risk of ischemic stroke in a Chinese population.
Ischemic Stroke
Homozygous ALDH2*2 Is an Independent Risk Factor for Ischemic Stroke in Taiwanese Men.
Ischemic Stroke
Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study.
Ischemic Stroke
Synergistic Effects of Aldehyde Dehydrogenase 2 Polymorphisms and Alcohol Consumption on Cognitive Impairment after Ischemic Stroke in Han Chinese.
Keloid
MiR-21-5p Links Epithelial-Mesenchymal Transition Phenotype with Stem-Like Cell Signatures via AKT Signaling in Keloid Keratinocytes.
Keratoconus
Association with Corneal Remodeling Related Genes, ALDH3A1, LOX, and SPARC Genes Variations in Korean Keratoconus Patients.
Keratosis, Actinic
Aldehyde dehydrogenase 1 expression in basal cell carcinoma, actinic keratosis and Bowen's disease.
Ketosis
Alcohol Dehydrogenase-1B (rs1229984) and Aldehyde Dehydrogenase-2 (rs671) Genotypes and Alcoholic Ketosis Are Associated with the Serum Uric Acid Level in Japanese Alcoholic Men.
Ketosis
Associations among liver disease, serum lipid profile, body mass index, ketonuria, meal skipping, and the alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 genotypes in Japanese men with alcohol dependence.
Kidney Failure, Chronic
Influence of ALDH2 genetic polymorphisms on aciclovir pharmacokinetics following oral administration of valaciclovir in Japanese end-stage renal disease patients.
Kidney Failure, Chronic
[Aldehyde dehydrogenase 2(ALDH2) gene polymorphism in NIDDM patients with chronic renal failure]
Kidney Neoplasms
Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Laryngeal Neoplasms
Heavy alcohol drinking downregulates ALDH2 gene expression but heavy smoking up-regulates SOD2 gene expression in head and neck squamous cell carcinoma.
Laryngeal Neoplasms
[Aldehyde dehydrogenase 1 can be used as a new marker of cancer stem cells in laryngeal cancer cells in vitro].
Leiomyoma
Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues.
Leiomyoma
Retinoic acid pathway genes show significantly altered expression in uterine fibroids when compared with normal myometrium.
Leiomyoma
Retinoids regulate genes involved in retinoic acid synthesis and transport in human myometrial and fibroid smooth muscle cells.
Leiomyoma
Screening of potential biomarkers in uterine leiomyomas disease via gene expression profiling analysis.
Lentivirus Infections
Aldehyde dehydrogenase 2 deficiency promotes atherosclerotic plaque instability through accelerating mitochondrial ROS-mediated vascular smooth muscle cell senescence.
Leukemia
4-(N,N-dipropylamino)benzaldehyde inhibits the oxidation of all-trans retinal to all-trans retinoic acid by ALDH1A1, but not the differentiation of HL-60 promyelocytic leukemia cells exposed to all-trans retinal.
Leukemia
A retrospective review of the prognostic value of ALDH-1, Bmi-1 and Nanog stem cell markers in esophageal squamous cell carcinoma.
Leukemia
ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.
Leukemia
Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
Leukemia
Distinct prognostic values of ALDH1 isoenzymes in breast cancer.
Leukemia
Expression and associations of TRAF1, BMI-1, ALDH1, and Lin28B in oral squamous cell carcinoma.
Leukemia
Hsa-circ_0003420 induces apoptosis in acute myeloid leukemia stem cells and impairs stem cell properties.
Leukemia
Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay.
Leukemia
Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer.
Leukemia
Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance.
Leukemia
Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
Leukemia
RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1.
Leukemia
Sorafenib treatment of FLT3-ITD+ acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent non-responsiveness associated with a D835 mutation.
Leukemia
Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1.
Leukemia
The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.
Leukemia
Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis.
Leukemia, Myeloid
Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers.
Leukemia, Myeloid, Acute
Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1.
Leukemia, Myeloid, Acute
Transcriptional Silencing of ALDH2 Confers a Dependency on Fanconi Anemia Proteins in Acute Myeloid Leukemia.
Leukoencephalopathies
Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
Leukopenia
Recovery from anemia and leukocytopenia after abstinence in Japanese alcoholic men and their genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2.
Leukoplakia, Oral
ALDH1 and podoplanin expression patterns predict the risk of malignant transformation in oral leukoplakia.
Leukoplakia, Oral
Different Expression of Aldehyde Dehydrogenases 1A1 and 2 in Oral Leukoplakia With Epithelial Dysplasia and in Oral Squamous Cell Carcinoma.
Leukoplakia, Oral
Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.
Lichen Planus, Oral
Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus.
Lichen Planus, Oral
Increased salivary aldehyde dehydrogenase 1 in non-reticular oral lichen planus.
Lip Neoplasms
Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer.
Lipid Metabolism Disorders
Transcriptome analysis in normal human liver cells exposed to 2, 3, 3', 4, 4', 5 - Hexachlorobiphenyl (PCB 156).
Liver Cirrhosis
Aldehyde dehydrogenase 2 activation ameliorates CCl4 -induced chronic liver fibrosis in mice by up-regulating Nrf2/HO-1 antioxidant pathway.
Liver Cirrhosis
Association of restriction fragment-length polymorphisms in the alcohol dehydrogenase 2 gene with alcoholic brain atrophy.
Liver Cirrhosis
Chinese alcoholic patients with esophageal cancer are genetically different from alcoholics with acute pancreatitis and liver cirrhosis.
Liver Cirrhosis
Effect of the CYP2E1 genotype on vinyl chloride monomer-induced liver fibrosis among polyvinyl chloride workers.
Liver Cirrhosis
Effects of "Essential AD2" Supplement on Blood Acetaldehyde Levels in Individuals Who Have Aldehyde Dehydrogenase (ALDH2) Deficiency.
Liver Cirrhosis
Genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 and liver cirrhosis, chronic calcific pancreatitis, diabetes mellitus, and hypertension among Japanese alcoholic men.
Liver Cirrhosis
Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver.
Liver Cirrhosis
Macrocytosis, a new predictor for esophageal squamous cell carcinoma in Japanese alcoholic men.
Liver Cirrhosis, Alcoholic
Aldehyde Dehydrogenase 2 (ALDH2) Polymorphism and the Risk of Alcoholic Liver Cirrhosis among East Asians: A Meta-Analysis.
Liver Cirrhosis, Alcoholic
Aldehyde dehydrogenase 2 activation ameliorates CCl4 -induced chronic liver fibrosis in mice by up-regulating Nrf2/HO-1 antioxidant pathway.
Liver Cirrhosis, Alcoholic
Aldehyde dehydrogenase 2 polymorphism affects the outcome of methanol poisoning in exposed humans.
Liver Cirrhosis, Alcoholic
Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis.
Liver Cirrhosis, Alcoholic
Association between aldehyde dehydrogenase 2 gene rs671 G>A polymorphism and alcoholic liver cirrhosis in southern Chinese Hakka population.
Liver Cirrhosis, Alcoholic
Association between polymorphisms of ethanol-metabolizing enzymes and susceptibility to alcoholic cirrhosis in a Korean male population.
Liver Cirrhosis, Alcoholic
CD14 promoter polymorphism in Chinese alcoholic patients with cirrhosis of liver and acute pancreatitis.
Liver Cirrhosis, Alcoholic
Genetic polymorphisms of ADH1B, ADH1C and ALDH2 in Turkish alcoholics: lack of association with alcoholism and alcoholic cirrhosis.
Liver Cirrhosis, Alcoholic
Genetic Polymorphisms of Genes Coding to Alcohol-Metabolizing Enzymes in Western Mexicans: Association of CYP2E1*c2/CYP2E1*5B Allele with Cirrhosis and Liver Function.
Liver Cirrhosis, Alcoholic
Genotypes of alcohol-metabolizing enzymes in Mexicans with alcoholic liver cirrhosis.
Liver Cirrhosis, Alcoholic
Polymorphism in alcohol-metabolizing enzymes, glutathione S-transferases and apolipoprotein E and susceptibility to alcohol-induced cirrhosis and chronic pancreatitis.
Liver Cirrhosis, Alcoholic
[Effects of genetic polymorphisms of ethanol-metabolizing enzymes on alcohol drinking behaviors]
Liver Cirrhosis, Alcoholic
[Genetic polymorphisms of alcohol-metabolizing enzymes and cytokines in patients with alcohol induced pancreatitis and alcoholic liver cirrhosis]
Liver Diseases
Alcoholism and alcoholic organ damage and genetic polymorphisms of alcohol metabolizing enzymes in Chinese patients.
Liver Diseases
Aldehyde dehydrogenase (E.C. 1.2.1.3) in chronic alcoholic liver diseases.
Liver Diseases
Aldehyde dehydrogenase 2 and beta3-adrenergic receptor gene polymorphisms: their association with elevated liver enzymes and metabolic syndrome.
Liver Diseases
Aldehyde Dehydrogenase Mutation Exacerbated High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease with Gut Microbiota Remodeling in Male Mice.
Liver Diseases
Aldehyde Dehydrogenase, Liver Disease and Cancer.
Liver Diseases
ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
Liver Diseases
Association Between Aldehyde Dehydrogenase 2 Glu504Lys Polymorphism and Alcoholic Liver Disease.
Liver Diseases
Association between polymorphisms of ethanol-metabolizing enzymes and susceptibility to alcoholic cirrhosis in a Korean male population.
Liver Diseases
Associations among liver disease, serum lipid profile, body mass index, ketonuria, meal skipping, and the alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 genotypes in Japanese men with alcohol dependence.
Liver Diseases
Change of components of the metabolic syndrome in a workers' health checkup after five years--relation with elevated liver enzymes, gene polymorphisms for ALDH 2, beta3-AR and lifestyle.
Liver Diseases
CYP2E1 genotypes and serum LAP in Japanese alcoholics.
Liver Diseases
Detection of usual and atypical aldehyde dehydrogenase alleles by mismatch amplification mutation assay.
Liver Diseases
Distribution of ADH2 and ALDH2 genotypes in different populations.
Liver Diseases
Effect of liver disorders on ethanol elimination and alcohol and aldehyde dehydrogenase activities in liver and erythrocytes.
Liver Diseases
Epidemiologic study of the association of low-Km mitochondrial acetaldehyde dehydrogenase genotypes with blood pressure level and the prevalence of hypertension in a general population.
Liver Diseases
Ethanol-induced oxidative DNA damage and CYP2E1 expression in liver tissue of Aldh2 knockout mice.
Liver Diseases
Genetic polymorphism of enzymes of alcohol metabolism and susceptibility to alcoholic liver disease.
Liver Diseases
Identification of Serum Biomarkers to Distinguish Hazardous and Benign Aminotransferase Elevations.
Liver Diseases
Influence of alcohol consumption and gene polymorphisms of ADH2 and ALDH2 on hepatocellular carcinoma in a Japanese population.
Liver Diseases
New strategy for detection of ALDH2 mutant.
Liver Diseases
Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis.
Liver Diseases
The Association and Interaction of Aldehyde Dehydrogenase 2 Polymorphisms with Food Group Intake and Probability of Having Non-Alcoholic Fatty Liver Disease.
Liver Diseases
The murine hepatic sequelae of long-term ethanol consumption are sex-specific and exacerbated by Aldh1b1 loss.
Liver Diseases
Toxicogenomics directory of chemically exposed human hepatocytes.
Liver Diseases
Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease.
Liver Diseases, Alcoholic
Alcoholic liver disease in heterozygotes of mutant and normal aldehyde dehydrogenase-2 genes.
Liver Diseases, Alcoholic
Aldehyde dehydrogenase (E.C. 1.2.1.3) in chronic alcoholic liver diseases.
Liver Diseases, Alcoholic
Association Between Aldehyde Dehydrogenase 2 Glu504Lys Polymorphism and Alcoholic Liver Disease.
Liver Diseases, Alcoholic
Effect of ALDH2 and CYP2E1 gene polymorphisms on drinking behavior and alcoholic liver disease in Japanese male workers.
Liver Diseases, Alcoholic
Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men: lack of association with alcoholism and alcoholic liver disease.
Liver Diseases, Alcoholic
Genotypes of alcohol-metabolizing enzymes in Japanese with alcohol liver diseases: a strong association of the usual Caucasian-type aldehyde dehydrogenase gene (ALDH1(2)) with the disease.
Liver Diseases, Alcoholic
Genotypes of ALDH2 related to liver and pulmonary diseases and other genetic factors related to alcoholic liver disease.
Liver Diseases, Alcoholic
Genotyping of the aldehyde dehydrogenase 2 (ALDH2) gene using the polymerase chain reaction: evidence for single point mutation in the ALDH2 gene of ALDH2-deficiency.
Liver Diseases, Alcoholic
Hepatocellular carcinoma associated with alcoholic liver disease: a clinicopathological study and genetic polymorphism of aldehyde dehydrogenase 2.
Liver Diseases, Alcoholic
High incidence of ADH2*1/ALDH2*1 genes among Japanese alcohol dependents and patients with alcoholic liver disease.
Liver Diseases, Alcoholic
Mitochondria-targeted ubiquinone (MitoQ) enhances acetaldehyde clearance by reversing alcohol-induced posttranslational modification of aldehyde dehydrogenase 2: A molecular mechanism of protection against alcoholic liver disease.
Liver Diseases, Alcoholic
Pharmacological activation of aldehyde dehydrogenase 2 by Alda-1 reverses alcohol-induced hepatic steatosis and cell death in mice.
Liver Diseases, Alcoholic
Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men.
Liver Diseases, Alcoholic
Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications.
Liver Diseases, Alcoholic
The Role of ALDH2 in Alcoholic Liver Disease.
Liver Diseases, Alcoholic
[Genetic and epidemiologic studies on alcoholic liver diseases]
Liver Diseases, Alcoholic
[Genotypes of alcohol dehydrogenase and aldehyde dehydrogenase and their significance for alcohol sensitivity]
Liver Neoplasms
Aldehyde dehydrogenase 1A1 stabilizes transcription factor Gli2 and enhances the activity of Hedgehog signaling in hepatocellular cancer.
Liver Neoplasms
Aldehyde Dehydrogenase, Liver Disease and Cancer.
Liver Neoplasms
ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
Liver Neoplasms
ALDH2 gene polymorphism in different types of cancers and its clinical significance.
Liver Neoplasms
Detection of ALDH1 activity in rabbit hepatic VX2 tumors and isolation of ALDH1 positive cancer stem cells.
Liver Neoplasms
Genetic polymorphisms of aldehyde dehydrogenase 2, cytochrome p450 2E1 for liver cancer risk in HCV antibody-positive japanese patients and the variations of CYP2E1 mRNA expression levels in the liver due to its polymorphism.
Liver Neoplasms
Genetic-epidemiological evidence for the role of acetaldehyde in cancers related to alcohol drinking.
Liver Neoplasms
Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients.
Liver Neoplasms
Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
Liver Neoplasms
[Aldehyde dehydrogenase with hepatocellular carcinoma].
Liver Neoplasms
[Association between aldehyde dehydrogenase-2/cytochrome P450 2E1 genetic polymorphism and habit of alcohol drinking and the susceptibility of hepatocellular carcinoma]
Lung Diseases
Genotypes of ALDH2 related to liver and pulmonary diseases and other genetic factors related to alcoholic liver disease.
Lung Injury
Alda-1 Prevents Pulmonary Epithelial Barrier Dysfunction following Severe Hemorrhagic Shock through Clearance of Reactive Aldehydes.
Lung Injury
Alda-1 Protects Against Acrolein-induced Acute Lung Injury and Endothelial Barrier Dysfunction.
Lung Injury
Effect of low-dose ethanol on NLRP3 inflammasome in diabetes-induced lung injury.
Lung Injury
Effects of the common polymorphism in the human aldehyde dehydrogenase 2 (ALDH2) gene on the lung.
Lung Injury
Ethanol at low concentration attenuates diabetes induced lung injury in rats model.
Lung Injury
Metabolic disturbances of the vitamin A pathway in human diaphragmatic hernia.
Lung Neoplasms
?-Escin Inhibits NNK-Induced Lung Adenocarcinoma and ALDH1A1 and RhoA/Rock Expression in A/J Mice and Growth of H460 Human Lung Cancer Cells.
Lung Neoplasms
A prospective study of association of cancer stem cell marker aldehyde dehydrogenase 1 with clinicopathological profile in lung carcinoma patients.
Lung Neoplasms
Advances in cancer epidemiology in Japan.
Lung Neoplasms
Aldehyde dehyderogenase (ALDH1A1) delineating the normal and cancer stem cells in spectral lung lesions: An immunohistochemical appraisal.
Lung Neoplasms
Aldehyde Dehydrogenase 1 (ALDH1) Promotes the Toxicity of TRAIL in Non-Small Cell Lung Cancer Cells via Post-Transcriptional Regulation of MEK-1 Expression.
Lung Neoplasms
Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: identification of prognostic microenvironmental factors after chemoradiation.
Lung Neoplasms
Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
Lung Neoplasms
Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
Lung Neoplasms
Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
Lung Neoplasms
Aldehyde dehydrogenases in early stage lung cancer: nuclear expression.
Lung Neoplasms
ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells.
Lung Neoplasms
ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors.
Lung Neoplasms
ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis.
Lung Neoplasms
ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors.
Lung Neoplasms
ALDH2 Repression Promotes Lung Tumor Progression via Accumulated Acetaldehyde and DNA Damage.
Lung Neoplasms
ATG7-mediated autophagy involves in miR-138-5p regulated self-renewal and invasion of lung cancer stem-like cells derived from A549 cells.
Lung Neoplasms
Auramine O, an incense smoke ingredient, promotes lung cancer malignancy.
Lung Neoplasms
Blockade of Notch3 inhibits the stem-like property and is associated with ALDH1A1 and CD44 via autophagy in non-small lung cancer.
Lung Neoplasms
Cancer stem cell marker Musashi-1 rs2522137 genotype is associated with an increased risk of lung cancer.
Lung Neoplasms
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung.
Lung Neoplasms
Casticin suppresses self-renewal and invasion of lung cancer stem-like cells from A549 cells through down-regulation of pAkt.
Lung Neoplasms
Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target.
Lung Neoplasms
CircRNA circ_POLA2 promotes lung cancer cell stemness via regulating the miR-326/GNB1 axis.
Lung Neoplasms
Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis.
Lung Neoplasms
Comparative proteomic analysis of anti-cancer mechanism by periplocin treatment in lung cancer cells.
Lung Neoplasms
Comprehensive proteomic profiling of aldehyde dehydrogenases in lung adenocarcinoma cell lines.
Lung Neoplasms
Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP.
Lung Neoplasms
Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes.
Lung Neoplasms
Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
Lung Neoplasms
Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.
Lung Neoplasms
Effect of alcohol and its metabolites in lung cancer: CAPUA study.
Lung Neoplasms
Effects of acetaldehyde inhalation in mitochondrial aldehyde dehydrogenase deficient mice (Aldh2-/-).
Lung Neoplasms
Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.
Lung Neoplasms
Exosomes carrying ALDOA and ALDH3A1 from irradiated lung cancer cells enhance migration and invasion of recipients by accelerating glycolysis.
Lung Neoplasms
Finding Genes Discriminating Smokers from Non-smokers by Applying a Growing Self-organizing Clustering Method to Large Airway Epithelium Cell Microarray Data.
Lung Neoplasms
Garcinol from Garcinia indica Downregulates Cancer Stem-like Cell Biomarker ALDH1A1 in Nonsmall Cell Lung Cancer A549 Cells through DDIT3 Activation.
Lung Neoplasms
Ginsenoside Rg3 attenuates the osimertinib resistance by reducing the stemness of non-small cell lung cancer cells.
Lung Neoplasms
GnRH participates in the self-renewal of A549-derived lung cancer stem-like cells through upregulation of the JNK signaling pathway.
Lung Neoplasms
Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer.
Lung Neoplasms
HSPA1L Enhances Cancer Stem Cell-Like Properties by Activating IGF1R? and Regulating ?-Catenin Transcription.
Lung Neoplasms
Impact of smoking on lung cancer risk is stronger in those with the homozygous aldehyde dehydrogenase 2 null allele in a Japanese population.
Lung Neoplasms
Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans.
Lung Neoplasms
Itraconazole Alters the Stem Cell Characteristics of A549 and NCI-H460 Human Lung Cancer Cells by Suppressing Wnt Signaling.
Lung Neoplasms
Long-term PM2.5 exposure increases the risk of non-small cell lung cancer (NSCLC) progression by enhancing interleukin-17a (IL-17a)-regulated proliferation and metastasis.
Lung Neoplasms
Low-folate stress reprograms cancer stem cell-like potentials and bioenergetics metabolism through activation of mTOR signaling pathway to promote in vitro invasion and in vivo tumorigenicity of lung cancers.
Lung Neoplasms
Lung cancer stem cells-origin, characteristics and therapy.
Lung Neoplasms
Measurement of Aldehyde Dehydrogenase 1 Expression Defines a Group with Better Prognosis in Patients with Non-Small Cell Lung Cancer.
Lung Neoplasms
Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Lung Neoplasms
Multiple Copies in T-Cell Malignancy 1 (MCT-1) Promotes the Stemness of Non-Small Cell Lung Cancer Cells via Activating Interleukin-6 (IL-6) Signaling through Suppressing MiR-34a Expression.
Lung Neoplasms
Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
Lung Neoplasms
PPARgamma-mediated ALDH1A3 suppression exerts anti-proliferative effects in lung cancer by inducing lipid peroxidation.
Lung Neoplasms
Prognostic value of ALDH1 expression in lung cancer: a meta-analysis.
Lung Neoplasms
Puerarin 6?-O-xyloside suppresses growth, self-renewal and invasion of lung cancer stem-like cells derived from A549 cells via regulating Akt/c-Myc signalling.
Lung Neoplasms
Serum ALDH1A1 is a tumor marker for the diagnosis of non-small cell lung cancer.
Lung Neoplasms
Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells.
Lung Neoplasms
Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin.
Lung Neoplasms
Susceptibility to lung cancer and genetic polymorphisms in the alcohol metabolite-related enzymes alcohol dehydrogenase 3, aldehyde dehydrogenase 2, and cytochrome P450 2E1 in the Japanese population.
Lung Neoplasms
Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
Lung Neoplasms
TAZ induces lung cancer stem cell properties and tumorigenesis by up-regulating ALDH1A1.
Lung Neoplasms
The cancer stem-cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy.
Lung Neoplasms
The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.
Lung Neoplasms
The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer.
Lung Neoplasms
The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
Lung Neoplasms
[Expression of Acetaldehyde Dehydrogenase in Gefitinib-resistant Human Lung Adenocarcinoma HCC-827/GR Cells].
Lymphatic Metastasis
A review of the racial heterogeneity of breast cancer stem cells.
Lymphatic Metastasis
Aberrant expression of ALDH1, MMP9, Integrin ?v?3, and KiSS-1 in invasive ductal carcinoma and their clinical significance.
Lymphatic Metastasis
Aldehyde Dehydragenase 1 and Nodal as Significant Prognostic Markers in Colorectal Cancer.
Lymphatic Metastasis
Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.
Lymphatic Metastasis
ALDH1 as a prognostic marker for lymph node metastasis in OSCC.
Lymphatic Metastasis
ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis.
Lymphatic Metastasis
ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer.
Lymphatic Metastasis
ALDH3A1 acts as a prognostic biomarker and inhibits the epithelial mesenchymal transition of oral squamous cell carcinoma through IL-6/STAT3 signaling pathway.
Lymphatic Metastasis
Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
Lymphatic Metastasis
Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis.
Lymphatic Metastasis
Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis.
Lymphatic Metastasis
Clinicopathological Significance of CD133 and ALDH1 Cancer Stem Cell Marker Expression in Invasive Ductal Breast Carcinoma.
Lymphatic Metastasis
Combined expression of aldehyde dehydrogenase 1A1 and ?-catenin is associated with lymph node metastasis and poor survival in breast cancer patients following cyclophosphamide treatment.
Lymphatic Metastasis
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
Lymphatic Metastasis
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Lymphatic Metastasis
Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor.
Lymphatic Metastasis
Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.
Lymphatic Metastasis
Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
Lymphatic Metastasis
Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases.
Lymphatic Metastasis
Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
Lymphatic Metastasis
High ALDH1A1 expression indicates a poor prognosis in gastric neuroendocrine carcinoma.
Lymphatic Metastasis
High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis.
Lymphatic Metastasis
Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Lymphatic Metastasis
Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Lymphatic Metastasis
Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression.
Lymphatic Metastasis
Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer.
Lymphatic Metastasis
Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Lymphatic Metastasis
Prognostic value of ALDH1 expression in lung cancer: a meta-analysis.
Lymphatic Metastasis
Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.
Lymphatic Metastasis
Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.
Lymphatic Metastasis
The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.
Lymphatic Metastasis
The expressions of CD133, ALDH1, and vasculogenic mimicry in osteosarcoma and their clinical significance.
Lymphatic Metastasis
The long non-coding RNA MACC1-AS1 promotes nasopharyngeal carcinoma cell stemness via suppressing miR-145-mediated inhibition on SMAD2/MACC1-AS1 axis.
Lymphatic Metastasis
The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
Lymphatic Metastasis
The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Lymphatic Metastasis
Value of CagA, HER2, ALDH1, and KiSS-1 in predicting metastasis and prognosis for gastric adenocarcinoma.
Lymphatic Metastasis
Vasculogenic mimicry and expression of ALDH1, Beclin1, and p16 correlate with metastasis and prognosis in oral squamous cell carcinoma.
Lymphatic Metastasis
[Expression and Clinical Significance of ALDH1 and Twist in Gastric Adenocarcinoma].
Lymphatic Metastasis
[Expression of ALDH1, CXCR4 and E-cadherin in castric carcinoma and their roles in lymphatic metastasis].
Lymphatic Metastasis
[Expressions and Significance of ALDH1, HIF-1? and VEGF in Laryngeal Squamous Cell Carcinoma].
Lymphatic Metastasis
[High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma].
Lymphoma
ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen.
Lymphoma
Expression of CD44, CD44v9, ABCG2, CD24, Bmi-1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological factors.
Lymphoma
Gene-environment Interactions and Polymorphism Studies of Cancer Risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II).
Lymphoma
Significance of aldehyde dehydrogenase 1 expression in stromal cells of diffuse large B-cell lymphoma.
Lymphoma, B-Cell
ALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway.
Lymphoma, B-Cell
ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen.
Lymphoma, B-Cell
Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP.
Lymphoma, B-Cell
Significance of aldehyde dehydrogenase 1 expression in stromal cells of diffuse large B-cell lymphoma.
Lymphoma, B-Cell
WITHDRAWN: ALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway.
Lymphoma, Large B-Cell, Diffuse
ALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway.
Lymphoma, Large B-Cell, Diffuse
ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen.
Lymphoma, Large B-Cell, Diffuse
Significance of aldehyde dehydrogenase 1 expression in stromal cells of diffuse large B-cell lymphoma.
Lymphoma, Large B-Cell, Diffuse
WITHDRAWN: ALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway.
Lymphoma, Non-Hodgkin
The role of aldehyde dehydrogenase 1A1 in B-cell non-Hodgkin's lymphoma.
Macular Degeneration
Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
Malaria
Multiple-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage.
Mastitis
High expression of aldehyde dehydrogenase 1 and tissue necrosis factor alpha may relate to chronic infection of buffalo mammary gland.
medium-chain acyl-coa dehydrogenase deficiency
Detection of single nucleotide substitution by competitive allele-specific short oligonucleotide hybridization (CASSOH) with immunochromatographic strip.
Melanoma
ALDH1 Bio-activates Nifuroxazide to Eradicate ALDHHigh Melanoma-Initiating Cells.
Melanoma
ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
Melanoma
ALDH3A1 Overexpression in Melanoma and Lung Tumors Drives Cancer Stem Cell Expansion, Impairing Immune Surveillance through Enhanced PD-L1 Output.
Melanoma
Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes.
Melanoma
Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.
Melanoma
Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis.
Melanoma
High ALDH1 expression correlates with better prognosis in tumorigenic malignant melanoma.
Melanoma
Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach.
Melanoma
Prognostic impact of the putative cancer stem cell markers ABCG2, CD133, ALDH1A1 and CD44V7/8 in metastatic melanoma.
Melanoma
Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype.
Melanoma
Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma.
Melanoma
Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients.
Melanosis
Esophageal melanosis, an endoscopic finding associated with squamous cell neoplasms of the upper aerodigestive tract, and inactive aldehyde dehydrogenase-2 in alcoholic Japanese men.
Melanosis
Melanosis and squamous cell neoplasms of the upper aerodigestive tract in Japanese alcoholic men.
Melanosis
Soft palatal melanosis, a simple predictor for neoplasia in the upper aerodigestive tract in Japanese alcoholic men.
MELAS Syndrome
No association of ALDH2 genotype in MELAS.
Memory Disorders
Age-dependent neurodegeneration accompanying memory loss in transgenic mice defective in mitochondrial aldehyde dehydrogenase 2 activity.
Memory Disorders
Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification.
Meningioma
Differential Diagnosis of Meningeal SFT-HPC and Meningioma: Which Immunohistochemical Markers Should Be Used?
Meningioma
Intracranial anaplastic solitary fibrous tumor/hemangiopericytoma: immunohistochemical markers for definitive diagnosis.
Meningomyelocele
Analysis of ALDH1A2, CYP26A1, CYP26B1, CRABP1, and CRABP2 in human neural tube defects suggests a possible association with alleles in ALDH1A2.
Mesothelioma
Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma.
Metabolic Diseases
Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease.
Metabolic Diseases
Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders.
Metabolic Syndrome
Aldehyde dehydrogenase 2 and beta3-adrenergic receptor gene polymorphisms: their association with elevated liver enzymes and metabolic syndrome.
Metabolic Syndrome
Aldehyde Dehydrogenase Mutation Exacerbated High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease with Gut Microbiota Remodeling in Male Mice.
Metabolic Syndrome
Aldehyde Dehydrogenase-2 Attenuates Myocardial Remodeling and Contractile Dysfunction Induced by a High-Fat Diet.
Metabolic Syndrome
Change of components of the metabolic syndrome in a workers' health checkup after five years--relation with elevated liver enzymes, gene polymorphisms for ALDH 2, beta3-AR and lifestyle.
Metabolic Syndrome
Human-induced pluripotent stem cell approaches to model inborn and acquired metabolic heart diseases.
Microphthalmos
A homozygous mutation in a consanguineous family consolidates the role of ALDH1A3 in autosomal recessive microphthalmia.
Microphthalmos
ALDH1A3 mutations cause recessive anophthalmia and microphthalmia.
Microphthalmos
Conserved missense variant in ALDH1A3 ortholog impairs fecundity in C. elegans.
Microphthalmos
Mutations in ALDH1A3 cause microphthalmia.
Microphthalmos
Novel mutations in ALDH1A3 associated with autosomal recessive anophthalmia/microphthalmia, and review of the literature.
Mitochondrial Diseases
Mitochondrial aldehyde dehydrogenase in diabetes associated with mitochondrial tRNA(Leu(UUR)) mutation at position 3243.
Mouth Neoplasms
Alcohol intake and folate antagonism via CYP2E1 and ALDH1: effects on oral carcinogenesis.
Mouth Neoplasms
Aldehyde dehydrogenase 2 and glutathione S-transferase M 1 polymorphisms in relation to the risk for oral cancer in Japanese drinkers.
Mouth Neoplasms
ALDH1 and podoplanin expression patterns predict the risk of malignant transformation in oral leukoplakia.
Mouth Neoplasms
Epigenetic therapy regulates the expression of ALDH1 and immunologic response: Relevance to the prognosis of oral cancer.
Mouth Neoplasms
Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer.
Mouth Neoplasms
Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.
Mouth Neoplasms
Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit.
Mouth Neoplasms
MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer.
Mouth Neoplasms
Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages.
Mouth Neoplasms
Prognostic Implications of ALDH1 and Notch1 in Different Subtypes of Oral Cancer.
Multiple Myeloma
Aldehyde dehydrogenase 1A1: friend or foe to female metabolism?
Multiple Myeloma
Aldehyde dehydrogenase-1a1 induces oncogene suppressor genes in B cell populations.
Multiple Myeloma
ALDH1 activity identifies tumor-initiating cells and links to chromosomal instability signatures in multiple myeloma.
Multiple Myeloma
Disulfiram/copper targets stem cell-like ALDH+ population of multiple myeloma by inhibition of ALDH1A1 and Hedgehog pathway.
Multiple Myeloma
NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma.
Multiple Myeloma
[Gene expression of key enzymes for all-trans- retinoic acid biosynthesis - ALDHJAI and RDH10: relationship with co-expression of nuclear receptors RAR? and PPAR?/? genes and some clinical characteristics in multiple myeloma.
Muscle Spasticity
Alcohol flushing and positive ethanol patch test in patients with coronary spastic angina: possible role of aldehyde dehydrogenase 2 polymorphisms.
Muscle Spasticity
East Asian Variant of Aldehyde Dehydrogenase 2 (ALDH2*2) is Associated with Coronary Spastic Angina: Possible Roles of Reactive Aldehydes and Implications of Alcohol Flushing Syndrome.
Muscle Spasticity
East Asians Variant Mitochondrial Aldehyde Dehydrogenase 2 Genotype Exacerbates Nitrate Tolerance in Patients With Coronary Spastic Angina.
Muscle Spasticity
Letter by Ortega-Paz et al Regarding Article, "East Asian Variant of Aldehyde Dehydrogenase 2 Is Associated With Coronary Spastic Angina: Possible Roles of Reactive Aldehydes and Implications of Alcohol Flushing Syndrome".
Muscle Spasticity
Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.
Muscle Spasticity
Novel Mutation in Sjogren-Larsson Syndrome Is Associated With Divergent Neurologic Phenotypes.
Muscle Spasticity
Response to Letter Regarding Article, "East Asian Variant of Aldehyde Dehydrogenase 2 Is Associated With Coronary Spastic Angina: Possible Roles of Reactive Aldehydes and Implications of Alcohol Flushing Syndrome".
Muscle Spasticity
Sjögren-Larsson syndrome: Novel mutations in the ALDH3A2 gene in a French cohort.
Muscular Atrophy
ALDH2 mutation promotes skeletal muscle atrophy in mice via accumulation of oxidative stress.
Muscular Atrophy
Mitochondrial Aldehyde Dehydrogenase 2 Regulates Revascularization in Chronic Ischemia: Potential Impact on the Development of Coronary Collateral Circulation.
Muscular Atrophy
Preventive effects of Chlorella on skeletal muscle atrophy in muscle-specific mitochondrial aldehyde dehydrogenase 2 activity-deficient mice.
Myocardial Infarction
A Glu487Lys polymorphism in the gene for mitochondrial aldehyde dehydrogenase 2 is associated with myocardial infarction in elderly Korean men.
Myocardial Infarction
Aberrant hypermethylation of aldehyde dehydrogenase 2 promoter upstream sequence in rats with experimental myocardial infarction.
Myocardial Infarction
Alda?1, an aldehyde dehydrogenase?2 agonist, improves long?term survival in rats with chronic heart failure following myocardial infarction.
Myocardial Infarction
Aldehyde dehydrogenase 2 activation and coevolution of its ?PKC-mediated phosphorylation sites.
Myocardial Infarction
Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese men.
Myocardial Infarction
Aldehyde Dehydrogenase 2 Has Cardioprotective Effects on Myocardial Ischaemia/Reperfusion Injury via Suppressing Mitophagy.
Myocardial Infarction
Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?
Myocardial Infarction
Aldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt/?-catenin signaling pathway.
Myocardial Infarction
ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance.
Myocardial Infarction
ALDH2 Glu504Lys polymorphism and susceptibility to coronary artery disease and myocardial infarction in East Asians: a meta-analysis.
Myocardial Infarction
ALDH2 rs671 Polymorphism and coronary heart disease risk among Asian populations: a meta-analysis and meta-regression.
Myocardial Infarction
APSH YI-02 THE POLYMORPHISM IN ALDEHYDE DEHYDROGENASE-2 (ALDH2) GENE IS ASSOCIATED WITH MYOCARDIAL INFARCTION AND STROKE IN A CHINESE POPULATION.
Myocardial Infarction
Association between ALDH2 Glu504Lys Polymorphism and Susceptibility to Coronary Artery Disease and Myocardial Infarction: Need for Clarification of Data in a Recent Meta-analysis.
Myocardial Infarction
Association of Aldehyde Dehydrogenase 2 Gene Polymorphism with Myocardial Infarction.
Myocardial Infarction
Association of East Asian Variant Aldehyde Dehydrogenase 2 Genotype (ALDH2*2*) with Coronary Spasm and Acute Myocardial Infarction.
Myocardial Infarction
Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardial infarction: a meta-analysis.
Myocardial Infarction
Association of Genetically Determined Aldehyde Dehydrogenase 2 Activity with Diabetic Complications in Relation to Alcohol Consumption in Japanese Patients with Type 2 Diabetes Mellitus: The Fukuoka Diabetes Registry.
Myocardial Infarction
Combined effects of current-smoking and the aldehyde dehydrogenase 2*2 allele on the risk of myocardial infarction in Japanese patients.
Myocardial Infarction
Diabetic Aldehyde Dehydrogenase 2 Mutant (ALDH2*2) Mice Are More Susceptible to Cardiac Ischemic-Reperfusion Injury Due to 4-Hydroxy-2-Nonenal Induced Coronary Endothelial Cell Damage.
Myocardial Infarction
East Asian variant aldehyde dehydrogenase type 2 genotype exacerbates ischemia/reperfusion injury with ST-elevation myocardial infarction in men: possible sex differences.
Myocardial Infarction
Efficient expression of codon-adapted human acetaldehyde dehydrogenase 2 cDNA with 6xHis tag in Pichia pastoris.
Myocardial Infarction
Genetic deficiency of a mitochondrial aldehyde dehydrogenase increases serum lipid peroxides in community-dwelling females.
Myocardial Infarction
Identification of Candidate Genes and MicroRNAs for Acute Myocardial Infarction by Weighted Gene Coexpression Network Analysis.
Myocardial Infarction
MicroRNA-34a Promotes Cardiomyocyte Apoptosis Post Myocardial Infarction Through Down-regulating Aldehyde Dehydrogenase 2.
Myocardial Infarction
miR-28 promotes cardiac ischemia by targeting mitochondrial aldehyde dehydrogenase 2 (ALDH2) in mus musculus cardiac myocytes.
Myocardial Infarction
Mitochondrial aldehyde dehydrogenase 2 plays protective roles in heart failure after myocardial infarction via suppression of the cytosolic JNK/p53 pathway in mice.
Myocardial Infarction
Mitochondrial aldehyde dehydrogenase in myocardial ischemia-reperfusion injury: from bench to bedside.
Myocardial Infarction
Mitochondrial import of PKCepsilon is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury.
Myocardial Infarction
Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications.
Myocardial Infarction
Regulation of Human Mitochondrial Aldehyde Dehydrogenase (ALDH-2) Activity by Electrophiles in Vitro.
Myocardial Infarction
Reply to: ALDH2 Glu504Lys Polymorphism and Susceptibility to Coronary Artery Disease and Myocardial Infarction in East Asians: A Meta-analysis.
Myocardial Infarction
The polymorphism in aldehyde dehydrogenase-2 gene is associated with elevated plasma levels of high-sensitivity C-reactive protein in the early phase of myocardial infarction.
Myocardial Infarction
Variant Aldehyde Dehydrogenase 2 (ALDH2*2) Is a Risk Factor for Coronary Spasm and ST-Segment Elevation Myocardial Infarction.
Myocardial Ischemia
Aberrant hypermethylation of aldehyde dehydrogenase 2 promoter upstream sequence in rats with experimental myocardial infarction.
Myocardial Ischemia
Aldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt/?-catenin signaling pathway.
Myocardial Ischemia
miR-28 promotes cardiac ischemia by targeting mitochondrial aldehyde dehydrogenase 2 (ALDH2) in mus musculus cardiac myocytes.
Myocardial Ischemia
Salvaging the ischemic heart: Gi-coupled receptors in mast cells activate a PKC?/ALDH2 pathway providing anti-RAS cardioprotection.
Myoma
Acetaldehyde differentially affects the growth of uterine leiomyomata and myometrial cells in tissue cultures.
Nasopharyngeal Carcinoma
Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Increased expression of aldehyde dehydrogenase 1 A1 in nasopharyngeal carcinoma is associated with enhanced invasiveness.
Nasopharyngeal Carcinoma
Tumour budding and the expression of cancer stem cell marker aldehyde dehydrogenase 1 in nasopharyngeal carcinoma.
Nasopharyngitis
Inflammation-Related DNA Damage and Cancer Stem Cell Markers in Nasopharyngeal Carcinoma.
Neoplasm Metastasis
?-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids.
Neoplasm Metastasis
A review of the racial heterogeneity of breast cancer stem cells.
Neoplasm Metastasis
A triple negative breast cancer: what it is not!
Neoplasm Metastasis
Aberrant expression of ALDH1, MMP9, Integrin ?v?3, and KiSS-1 in invasive ductal carcinoma and their clinical significance.
Neoplasm Metastasis
Aldehyde Dehydragenase 1 and Nodal as Significant Prognostic Markers in Colorectal Cancer.
Neoplasm Metastasis
Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.
Neoplasm Metastasis
Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.
Neoplasm Metastasis
Aldehyde dehydrogenase 1 expression correlates with clinicopathologic features of patients with breast cancer: a meta-analysis.
Neoplasm Metastasis
Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.
Neoplasm Metastasis
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.
Neoplasm Metastasis
Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.
Neoplasm Metastasis
Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells is Primarily Due to Isoform ALDH1A3 and Its Expression is Predictive of Metastasis.
Neoplasm Metastasis
Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Neoplasm Metastasis
Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice.
Neoplasm Metastasis
ALDH1 as a prognostic marker for lymph node metastasis in OSCC.
Neoplasm Metastasis
ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis.
Neoplasm Metastasis
ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status.
Neoplasm Metastasis
ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer.
Neoplasm Metastasis
ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
Neoplasm Metastasis
ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer.
Neoplasm Metastasis
ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose Metabolism.
Neoplasm Metastasis
ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells.
Neoplasm Metastasis
ALDH3A1 acts as a prognostic biomarker and inhibits the epithelial mesenchymal transition of oral squamous cell carcinoma through IL-6/STAT3 signaling pathway.
Neoplasm Metastasis
ALDH3A1 driving tumor metastasis is mediated by p53/BAG1 in lung adenocarcinoma.
Neoplasm Metastasis
Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
Neoplasm Metastasis
Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Neoplasm Metastasis
Bmi-1 Regulates Snail Expression and Promotes Metastasis Ability in Head and Neck Squamous Cancer-Derived ALDH1 Positive Cells.
Neoplasm Metastasis
Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
Neoplasm Metastasis
Cancer stem cell markers in eyelid sebaceous gland carcinoma: high expression of ALDH1, CD133, and ABCG2 correlates with poor prognosis.
Neoplasm Metastasis
Causal Bayesian gene networks associated with bone, brain and lung metastasis of breast cancer.
Neoplasm Metastasis
CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
Neoplasm Metastasis
Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis.
Neoplasm Metastasis
Clinicopathological correlation of stem cell markers expression in oral squamous cell carcinoma; relation to patients` outcome.
Neoplasm Metastasis
Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis.
Neoplasm Metastasis
Clinicopathological Significance of CD133 and ALDH1 Cancer Stem Cell Marker Expression in Invasive Ductal Breast Carcinoma.
Neoplasm Metastasis
Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases.
Neoplasm Metastasis
Combined expression of aldehyde dehydrogenase 1A1 and ?-catenin is associated with lymph node metastasis and poor survival in breast cancer patients following cyclophosphamide treatment.
Neoplasm Metastasis
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
Neoplasm Metastasis
Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer.
Neoplasm Metastasis
Correlations of aldehyde dehydrogenase-1 (ALDH1) expression with traditional prognostic parameters and different molecular subtypes of breast carcinoma.
Neoplasm Metastasis
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Neoplasm Metastasis
Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells.
Neoplasm Metastasis
Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis.
Neoplasm Metastasis
Discovery of microarray-identified genes associated with ovarian cancer progression.
Neoplasm Metastasis
Distinct patterns of ALDH1A1 expression predict metastasis and poor outcome of colorectal carcinoma.
Neoplasm Metastasis
Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype.
Neoplasm Metastasis
EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
Neoplasm Metastasis
Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor.
Neoplasm Metastasis
Evaluation of expression of cancer stem cell markers and fusion gene in synovial sarcoma: Insights into histogenesis and pathogenesis.
Neoplasm Metastasis
Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.
Neoplasm Metastasis
Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma.
Neoplasm Metastasis
Exploration of bladder cancer molecular mechanisms based on miRNA-mRNA regulatory network.
Neoplasm Metastasis
Expression Analysis of Aldehyde Dehydrogenase 1A1 (ALDH1A1) in Colon and Rectal Cancer in Association with Prognosis and Response to Chemotherapy.
Neoplasm Metastasis
Expression of Aldehyde Dehydrogenase (ALDH1) and ATP Binding Cassette Transporter G2 (ABCG2) in Iraqi Patients with Colon Cancer and the Relation with Clinicopathological Features.
Neoplasm Metastasis
Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
Neoplasm Metastasis
Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases.
Neoplasm Metastasis
Expression of ALDH1A1 and CD133 is associated with the prognosis and effect of different chemotherapeutic regimens in gastric cancer.
Neoplasm Metastasis
Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
Neoplasm Metastasis
Expression of CD44, CD44v9, ABCG2, CD24, Bmi-1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological factors.
Neoplasm Metastasis
Gastric Adenocarcinoma Biomarker Expression Profiles and their Prognostic Value.
Neoplasm Metastasis
High ALDH1A1 expression indicates a poor prognosis in gastric neuroendocrine carcinoma.
Neoplasm Metastasis
High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis.
Neoplasm Metastasis
Identification of ALDH1A3 as a viable therapeutic target in breast cancer metastasis-initiating cells.
Neoplasm Metastasis
Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Neoplasm Metastasis
Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer.
Neoplasm Metastasis
Mesenchymal Stem/Stromal Cell Engulfment Reveals Metastatic Advantage in Breast Cancer.
Neoplasm Metastasis
Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
Neoplasm Metastasis
Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Neoplasm Metastasis
Methylation-Induced Silencing of ALDH2 Facilitates Lung Adenocarcinoma Bone Metastasis by Activating the MAPK Pathway.
Neoplasm Metastasis
MicroRNA?487b?3p inhibits osteosarcoma chemoresistance and metastasis by targeting ALDH1A3.
Neoplasm Metastasis
MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
Neoplasm Metastasis
MIR600HG suppresses metastasis and enhances oxaliplatin chemosensitivity by targeting ALDH1A3 in colorectal cancer.
Neoplasm Metastasis
Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression.
Neoplasm Metastasis
Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.
Neoplasm Metastasis
Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
Neoplasm Metastasis
Overexpression of ALDH1 and EMT marker profile are linked with unfavorable outcome in head and neck cancer.
Neoplasm Metastasis
Phosphorylation-dependent regulation of ALDH1A1 by Aurora kinase A: insights on their synergistic relationship in pancreatic cancer.
Neoplasm Metastasis
Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.
Neoplasm Metastasis
Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer.
Neoplasm Metastasis
Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.
Neoplasm Metastasis
Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Neoplasm Metastasis
Prognostic value of ALDH1 expression in lung cancer: a meta-analysis.
Neoplasm Metastasis
Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells.
Neoplasm Metastasis
RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance.
Neoplasm Metastasis
Reporters of Cancer Stem Cells as a Tool for Drug Discovery.
Neoplasm Metastasis
Silencing TAK1 alters gene expression signatures in bladder cancer cells.
Neoplasm Metastasis
Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.
Neoplasm Metastasis
SOX9 Regulates Cancer Stem-Like Properties and Metastatic Potential of Single-Walled Carbon Nanotube-Exposed Cells.
Neoplasm Metastasis
Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.
Neoplasm Metastasis
Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.
Neoplasm Metastasis
Tamoxifen enhances stemness and promotes metastasis of ER?36
Neoplasm Metastasis
Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma.
Neoplasm Metastasis
The Effect of P-Glycoprotein (P-gp), Nuclear Factor-Kappa B (Nf-?b), and Aldehyde Dehydrogenase-1 (ALDH-1) Expression on Metastases, Recurrence and Survival in Advanced Breast Cancer Patients
Neoplasm Metastasis
The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.
Neoplasm Metastasis
The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
Neoplasm Metastasis
The expressions of CD133, ALDH1, and vasculogenic mimicry in osteosarcoma and their clinical significance.
Neoplasm Metastasis
The long non-coding RNA MACC1-AS1 promotes nasopharyngeal carcinoma cell stemness via suppressing miR-145-mediated inhibition on SMAD2/MACC1-AS1 axis.
Neoplasm Metastasis
The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
Neoplasm Metastasis
The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Neoplasm Metastasis
The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
Neoplasm Metastasis
Tracing Tumor Evolution in Sarcoma Reveals Clonal Origin of Advanced Metastasis.
Neoplasm Metastasis
Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Neoplasm Metastasis
Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain.
Neoplasm Metastasis
Value of CagA, HER2, ALDH1, and KiSS-1 in predicting metastasis and prognosis for gastric adenocarcinoma.
Neoplasm Metastasis
Vasculogenic mimicry and expression of ALDH1, Beclin1, and p16 correlate with metastasis and prognosis in oral squamous cell carcinoma.
Neoplasm Metastasis
[Expression and Clinical Significance of ALDH1 and Twist in Gastric Adenocarcinoma].
Neoplasm Metastasis
[Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship with Ovarian Cancer Stem Cell Markers CD117, CD133, ALDH1.]
Neoplasm Metastasis
[Expression of ALDH1, CXCR4 and E-cadherin in castric carcinoma and their roles in lymphatic metastasis].
Neoplasm Metastasis
[Expressions and Significance of ALDH1, HIF-1? and VEGF in Laryngeal Squamous Cell Carcinoma].
Neoplasm Metastasis
[High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma].
Neoplasm Metastasis
[Proliferation of cancer stem cells in colorectal adenocarcinoma].
Neoplasm, Residual
IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells.
Neoplasm, Residual
Proliferation rate and breast cancer subtype, but not ALDH1 expression, predict pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.
Neoplasm, Residual
Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
Neoplasm, Residual
[Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship with Ovarian Cancer Stem Cell Markers CD117, CD133, ALDH1.]
Neoplasms
(-)-Epigallocatechin gallate inhibits stemness and tumourigenicity stimulated by AXL receptor tyrosine kinase in human lung cancer cells.
Neoplasms
2D-PAGE of ovarian cancer: analysis of soluble and insoluble fractions using medium-range immobilized pH gradients.
Neoplasms
75P Inhibition and exploitation of aldehyde dehydrogenase 1 (ALDH1) as a cancer stem cell marker in cisplatin resistant NSCLC.
Neoplasms
?,?-Acetylenic Amino Thiolester Inhibitors of Aldehyde Dehydrogenases 1&3: Suppressors of Apoptogenic Aldehyde Oxidation and Activators of Apoptosis.
Neoplasms
?-Arrestins regulate stem cell-like phenotype and response to chemotherapy in bladder cancer.
Neoplasms
?-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids.
Neoplasms
?-catenin/POU5F1/SOX2 transcription factor complex mediates IGF-1 receptor signaling and predicts poor prognosis in lung adenocarcinoma.
Neoplasms
A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
Neoplasms
A combination of nuclear ?-catenin and atypical scores as useful diagnostic markers for borderline malignancy of gastric tumours.
Neoplasms
A comparison of covalent binding of ethanol metabolites to DNA according to Aldh2 genotype.
Neoplasms
A glycolysis-related gene expression signature in predicting recurrence of breast cancer.
Neoplasms
A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity.
Neoplasms
A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer.
Neoplasms
A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells.
Neoplasms
A novel HSP90 inhibitor targeting the C-terminal domain attenuates trastuzumab resistance in HER2-positive breast cancer.
Neoplasms
A novel orthotopic mouse model of head and neck cancer and lymph node metastasis.
Neoplasms
A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
Neoplasms
A prospective study of association of cancer stem cell marker aldehyde dehydrogenase 1 with clinicopathological profile in lung carcinoma patients.
Neoplasms
A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro.
Neoplasms
A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells.
Neoplasms
A Therapeutic Strategy for Chemotherapy-Resistant Gastric Cancer via Destabilization of Both ?-Catenin and RAS.
Neoplasms
A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.
Neoplasms
A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
Neoplasms
ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.
Neoplasms
Aberrant expression of ALDH1, MMP9, Integrin ?v?3, and KiSS-1 in invasive ductal carcinoma and their clinical significance.
Neoplasms
Ablation of breast cancer stem cells with radiation.
Neoplasms
Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.
Neoplasms
Acetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancers.
Neoplasms
Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Neoplasms
Across-site differences in the mechanism of alcohol-induced digestive tract carcinogenesis: an evaluation by mediation analysis.
Neoplasms
Activation of ALDH2 attenuates high glucose induced rat cardiomyocyte fibrosis and necroptosis.
Neoplasms
Activation of Inflammatory Responses Correlate With Hedgehog Activation and Precede Expansion of Cancer Stem-Like Cells in an Animal Model of Residual Triple Negative Breast Cancer after Neoadjuvant Chemotherapy.
Neoplasms
Activities of cytosolic aldehyde dehydrogenase isozymes in colon cancer: determination using selective, fluorimetric assays.
Neoplasms
Acylglycerol kinase promotes the stemness of nasopharyngeal carcinoma cells by promoting ?-catenin translocation to the nucleus through activating PI3K/Akt pathway.
Neoplasms
Advances in cancer epidemiology in Japan.
Neoplasms
Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
Neoplasms
Aggressive progression of breast cancer with microscopic pulmonary emboli possessing a stem cell-like phenotype independent of its origin.
Neoplasms
Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations.
Neoplasms
Aggressiveness and Metastatic Potential of Breast Cancer Cells Co-Cultured with Preadipocytes and Exposed to an Environmental Pollutant Dioxin: An in Vitro and in Vivo Zebrafish Study.
Neoplasms
Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics.
Neoplasms
Alcohol and aldehyde dehydrogenase gene polymorphisms influence susceptibility to esophageal cancer in Japanese alcoholics.
Neoplasms
Alcohol and aldehyde dehydrogenase polymorphisms and a new strategy for prevention and screening for cancer in the upper aerodigestive tract in East Asians.
Neoplasms
Alcohol and cancer.
Neoplasms
Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer.
Neoplasms
Alcohol drinking and bladder cancer risk from a pooled analysis of ten cohort studies in Japan.
Neoplasms
Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention.
Neoplasms
Alcohol drinking, mean corpuscular volume of erythrocytes, and alcohol metabolic genotypes in drunk drivers.
Neoplasms
Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men.
Neoplasms
Alcohol ingestion and colorectal neoplasia: a meta-analysis based on a Mendelian randomization approach.
Neoplasms
Alcohol intake and folate antagonism via CYP2E1 and ALDH1: effects on oral carcinogenesis.
Neoplasms
Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics.
Neoplasms
Aldehyde dehyderogenase (ALDH1A1) delineating the normal and cancer stem cells in spectral lung lesions: An immunohistochemical appraisal.
Neoplasms
Aldehyde Dehydragenase 1 and Nodal as Significant Prognostic Markers in Colorectal Cancer.
Neoplasms
Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC).
Neoplasms
Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.
Neoplasms
Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma.
Neoplasms
Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma.
Neoplasms
Aldehyde dehydrogenase 1 (ALDH1) positivity correlates with poor prognosis in cervical cancer.
Neoplasms
Aldehyde dehydrogenase 1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma.
Neoplasms
Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.
Neoplasms
Aldehyde dehydrogenase 1 as a predictor of the neoadjuvant chemotherapy response in breast cancer: A meta-analysis.
Neoplasms
Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus.
Neoplasms
Aldehyde dehydrogenase 1 expression correlates with clinicopathologic features of patients with breast cancer: a meta-analysis.
Neoplasms
Aldehyde dehydrogenase 1 expression correlates with the invasion of breast cancer.
Neoplasms
Aldehyde dehydrogenase 1 expression has prognostic significance in patients with glioma.
Neoplasms
Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: identification of prognostic microenvironmental factors after chemoradiation.
Neoplasms
Aldehyde Dehydrogenase 1 Expression in Inflammatory Breast Cancer as Measured by Immunohistochemical Staining.
Neoplasms
Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study.
Neoplasms
Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.
Neoplasms
Aldehyde Dehydrogenase 1 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
Neoplasms
Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
Neoplasms
Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
Neoplasms
Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.
Neoplasms
Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.
Neoplasms
Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.
Neoplasms
Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
Neoplasms
Aldehyde dehydrogenase 1 is associated with recurrence-free survival but not stem cell-like properties in hepatocellular carcinoma.
Neoplasms
Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis.
Neoplasms
Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity.
Neoplasms
Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma.
Neoplasms
Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.
Neoplasms
Aldehyde dehydrogenase 1-positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with lymph node-positive breast cancer.
Neoplasms
Aldehyde Dehydrogenase 1-related Genes in Triple-negative Breast Cancer Investigated Using Network Analysis.
Neoplasms
Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
Neoplasms
Aldehyde dehydrogenase 1: A specific cancer stem cell marker for human colorectal carcinoma.
Neoplasms
Aldehyde dehydrogenase 1A1 and 1A3 isoforms - mechanism of activation and regulation in cancer.
Neoplasms
Aldehyde dehydrogenase 1A1 circumscribes high invasive glioma cells and predicts poor prognosis.
Neoplasms
Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.
Neoplasms
Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy.
Neoplasms
Aldehyde dehydrogenase 1A1 in stem cells and cancer.
Neoplasms
Aldehyde dehydrogenase 1A1 increases NADH levels and promotes tumor growth via glutathione/dihydrolipoic acid-dependent NAD
Neoplasms
Aldehyde dehydrogenase 1A1 up-regulates stem cell markers in benzo[a]pyrene-induced malignant transformation of BEAS-2B cells.
Neoplasms
Aldehyde dehydrogenase 1A3 (ALDH1A3) is regulated by autophagy in human glioblastoma cells.
Neoplasms
Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.
Neoplasms
Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer.
Neoplasms
Aldehyde Dehydrogenase 1B1 as a Modulator of Pancreatic Adenocarcinoma.
Neoplasms
Aldehyde dehydrogenase 1B1 is a potential marker of colorectal tumors.
Neoplasms
Aldehyde Dehydrogenase 1B1 Is Associated with Altered Cell Morphology, Proliferation, Migration and Chemosensitivity in Human Colorectal Adenocarcinoma Cells.
Neoplasms
Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancer.
Neoplasms
Aldehyde dehydrogenase 2 (ALDH2) and alcohol dehydrogenase 1B (ADH1B) polymorphisms exacerbate bladder cancer risk associated with alcohol drinking: Gene-environment interaction.
Neoplasms
Aldehyde Dehydrogenase 2 Ameliorates Chronic Alcohol Consumption-Induced Atrial Fibrillation through Detoxification of 4-HNE.
Neoplasms
Aldehyde dehydrogenase 2 and glutathione S-transferase M 1 polymorphisms in relation to the risk for oral cancer in Japanese drinkers.
Neoplasms
Aldehyde dehydrogenase 2 genotype in tolerability of alcohol contained in paclitaxel in Japanese breast cancer patients.
Neoplasms
Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced Colorectal Cancer Immune Escape through Stabilizing PD-L1 Expression.
Neoplasms
Aldehyde dehydrogenase 2 protects against acute kidney injury by regulating autophagy via the Beclin-1 pathway.
Neoplasms
Aldehyde dehydrogenase 3A1 promotes multi-modality resistance and alters gene expression profile in human breast adenocarcinoma MCF-7 cells.
Neoplasms
Aldehyde Dehydrogenase 3B1 (ALDH3B1): Immunohistochemical Tissue Distribution and Cellular-specific Localization in Normal and Cancerous Human Tissues.
Neoplasms
Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues.
Neoplasms
Aldehyde dehydrogenase activity as a functional marker for lung cancer.
Neoplasms
Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells is Primarily Due to Isoform ALDH1A3 and Its Expression is Predictive of Metastasis.
Neoplasms
Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Neoplasms
Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
Neoplasms
Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
Neoplasms
Aldehyde dehydrogenase activity selects for the holoclone phenotype in prostate cancer cells.
Neoplasms
Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM/ATR inhibitors.
Neoplasms
Aldehyde dehydrogenase is regulated by Beta-catenin/TCF and promotes radioresistance in prostate cancer progenitor cells.
Neoplasms
Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer.
Neoplasms
Aldehyde Dehydrogenase, Liver Disease and Cancer.
Neoplasms
Aldehyde Dehydrogenase-1 Expression Predicts Unfavorable Outcomes in Patients with Esophageal Squamous Cell Carcinoma.
Neoplasms
Aldehyde dehydrogenase-1 positivity is associated with ER negativity in patients with invasive ductal carcinoma of the breast.
Neoplasms
Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice.
Neoplasms
Aldehyde dehydrogenase-2 genotypes and HLA haplotypes in Japanese patients with esophageal cancer.
Neoplasms
Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines.
Neoplasms
Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells.
Neoplasms
Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform.
Neoplasms
Aldehyde dehydrogenases and cell proliferation.
Neoplasms
Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable Target.
Neoplasms
Aldehyde dehydrogenases in early stage lung cancer: nuclear expression.
Neoplasms
Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells.
Neoplasms
Aldehyde-dehydrogenase gene-transduced hematopoietic cell line K562 overcomes the cytoxicity of cyclophosphamide in vitro.
Neoplasms
ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors.
Neoplasms
ALDH1 - A new immunohistochemical diagnostic marker for Schwann cell-derived tumors.
Neoplasms
ALDH1 and tumor infiltrating lymphocytes as predictors for neoadjuvant chemotherapy response in breast cancer.
Neoplasms
ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells.
Neoplasms
ALDH1 as a prognostic marker for lymph node metastasis in OSCC.
Neoplasms
ALDH1 Bio-activates Nifuroxazide to Eradicate ALDHHigh Melanoma-Initiating Cells.
Neoplasms
ALDH1 Cancer Stem Cell Marker as a Prognostic Factor in Triple-Negative Breast Cancer.
Neoplasms
Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations.
Neoplasms
ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis.
Neoplasms
ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data.
Neoplasms
ALDH1 expression correlates with favorable prognosis in ovarian cancers.
Neoplasms
ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer.
Neoplasms
ALDH1 expression is enriched in breast cancers arising in young women but does not predict outcome.
Neoplasms
ALDH1 expression predicts progression of premalignant lesions to cancer in Type I endometrial carcinomas.
Neoplasms
ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinoma.
Neoplasms
ALDH1 in Combination with CD44 as Putative Cancer Stem Cell Markers are Correlated with Poor Prognosis in Urothelial Carcinoma of the Urinary Bladder.
Neoplasms
ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype.
Neoplasms
ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study.
Neoplasms
ALDH1 might influence the metastatic capability of HeLa cells.
Neoplasms
ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status.
Neoplasms
ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer.
Neoplasms
ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors.
Neoplasms
ALDH1A1 and HLTF modulate the activity of lysosomal autophagy inhibitors in cancer cells.
Neoplasms
ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Neoplasms
ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis.
Neoplasms
ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
Neoplasms
ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
Neoplasms
ALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway.
Neoplasms
ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.
Neoplasms
ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients.
Neoplasms
ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling.
Neoplasms
ALDH1A1 maintains the cancer stem-like cells properties of esophageal squamous cell carcinoma by activating the AKT signal pathway and interacting with ?-catenin.
Neoplasms
ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer.
Neoplasms
ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer.
Neoplasms
ALDH1A1 positive cells are a unique component of the tonsillar crypt niche and are lost along with NGFR positive stem cells during tumourigenesis.
Neoplasms
ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.
Neoplasms
ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors.
Neoplasms
ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer.
Neoplasms
ALDH1A2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating STAT3.
Neoplasms
ALDH1A3 affects colon cancer in vitro proliferation and invasion depending on CXCR4 status.
Neoplasms
ALDH1A3 correlates with luminal phenotype in prostate cancer.
Neoplasms
ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
Neoplasms
ALDH1A3, a metabolic target for cancer diagnosis and therapy.
Neoplasms
ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer.
Neoplasms
ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion.
Neoplasms
Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer.
Neoplasms
ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/?-Catenin, Notch and PI3K/Akt Signaling Pathways.
Neoplasms
ALDH2 and Cancer Therapy.
Neoplasms
ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
Neoplasms
ALDH2 gene polymorphism in different types of cancers and its clinical significance.
Neoplasms
Aldh2 gene reduces oxidative stress in the bladder by regulating the NF-?B pathway in a mouse model of ketamine-induced cystitis.
Neoplasms
ALDH2 Genotype Has No Effect on Salivary Acetaldehyde without the Presence of Ethanol in the Systemic Circulation.
Neoplasms
ALDH2 modulates autophagy flux to regulate acetaldehyde-mediated toxicity thresholds.
Neoplasms
ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective.
Neoplasms
ALDH2 Polymorphism and Ethanol Consumption: A Genetic-Environmental Interaction in Carcinogenesis.
Neoplasms
ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies.
Neoplasms
ALDH2 Repression Promotes Lung Tumor Progression via Accumulated Acetaldehyde and DNA Damage.
Neoplasms
ALDH2(E487K) mutation increases protein turnover and promotes murine hepatocarcinogenesis.
Neoplasms
ALDH2-deficiency as genetic epidemiologic and biochemical model for the carcinogenicity of acetaldehyde.
Neoplasms
ALDH3A1 driving tumor metastasis is mediated by p53/BAG1 in lung adenocarcinoma.
Neoplasms
ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway.
Neoplasms
ALDH3A1 Overexpression in Melanoma and Lung Tumors Drives Cancer Stem Cell Expansion, Impairing Immune Surveillance through Enhanced PD-L1 Output.
Neoplasms
Alkynol natural products target ALDH2 in cancer cells by irreversible binding to the active site.
Neoplasms
All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells.
Neoplasms
All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth.
Neoplasms
An Effective Primary Head and Neck Squamous Cell Carcinoma In Vitro Model.
Neoplasms
An ornamental plant targets epigenetic signaling to block cancer stem cell-driven colon carcinogenesis.
Neoplasms
Androgen Deprivation Induces Transcriptional Reprogramming in Prostate Cancer Cells to Develop Stem Cell-Like Characteristics.
Neoplasms
Androgen Receptor and ALDH1 Expression Among Internationally Diverse Patient Populations.
Neoplasms
Anlotinib exerts anti-cancer efficiency on lung cancer stem cells in vitro and in vivo through reducing NF-?B activity.
Neoplasms
Anti-colorectal cancer biotargets and biological mechanisms of puerarin: Study of molecular networks.
Neoplasms
Antitumor activity of potent pyruvate dehydrogenase kinase 4 inhibitors from plants in pancreatic cancer.
Neoplasms
Arachidonic acid suppresses growth of human lung tumor A549 cells through down-regulation of ALDH3A1 expression.
Neoplasms
Artesunate induces apoptosis and inhibits the proliferation, stemness, and tumorigenesis of leukemia.
Neoplasms
Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
Neoplasms
Association between ALDH1+/CD133+ stem-like cells and tumor angiogenesis in invasive ductal breast carcinoma.
Neoplasms
Association between Glu504Lys Polymorphism of ALDH2 Gene and Cancer Risk: A Meta-Analysis.
Neoplasms
Association of aldehyde dehydrogenase 1 expression and biologically aggressive features in breast cancer.
Neoplasms
Association of aldehyde dehydrogenase 2 gene polymorphism with pancreatic cancer but not colon cancer.
Neoplasms
Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Neoplasms
Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
Neoplasms
Associations of mammographic breast density with breast stem cell marker-defined breast cancer subtypes.
Neoplasms
ATG7-mediated autophagy involves in miR-138-5p regulated self-renewal and invasion of lung cancer stem-like cells derived from A549 cells.
Neoplasms
Attenuation of p38? MAPK stress response signaling delays the in vivo aging of skeletal muscle myofibers and progenitor cells.
Neoplasms
Auramine O, an incense smoke ingredient, promotes lung cancer malignancy.
Neoplasms
Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Neoplasms
BCMA (TNFRSF17) Induces APRIL and BAFF Mediated Breast Cancer Cell Stemness.
Neoplasms
BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer.
Neoplasms
Bifunctional Duocarmycin Analogues as Inhibitors of Protein Tyrosine Kinases.
Neoplasms
Biochemical and histochemical properties of hepatic tumors of rainbow trout, Oncorhynchus mykiss.
Neoplasms
Bioinformatic analysis of differentially expressed genes as prognostic markers in pheochromocytoma and paraganglioma tumors.
Neoplasms
Biological evaluation and 3D-QSAR studies of curcumin analogues as aldehyde dehydrogenase 1 inhibitors.
Neoplasms
Bisphenol A and polychlorinated biphenyls enhance the cancer stem cell properties of human ovarian cancer cells by activating the WNT signaling pathway.
Neoplasms
Bmi-1 Regulates Snail Expression and Promotes Metastasis Ability in Head and Neck Squamous Cancer-Derived ALDH1 Positive Cells.
Neoplasms
BMI1, ALDH1A1, and CD133 Transcripts Connect Epithelial-Mesenchymal Transition to Cancer Stem Cells in Lung Carcinoma.
Neoplasms
Bone Marrow Mesenchymal Stem Cells Promote the Stemness of Hypopharyngeal Cancer Cells.
Neoplasms
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Neoplasms
Breast cancer stem cells and intrinsic subtypes: controversies rage on.
Neoplasms
Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1.
Neoplasms
C/EBP?-1 promotes transformation and chemoresistance in Ewing sarcoma cells.
Neoplasms
Can lower aldehyde dehydrogenase activity in saliva be a risk factor for oral cavity cancer?
Neoplasms
Cancer Chemopreventive Activities of Silibinin on Colorectal Cancer through Regulation of E-Cadherin/?-Catenin Pathway.
Neoplasms
Cancer screening of upper aerodigestive tract in Japanese alcoholics with reference to drinking and smoking habits and aldehyde dehydrogenase-2 genotype.
Neoplasms
Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma.
Neoplasms
Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
Neoplasms
Cancer stem cell markers ALDH1 and Bmi1 expression in oral erythroplakia revisited: Implication for driving the process of field cancerization.
Neoplasms
Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinoma.
Neoplasms
Cancer stem cell markers in adenocarcinoma of the salivary glands - reliable prognostic markers?
Neoplasms
Cancer stem cell markers in eyelid sebaceous gland carcinoma: high expression of ALDH1, CD133, and ABCG2 correlates with poor prognosis.
Neoplasms
Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2.
Neoplasms
Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development.
Neoplasms
Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
Neoplasms
Cancer Stem Cell Properties as Factors Predictive of Chemoresistance in Neoadjuvantly-treated Patients with Ovarian Cancer.
Neoplasms
Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
Neoplasms
Cancer stem cells in Helicobacter pylori infection and aging: Implications for gastric carcinogenesis.
Neoplasms
Cancer stem cells in oesophageal squamous cell carcinoma: Identification, prognostic and treatment perspectives.
Neoplasms
Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
Neoplasms
Cancer Stemness, Immune Cells, and Epithelial-Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma.
Neoplasms
CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway.
Neoplasms
CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells.
Neoplasms
CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis.
Neoplasms
CD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancer.
Neoplasms
CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma.
Neoplasms
CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
Neoplasms
CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3?-dependent cancer stem cell properties.
Neoplasms
CD44+ cancer cell-induced metastasis: A feasible neck metastasis model.
Neoplasms
Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells.
Neoplasms
Cell-based selection provides novel molecular probes for cancer stem cells.
Neoplasms
Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens.
Neoplasms
Characteristic Genes in Luminal Subtype Breast Tumors with CD44+CD24-/Low Gene Expression Signature.
Neoplasms
Characteristics of aldehyde dehydrogenase 2 (Aldh2) knockout mice.
Neoplasms
Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures.
Neoplasms
Characterization of Two Distinct Structural Classes of Selective Aldehyde Dehydrogenase 1A1 Inhibitors.
Neoplasms
Chemoradiation therapy reduces aldehyde dehydrogenase 1 expression in cervical cancer but does not improve patient survival.
Neoplasms
Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling.
Neoplasms
Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization.
Neoplasms
Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.
Neoplasms
Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
Neoplasms
Clinical features and treatment outcomes of Japanese head and neck cancer patients with a second primary cancer.
Neoplasms
Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes.
Neoplasms
Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact.
Neoplasms
Clinical influence of cancer stem cells on residual disease after preoperative chemoradiotherapy for rectal cancer.
Neoplasms
Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer.
Neoplasms
Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse.
Neoplasms
Clinical significance of ALDH1 combined with DAPI expression in patients with esophageal carcinoma.
Neoplasms
Clinical significance of ALDH2 rs671 polymorphism in esophageal cancer: evidence from 31 case-control studies.
Neoplasms
Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.
Neoplasms
Clinicopathological analysis of breast ductal carcinoma in situ with ALDH1-positive cancer stem cells.
Neoplasms
Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis.
Neoplasms
Clinicopathological correlation of stem cell markers expression in oral squamous cell carcinoma; relation to patients` outcome.
Neoplasms
Clinicopathological features to distinguish malignant solitary fibrous tumors of the prostate from prostatic stromal tumors.
Neoplasms
Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis.
Neoplasms
Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer.
Neoplasms
Clinicopathological Significance of CD133 and ALDH1 Cancer Stem Cell Marker Expression in Invasive Ductal Breast Carcinoma.
Neoplasms
Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma.
Neoplasms
Co-detection of ALDH1A1, ABCG2, ALCAM and CD133 in three A549 subpopulations at the single cell level by one-step digital RT-PCR.
Neoplasms
Colorectal cancer-derived tumor spheroids retain the characteristics of original tumors.
Neoplasms
Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases.
Neoplasms
Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.
Neoplasms
Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma.
Neoplasms
Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.
Neoplasms
Comparison between self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese population.
Neoplasms
Comparison of hybrid clones derived from human breast epithelial cells and three different cancer cell lines regarding in vitro cancer stem/ initiating cell properties.
Neoplasms
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
Neoplasms
Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer.
Neoplasms
Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer.
Neoplasms
Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas.
Neoplasms
Comprehensive in situ analysis of ALDH1 and SOX2 reveals increased expression of stem cell markers in high-grade serous carcinomas compared to low-grade serous carcinomas and atypical proliferative serous tumors.
Neoplasms
Comprehensive prognostic analysis in breast cancer integrating clinical, tumoral, micro-environmental and immunohistochemical criteria.
Neoplasms
Contribution of the alcohol dehydrogenase-1B genotype and oral microorganisms to high salivary acetaldehyde concentrations in Japanese alcoholic men.
Neoplasms
Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-?
Neoplasms
Correction to: Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1?/VEGF signalling in MCF-7 breast cancer cells.
Neoplasms
Correlations of aldehyde dehydrogenase-1 (ALDH1) expression with traditional prognostic parameters and different molecular subtypes of breast carcinoma.
Neoplasms
Cryptotanshinone attenuates the stemness of non-small cell lung cancer cells via promoting TAZ translocation from nuclear to cytoplasm.
Neoplasms
CSN6-TRIM21 axis instigates cancer stemness during tumorigenesis.
Neoplasms
Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
Neoplasms
Cytokeratin 19 (KRT19) has a Role in the Reprogramming of Cancer Stem Cell-Like Cells to Less Aggressive and More Drug-Sensitive Cells.
Neoplasms
DCLK1 Inhibition Sensitizes Colorectal Cancer Cells to Radiation Treatment.
Neoplasms
DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1.
Neoplasms
DEAD box protein DDX1 promotes colorectal tumorigenesis through transcriptional activation of the LGR5 gene.
Neoplasms
Deep-Red/Near-Infrared Turn-On Fluorescence Probes for Aldehyde Dehydrogenase 1A1 in Cancer Stem Cells.
Neoplasms
Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP.
Neoplasms
Destruxin B Suppresses Drug-Resistant Colon Tumorigenesis and Stemness Is Associated with the Upregulation of miR-214 and Downregulation of mTOR/?-Catenin Pathway.
Neoplasms
Detection of ALDH1 activity in rabbit hepatic VX2 tumors and isolation of ALDH1 positive cancer stem cells.
Neoplasms
Detention and Identification of Cancer Stem Cells in Esophageal Squamous Cell Carcinoma.
Neoplasms
Development of a prediction model and estimation of cumulative risk for upper aerodigestive tract cancer on the basis of the aldehyde dehydrogenase 2 genotype and alcohol consumption in a Japanese population.
Neoplasms
Development of new disulfiram analogues as ALDH1a1-selective inhibitors.
Neoplasms
Development of Selective Inhibitors for Human Aldehyde Dehydrogenase 3A1 (ALDH3A1) for the Enhancement of Cyclophosphamide Cytotoxicity.
Neoplasms
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Neoplasms
Differential diagnosis of solitary fibrous tumors: A study of 454 soft tissue tumors indicating the diagnostic value of nuclear STAT6 relocation and ALDH1 expression combined with in situ proximity ligation assay.
Neoplasms
Differential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasis.
Neoplasms
Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors.
Neoplasms
Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes.
Neoplasms
Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis.
Neoplasms
Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors.
Neoplasms
Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity.
Neoplasms
Discovery of novel regulators of aldehyde dehydrogenase isoenzymes.
Neoplasms
Discrimination of Cancer Stem Cell Markers ALDH1A1, BCL11B, BMI-1, and CD44 in Different Tissues of HNSCC Patients.
Neoplasms
Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells.
Neoplasms
Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.
Neoplasms
Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.
Neoplasms
Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
Neoplasms
Distinct prognostic values of ALDH1 isoenzymes in breast cancer.
Neoplasms
Distribution of ADH1B, ALDH2, CYP2E1 *6, and CYP2E1 *7B genotypes in Turkish population.
Neoplasms
Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
Neoplasms
Diversified expression of aryl hydrocarbon receptor dependent genes in human laryngeal squamous cell carcinoma cell lines treated with ?-naphthoflavone.
Neoplasms
DKK1 maintained cancer stem-like properties of esophageal carcinoma cells via ALDH1A1/SOX2 axis.
Neoplasms
Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA let-7 Regulates Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells.
Neoplasms
Down-regulation of ALDH1A3, CD44 or MDR1 sensitizes resistant cancer cells to FAK autophosphorylation inhibitor Y15.
Neoplasms
Downexpression of aldehyde dehydrogenase 1 in murine lung tumors.
Neoplasms
Downregulation of ALDH1A1 expression in non-small cell lung carcinomas--its clinicopathologic and biological significance.
Neoplasms
Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer.
Neoplasms
DOXIL when combined with Withaferin A (WFA) targets ALDH1 positive cancer stem cells in ovarian cancer.
Neoplasms
Doxorubicin and ?-Mangostin oppositely affect luminal breast cancer cell stemness evaluated by a new retinaldehyde-dependent ALDH assay in MCF-7 tumor spheroids.
Neoplasms
Drastic morphological and molecular differences between lymph node micrometastatic tumors and macrometastatic tumors of lung adenocarcinoma.
Neoplasms
Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.
Neoplasms
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells.
Neoplasms
DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties.
Neoplasms
DUSP9-mediated reduction of pERK1/2 supports cancer stem cell-like traits and promotes triple negative breast cancer.
Neoplasms
Effect of aerobic exercise on acquired gefitinib resistance in lung adenocarcinoma.
Neoplasms
Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines.
Neoplasms
Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype.
Neoplasms
Effect of ALDH2 polymorphism on cancer risk in Asians: A meta-analysis.
Neoplasms
Effect of As2O3 on colorectal CSCs stained with ALDH1 in primary cell culture in vitro.
Neoplasms
Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcoma.
Neoplasms
Effects of 5-week ethanol feeding on the liver of aldehyde dehydrogenase 2 knockout mice.
Neoplasms
Effects of ADH1B and ALDH2 Genetic Polymorphisms on Alcohol Elimination Rates and Salivary Acetaldehyde Levels in Intoxicated Japanese Alcoholic Men.
Neoplasms
Effects of Apatinib on the "Stemness" of Non-Small-Cell Lung Cancer Cells In Vivo and Its Related Mechanisms.
Neoplasms
Effects of long-term ethanol consumption and Aldh1b1 depletion on intestinal tumourigenesis in mice.
Neoplasms
Effects of the common polymorphism in the human aldehyde dehydrogenase 2 (ALDH2) gene on the lung.
Neoplasms
Efficient isolation, culture, purification, and stem cell expression profiles of primary tumor cells derived from uterine cervical squamous cell carcinoma.
Neoplasms
EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
Neoplasms
Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK/ERK-dependent signaling pathway.
Neoplasms
Emerging targets for glioblastoma stem cell therapy.
Neoplasms
EMP2 is a novel therapeutic target for endometrial cancer stem cells.
Neoplasms
Enrichment and characterization of cancer stem?like cells from a cervical cancer cell line.
Neoplasms
Epigenetic modifications of gene expression by lifestyle and environment.
Neoplasms
Epigenetic therapy regulates the expression of ALDH1 and immunologic response: Relevance to the prognosis of oral cancer.
Neoplasms
Epithelial membrane protein 3 regulates lung cancer stem cells via the TGF?? signaling pathway.
Neoplasms
Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigm.
Neoplasms
Eprinomectin, a novel semi-synthetic macrocylic lactone is cytotoxic to PC3 metastatic prostate cancer cells via inducing apoptosis.
Neoplasms
Epstein-Barr virus latent membrane protein 1 (LMP1) regulates the aldehyde dehydrogenase (ALDH) positive cell population in nasopharyngeal carcinoma cell lines.
Neoplasms
Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.
Neoplasms
Esophageal melanosis, an endoscopic finding associated with squamous cell neoplasms of the upper aerodigestive tract, and inactive aldehyde dehydrogenase-2 in alcoholic Japanese men.
Neoplasms
Esophageal squamous cell carcinoma and aldehyde dehydrogenase-2 genotypes in Japanese females.
Neoplasms
Ethanol-induced oxidative DNA damage and CYP2E1 expression in liver tissue of Aldh2 knockout mice.
Neoplasms
Evaluation of a developmental hierarchy for breast cancer cells to assess risk-based patient selection for targeted treatment.
Neoplasms
Evaluation of ALDH1 expression in ipsilateral breast cancer recurrence.
Neoplasms
Evaluation of expression of cancer stem cell markers and fusion gene in synovial sarcoma: Insights into histogenesis and pathogenesis.
Neoplasms
Evaluation of spice and herb as phyto-derived selective modulators of human retinaldehyde dehydrogenases using a simple in vitro method.
Neoplasms
Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.
Neoplasms
Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma.
Neoplasms
Evaluation of the Role of ALDH1 as Cancer Stem Cell Marker in Colorectal Carcinoma: An Immunohistochemical Study.
Neoplasms
Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract.
Neoplasms
Evolving views of breast cancer stem cells and their differentiation States.
Neoplasms
Exploration of bladder cancer molecular mechanisms based on miRNA-mRNA regulatory network.
Neoplasms
Expression Analysis of Aldehyde Dehydrogenase 1A1 (ALDH1A1) in Colon and Rectal Cancer in Association with Prognosis and Response to Chemotherapy.
Neoplasms
Expression and associations of TRAF1, BMI-1, ALDH1, and Lin28B in oral squamous cell carcinoma.
Neoplasms
Expression and functional role of ALDH1 in cervical carcinoma cells.
Neoplasms
Expression and prognostic value of the aldehyde dehydrogenase 1 (ALDH1) and N-myc downstream regulated gene 2 (NDRG2) as potential markers in human astrocytomas.
Neoplasms
Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma.
Neoplasms
Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma.
Neoplasms
Expression of Aldehyde Dehydrogenase (ALDH1) and ATP Binding Cassette Transporter G2 (ABCG2) in Iraqi Patients with Colon Cancer and the Relation with Clinicopathological Features.
Neoplasms
Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications.
Neoplasms
Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer.
Neoplasms
Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women.
Neoplasms
Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
Neoplasms
Expression of ALDH1 and TGF?2 in benign and malignant breast tumors and their prognostic implications.
Neoplasms
Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse.
Neoplasms
Expression of ALDH1A Isozymes in Human Endometrium with and without Endometriosis and in Ovarian Endometrioma.
Neoplasms
Expression of ALDH1A1 and CD133 is associated with the prognosis and effect of different chemotherapeutic regimens in gastric cancer.
Neoplasms
Expression of ALDH1A1 and CD44 in primary head and neck squamous cell carcinoma and their value for carcinogenesis, tumor progression and cancer stem cell identification.
Neoplasms
Expression of Androgen Receptor and Cancer Stem Cell Markers (CD44+/CD24- and ALDH1+): Prognostic Implications in Invasive Breast Cancer.
Neoplasms
Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer.
Neoplasms
Expression of cancer stem cell marker during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
Neoplasms
Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer.
Neoplasms
Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
Neoplasms
Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors.
Neoplasms
Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer.
Neoplasms
Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer.
Neoplasms
Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma.
Neoplasms
Expression of CD133 in endometrial cancer cells and its implications.
Neoplasms
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells.
Neoplasms
Expression of stem cell markers as useful complementary factors in the early detection of urinary bladder carcinogens by immunohistochemistry for ?-H2AX.
Neoplasms
Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and ?-catenin, in primary lung adenocarcinoma--their prognostic significance.
Neoplasms
Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.
Neoplasms
Expression Profile of Genes Related to Drug Metabolism in Human Brain Tumors.
Neoplasms
EZH2 and ALDH1 expression in ductal carcinoma in situ: complex association with recurrence and progression to invasive breast cancer.
Neoplasms
Faciogenital dysplasia 5 confers the cancer stem cell-like traits of gastric cancer cells through enhancing Sox2 protein stability.
Neoplasms
Fibulin-3 negatively regulates ALDH1 via c-MET suppression and increases ?-radiation-induced sensitivity in some pancreatic cancer cell lines.
Neoplasms
FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties.
Neoplasms
Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.
Neoplasms
Folate, alcohol, ADH1B and ALDH2 and colorectal cancer risk.
Neoplasms
Formation of acetaldehyde-derived DNA adducts due to alcohol exposure.
Neoplasms
Formulation Comprising Arsenic Trioxide and Dimercaprol Enhances Radiosensitivity of Pancreatic Cancer Xenografts.
Neoplasms
FUBP1 promotes colorectal cancer stemness and metastasis via DVL1-mediated activation of Wnt/?-catenin signaling.
Neoplasms
Ganoderma lucidum extract (GLE) impairs breast cancer stem cells by targeting the STAT3 pathway.
Neoplasms
GAPDH and PUM1: Optimal Housekeeping Genes for Quantitative Polymerase Chain Reaction-Based Analysis of Cancer Stem Cells and Epithelial-Mesenchymal Transition Gene Expression in Rectal Tumors.
Neoplasms
Garcinol from Garcinia indica Downregulates Cancer Stem-like Cell Biomarker ALDH1A1 in Nonsmall Cell Lung Cancer A549 Cells through DDIT3 Activation.
Neoplasms
Gastric Adenocarcinoma Biomarker Expression Profiles and their Prognostic Value.
Neoplasms
Gastric cancer depends on aldehyde dehydrogenase 3A1 for fatty acid oxidation.
Neoplasms
Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.
Neoplasms
Genetic polymorphism of aldehyde dehydrogenase 2 in patients with upper aerodigestive tract cancer.
Neoplasms
Genetic Polymorphism of Aldehyde Dehydrogenase 2 in Patients With Upper Aerodigestive Tract Cancer.
Neoplasms
Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers.
Neoplasms
Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma.
Neoplasms
Genetic polymorphisms of alcohol dehydrogense-1B and aldehyde dehydrogenase-2, alcohol flushing, mean corpuscular volume, and aerodigestive tract neoplasia in Japanese drinkers.
Neoplasms
Genetic polymorphisms of ALDH2 are associated with lumbar disc herniation in a Chinese Han population.
Neoplasms
Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer.
Neoplasms
Genotype announcement in a genetic polymorphism study for health checkup examinees at Nagoya University Hospital.
Neoplasms
Glioma-associated oncogene homolog 1 stimulates FOXP3 to promote non-small cell lung cancer stemness.
Neoplasms
Glu504Lys Single Nucleotide Polymorphism of Aldehyde Dehydrogenase 2 Gene and the Risk of Human Diseases.
Neoplasms
Glyoxalase 1 gene is highly expressed in basal-like human breast cancers and contributes to survival of ALDH1-positive breast cancer stem cells.
Neoplasms
GRIK2 has a role in the maintenance of urothelial carcinoma stem-like cells, and its expression is associated with poorer prognosis.
Neoplasms
Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs).
Neoplasms
Heavy alcohol drinking downregulates ALDH2 gene expression but heavy smoking up-regulates SOD2 gene expression in head and neck squamous cell carcinoma.
Neoplasms
Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer.
Neoplasms
Helicobacter pylori, chronic atrophic gastritis, inactive aldehyde dehydrogenase-2, macrocytosis and multiple upper aerodigestive tract cancers and the risk for gastric cancer in alcoholic Japanese men.
Neoplasms
Heme oxygenase 1 protects ethanol-administered liver tissue in Aldh2 knockout mice.
Neoplasms
Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.
Neoplasms
Heterogeneity of vascular and progenitor cell compartments in tumours from MMTV-PyVmT transgenic mice during mammary cancer progression.
Neoplasms
High ALDH1 expression correlates with better prognosis in tumorigenic malignant melanoma.
Neoplasms
High ALDH1A1 expression correlates with poor survival in papillary thyroid carcinoma.
Neoplasms
High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis.
Neoplasms
High expression of ALDH1A3 might independently influence poor progression-free and overall survival in patients with glioma via maintaining glucose uptake and lactate production.
Neoplasms
High Expression of c-Met, PKC? and ALDH1A3 Predicts a Poor Prognosis in Late-stage Breast Cancer.
Neoplasms
High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma.
Neoplasms
High Expression of Stem Cell Marker ALDH1 is Associated with Reduced BRCA1 in Invasive Breast Carcinomas.
Neoplasms
High Expressions of Lgr5 and ALDH1 in Primary Epithelial Ovarian Cancer Correlate with Advanced Tumor Stage and Grade as well as Poor Prognosis of the Patients.
Neoplasms
High FOXK1 expression correlates with poor outcomes in hepatocellular carcinoma and regulates stemness of hepatocellular carcinoma cells.
Neoplasms
High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
Neoplasms
High PKC? expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients.
Neoplasms
High-dose folic acid supplementation alters the human sperm methylome and is influenced by the MTHFR C677T polymorphism.
Neoplasms
Histopathological findings and immunohistochemical expression of the stem cell markers CD44, ALDH1, Bmi-1, and Nanog in oral solitary fibrous tumors.
Neoplasms
HNSCC cells resistant to EGFR pathway inhibitors are hypermutated and sensitive to DNA damaging substances.
Neoplasms
Hsa-circ_0003420 induces apoptosis in acute myeloid leukemia stem cells and impairs stem cell properties.
Neoplasms
Hypoglycemia in a Patient With a Polyhormonal Pancreatic Neuroendocrine Tumor With Evidence of Endocrine Progenitors.
Neoplasms
Hypoxia upregulates aldehyde dehydrogenase isoform 1 (ALDH1) expression and induces functional stem cell characteristics in human glioblastoma cells.
Neoplasms
Identification of ALDH1A3 as a viable therapeutic target in breast cancer metastasis-initiating cells.
Neoplasms
Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay.
Neoplasms
Identification of differentially-expressed genes by DNA methylation in cervical cancer.
Neoplasms
Identification of Human Aldehyde Dehydrogenase 1 Family Member A1 as a Novel CD8+ T-Cell Defined Tumor Antigen in Squamous Cell Carcinoma of the Head and Neck.
Neoplasms
Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Neoplasms
Identification of pancreatic cancer invasion-related proteins by proteomic analysis.
Neoplasms
Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis.
Neoplasms
Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition.
Neoplasms
Identifying genetic variation for alcohol dependence.
Neoplasms
IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties.
Neoplasms
Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells.
Neoplasms
Immunohistochemical analysis of aldehyde dehydrogenase isoforms and their association with estrogen-receptor status and disease progression in breast cancer.
Neoplasms
Immunohistochemical Expression of CD56 and ALDH1 in Common Salivary Gland Tumors.
Neoplasms
Immunolocalization of Cancer Stem Cells Marker ALDH1 and its Association with Tumor Budding in Oral Squamous Cell Carcinoma.
Neoplasms
Impact of diabetes type II and chronic inflammation on pancreatic cancer.
Neoplasms
Impact of Multiple Alcohol Dehydrogenase Gene Polymorphisms on Risk of Upper Aerodigestive Tract Cancers in a Japanese Population.
Neoplasms
Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma.
Neoplasms
Importance of inverse correlation between ALDH3A1 and PPAR? in tumor cells and tissue regeneration.
Neoplasms
In phyllodes tumour of the breast expression of c-kit but not of ALDH1A1 is associated with adverse clinico-pathological features.
Neoplasms
In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.
Neoplasms
In vitro and in vivo expression of aldehyde dehydrogenase 1 in oral squamous cell carcinoma.
Neoplasms
In Vivo Study on the Effects of Xiaoaiping on the Stemness of Hepatocellular Carcinoma Cells.
Neoplasms
Inactive aldehyde dehydrogenase-2 increased the risk of pancreatic cancer among smokers in a Japanese male population.
Neoplasms
Inclusion of a gene-environment interaction between alcohol consumption and the aldehyde dehydrogenase 2 genotype in a risk prediction model for upper aerodigestive tract cancer in Japanese men.
Neoplasms
Increased DNA damage in ALDH2-deficient alcoholics.
Neoplasms
Increased expression of aldehyde dehydrogenase 1 A1 in nasopharyngeal carcinoma is associated with enhanced invasiveness.
Neoplasms
Increased Expression of ALDH1A1 in Prostate Cancer is Correlated With Tumor Aggressiveness: A Tissue Microarray Study of Iranian Patients.
Neoplasms
Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Neoplasms
Increased levels of active c-Src distinguish invasive from in situ lobular lesions.
Neoplasms
Increasing the number of thyroid lesions classes in microarray analysis improves the relevance of diagnostic markers.
Neoplasms
Induced Expression of Cancer Stem Cell Markers ALDH1A3 and Sox-2 in Hierarchical Reconstitution of Apoptosis-resistant Human Breast Cancer Cells.
Neoplasms
Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer.
Neoplasms
Inflammation-Related DNA Damage and Cancer Stem Cell Markers in Nasopharyngeal Carcinoma.
Neoplasms
Influence of genetic variations of ethanol-metabolizing enzymes on phenotypes of alcohol-related disorders.
Neoplasms
Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas.
Neoplasms
Inhibition of aldehyde dehydrogenase 1 enhances the cytotoxic effect of retinaldehyde on A549 cancer cells.
Neoplasms
Inhibition of ALDH3A1-catalyzed oxidation by chlorpropamide analogues.
Neoplasms
Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1.
Neoplasms
Inhibition of Wnt/?-catenin pathway by niclosamide: a therapeutic target for ovarian cancer.
Neoplasms
Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.
Neoplasms
Inhibitory effect of Nodal on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma of uterus.
Neoplasms
Insight into the Structural Requirements of Theophylline-Based Aldehyde Dehydrogenase lAl (ALDHlAl) Inhibitors Through Multi-QSAR Modeling and Molecular Docking Approaches.
Neoplasms
Interleukin-1 and tumor necrosis factor alpha induce class 1 aldehyde dehydrogenase mRNA and protein in bone marrow cells.
Neoplasms
Interplay between APC and ALDH1B1 in a newly developed mouse model of colorectal cancer.
Neoplasms
Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients.
Neoplasms
In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an Example.
Neoplasms
Isolation of head and neck squamous carcinoma cancer stem-like cells in a syngeneic mouse model and analysis of hypoxia effect.
Neoplasms
Key role of local acetaldehyde in upper GI tract carcinogenesis.
Neoplasms
Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma.
Neoplasms
lncRNA BORG:TRIM28 Complexes Drive Metastatic Progression by Inducing a6 Integrin/CD49f Expression in Breast Cancer Stem Cells.
Neoplasms
Long non-coding RNA SNHG20 promotes the tumorigenesis of oral squamous cell carcinoma via targeting miR-197/LIN28 axis.
Neoplasms
Long noncoding RNA MACC1-AS1 promotes the stemness of nonsmall cell lung cancer cells through promoting UPF1-mediated destabilization of LATS1/2.
Neoplasms
Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma.
Neoplasms
Loss of ARID1A induces a stemness gene ALDH1A1 expression with histone acetylation in the malignant subtype of cholangiocarcinoma.
Neoplasms
Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer.
Neoplasms
Loss of N-Cadherin Expression in Tumor Transplants Produced From As+3- and Cd+2-Transformed Human Urothelial (UROtsa) Cell Lines.
Neoplasms
Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.
Neoplasms
Low P16INK4A Expression Associated with High Expression of Cancer Stem Cell Markers Predicts Poor Prognosis in Cervical Cancer after Radiotherapy.
Neoplasms
Markers and Reporters to Reveal the Hierarchy in Heterogeneous Cancer Stem Cells.
Neoplasms
Measurement of Aldehyde Dehydrogenase 1 Expression Defines a Group with Better Prognosis in Patients with Non-Small Cell Lung Cancer.
Neoplasms
Mechanisms of Resistance to EGFR Inhibition Reveal Metabolic Vulnerabilities in Human GBM.
Neoplasms
Mesenchymal Stem/Stromal Cell Engulfment Reveals Metastatic Advantage in Breast Cancer.
Neoplasms
Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells.
Neoplasms
Metabolic Modification in Gastrointestinal Cancer Stem Cells: Characteristics and Therapeutic Approaches.
Neoplasms
Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
Neoplasms
Metastasis of Cancer Stem Cells Developed in the Microenvironment of Hepatocellular Carcinoma.
Neoplasms
Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Neoplasms
Methylation-Induced Silencing of ALDH2 Facilitates Lung Adenocarcinoma Bone Metastasis by Activating the MAPK Pathway.
Neoplasms
MicroRNA expression profiles of cancer stem cells in head and neck squamous cell carcinoma.
Neoplasms
MicroRNA-761 suppresses tumor progression in osteosarcoma via negatively regulating ALDH1B1.
Neoplasms
MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
Neoplasms
Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer.
Neoplasms
miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations.
Neoplasms
Modeling the effects of hyaluronic acid degradation on the regulation of human astrocyte phenotype using multicomponent interpenetrating polymer networks (mIPNs).
Neoplasms
Modulation of tumor stem cell characteristics by 17?-estradiol in human mesenchymal stem cells derived from ovarian endometrioma.
Neoplasms
Molecular epidemiology of preterm delivery: methodology and challenges.
Neoplasms
Molecular organization of the Escherichia coli gab cluster: nucleotide sequence of the structural genes gabD and gabP and expression of the GABA permease gene.
Neoplasms
Monitoring the response of urothelial precancerous lesions to Bacillus Calmette-Guerin at the proteome level in an in vivo rat model.
Neoplasms
Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer.
Neoplasms
Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-?B activity and apoptosis induction.
Neoplasms
MUC1-C drives stemness in progression of colitis to colorectal cancer.
Neoplasms
Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p.
Neoplasms
Multiple cancers associated with esophageal and oropharyngolaryngeal squamous cell carcinoma and the aldehyde dehydrogenase-2 genotype in male Japanese drinkers.
Neoplasms
Multiple machine learning models combined with virtual screening and molecular docking to identify selective human ALDH1A1 inhibitors.
Neoplasms
Multiple primary esophageal and concurrent upper aerodigestive tract cancer and the aldehyde dehydrogenase-2 genotype of Japanese alcoholics.
Neoplasms
Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression.
Neoplasms
Nano Let?7b sensitization of eliminating esophageal cancer stem?like cells is dependent on blockade of Wnt activation of symmetric division.
Neoplasms
NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice.
Neoplasms
NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma.
Neoplasms
Neuregulin-1-?1 and ?-secretase play a critical role in sphere-formation and cell survival of urothelial carcinoma cancer stem-like cells.
Neoplasms
Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.
Neoplasms
New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines.
Neoplasms
NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3?-Wnt/?-catenin-ALDH1A1 Signal Circuit.
Neoplasms
Normal and neoplastic urothelial stem cells: getting to the root of the problem.
Neoplasms
NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells.
Neoplasms
Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma.
Neoplasms
Novel composite drug delivery system as a novel radio sensitizer for the local treatment of cervical carcinoma.
Neoplasms
Novel prognostic markers revealed by a proteomic approach separating benign from malignant insulinomas.
Neoplasms
Nrf2 Depletion Sensitizes Pancreatic Cancer Cells to Gemcitabine via Aldehyde Dehydrogenase 3a1 Repression.
Neoplasms
Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer.
Neoplasms
Objective analysis of cancer stem cell marker expression using immunohistochemistry.
Neoplasms
Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam.
Neoplasms
Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells.
Neoplasms
Oncorequisite role of an aldehyde dehydrogenase in the pathogenesis of T-cell acute lymphoblastic leukemia.
Neoplasms
Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.
Neoplasms
Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.
Neoplasms
Overexpression of ALDH1 and EMT marker profile are linked with unfavorable outcome in head and neck cancer.
Neoplasms
Overexpression of CYP3A4 in a COLO 205 Colon Cancer Stem Cell Model in vitro.
Neoplasms
Overexpression of RRM2 is related to poor prognosis in oral squamous cell carcinoma.
Neoplasms
Overexpression of stem cell associated ALDH1A1, a target of the leukemogenic transcription factor TLX1/HOX11, inhibits lymphopoiesis and promotes myelopoiesis in murine hematopoietic progenitors.
Neoplasms
P-Cadherin is Co-Expressed with Cd44 and Cd49f and Mediates Stem Cell Properties in Basal-Like Breast Cancer.
Neoplasms
p21CIP1 Promotes Mammary Cancer-Initiating Cells via Activation of Wnt/TCF1/CyclinD1 Signaling.
Neoplasms
P2Y2R has a significant correlation with Notch-4 in patients with breast cancer.
Neoplasms
p53 Protein accumulation, cancer multiplicity, and aldehyde dehydrogenase-2 genotype in Japanese alcoholic men with early esophageal squamous cell carcinoma.
Neoplasms
p63 Cytoplasmic Aberrance is Associated with High Prostate Cancer Stem Cell Expression.
Neoplasms
Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma.
Neoplasms
Patterns of stemness-associated markers in the development of castration-resistant prostate cancer.
Neoplasms
Phenethyl Isothiocyanate Exposure Promotes Oxidative Stress and Suppresses Sp1 Transcription Factor in Cancer Stem Cells.
Neoplasms
Phenotypic and microRNA characterisation of the neglected CD24+ cell population in MCF-7 breast cancer 3D spheroid culture.
Neoplasms
Phenotypic and microRNA characterization of the neglected CD24+ cell population in MCF-7 breast cancer 3-dimensional spheroid culture.
Neoplasms
Phosphorylation-dependent regulation of ALDH1A1 by Aurora kinase A: insights on their synergistic relationship in pancreatic cancer.
Neoplasms
Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
Neoplasms
PKI-587 and sorafenib alone and in combination on inhibition of liver cancer stem cell proliferation.
Neoplasms
PO-52 - Effect of tissue factor expression by colorectal cancer on cancer stem cell activity.
Neoplasms
PODXL2 maintains cellular stemness and promotes breast cancer development through the Rac1/Akt pathway.
Neoplasms
Polymethoxylated Flavones Target Cancer Stemness and Improve the Antiproliferative Effect of 5-Fluorouracil in a 3D Cell Model of Colorectal Cancer.
Neoplasms
Polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 and the blood and salivary ethanol and acetaldehyde concentrations of Japanese alcoholic men.
Neoplasms
Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.
Neoplasms
Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease.
Neoplasms
Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance.
Neoplasms
Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications.
Neoplasms
Potential Involvement of Jagged1 in Metastatic Progression of Human Breast Carcinomas.
Neoplasms
PPARgamma-mediated ALDH1A3 suppression exerts anti-proliferative effects in lung cancer by inducing lipid peroxidation.
Neoplasms
Predictive Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Preventive medical services not covered by public health insurance at Daiko Medical Center in Japan, 2004-2011.
Neoplasms
Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer.
Neoplasms
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.
Neoplasms
Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
Neoplasms
Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract.
Neoplasms
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
Neoplasms
Prognostic impact of the putative cancer stem cell markers ABCG2, CD133, ALDH1A1 and CD44V7/8 in metastatic melanoma.
Neoplasms
Prognostic Implications of ALDH1 and Notch1 in Different Subtypes of Oral Cancer.
Neoplasms
Prognostic significance of ABCB1 in stage I lung adenocarcinoma.
Neoplasms
Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
Neoplasms
Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma.
Neoplasms
Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients.
Neoplasms
Prognostic value of aldehyde dehydrogenase 1 (ALDH1) in invasive breast carcinomas.
Neoplasms
Prognostic value of ALDH1 and Nestin in advanced cancer: a systematic meta-analysis with trial sequential analysis.
Neoplasms
Prognostic value of ALDH1 expression in lung cancer: a meta-analysis.
Neoplasms
Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Neoplasms
Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer.
Neoplasms
Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models.
Neoplasms
Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer.
Neoplasms
Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Neoplasms
Proliferation rate and breast cancer subtype, but not ALDH1 expression, predict pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.
Neoplasms
Proline?rich polypeptide?1 decreases cancer stem cell population by targeting BAFF chromatin?remodeling complexes in human chondrosarcoma JJ012 cells.
Neoplasms
Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells.
Neoplasms
Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic response.
Neoplasms
PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations.
Neoplasms
Pulmonary carcinosarcoma characterized by small round cells with neuroendocrine, myogenic, and chondrogenic differentiation: An extremely rare case.
Neoplasms
Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.
Neoplasms
Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1A1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM).
Neoplasms
RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance.
Neoplasms
Radioimmunotherapy for CD133(+) colonic cancer stem cells inhibits tumor development in nude mice.
Neoplasms
RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis.
Neoplasms
Rational Design of a Red Fluorescent Sensor for ALDH1A1 Displaying Enhanced Cellular Uptake and Reactivity.
Neoplasms
Rationales for the Use of Cancer Stem Cells Markers in the Staging of Papillary Thyroid Carcinoma.
Neoplasms
Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids.
Neoplasms
Relevance of mortalin to cancer cell stemness and cancer therapy.
Neoplasms
Reliability of a flushing questionnaire and the ethanol patch test in screening for inactive aldehyde dehydrogenase-2 and alcohol-related cancer risk.
Neoplasms
Renal cell carcinoma with synchronous ipsilateral urothelial carcinoma of the renal pelvis.
Neoplasms
Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate.
Neoplasms
Reporter gene systems for the identification and characterization of cancer stem cells.
Neoplasms
Reporters of Cancer Stem Cells as a Tool for Drug Discovery.
Neoplasms
Retinoid resistance and multifaceted impairment of retinoic acid synthesis in glioblastoma.
Neoplasms
Retinoid signaling regulates breast cancer stem cell differentiation.
Neoplasms
Reversal of cisplatin sensitization and abrogation of cisplatin-enriched cancer stem cells in 5-8F nasopharyngeal carcinoma cell line through a suppression of Wnt/?-catenin-signaling pathway.
Neoplasms
Role for the Aryl Hydrocarbon Receptor and Diverse Ligands in Oral Squamous Cell Carcinoma Migration and Tumorigenesis.
Neoplasms
Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment.
Neoplasms
Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC.
Neoplasms
Role of leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC) for anti-apoptosis and tumourigenesis in cancers.
Neoplasms
Roles of defective ALDH2 polymorphism on liver protection and cancer development.
Neoplasms
ROS-mediated genotoxic stress is involved in NaAsO2-induced cell cycle arrest, stemness enhancement and chemoresistance of prostate cancer cells in a p53-independent manner.
Neoplasms
Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway.
Neoplasms
Salivary acetaldehyde concentration according to alcoholic beverage consumed and aldehyde dehydrogenase-2 genotype.
Neoplasms
Salivary gland cancer patient-derived xenografts enable characterization of cancer stem cells and new gene fusions associated with tumor progression.
Neoplasms
Screening of potentially crucial genes and regulatory factors involved in epithelial ovarian cancer using microarray analysis.
Neoplasms
Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness.
Neoplasms
Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
Neoplasms
Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells.
Neoplasms
Serum ALDH1A1 is a tumor marker for the diagnosis of non-small cell lung cancer.
Neoplasms
SGCE Promotes Breast Cancer Stem Cells by Stabilizing EGFR.
Neoplasms
Short-term follow-up after endoscopic mucosectomy of early esophageal cancer and aldehyde dehydrogenase-2 genotype in Japanese alcoholics.
Neoplasms
Significant association between decreased ALDH2 activity and increased sensitivity to genotoxic effects in workers occupationally exposed to styrene.
Neoplasms
Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes.
Neoplasms
Silencing PTEN in the fallopian tube promotes enrichment of cancer stem cell-like function through loss of PAX2.
Neoplasms
Silencing TAK1 alters gene expression signatures in bladder cancer cells.
Neoplasms
Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
Neoplasms
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer.
Neoplasms
Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells.
Neoplasms
SIX1 maintains tumor basal cells via transforming growth factor-? pathway and associates with poor prognosis in esophageal cancer.
Neoplasms
Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.
Neoplasms
Sonic hedgehog and Wnt/?-catenin pathways mediate curcumin inhibition of breast cancer stem cells.
Neoplasms
SOX9 Regulates Cancer Stem-Like Properties and Metastatic Potential of Single-Walled Carbon Nanotube-Exposed Cells.
Neoplasms
Spatial distribution of cancer stem cells in head and neck squamous cell carcinomas.
Neoplasms
Spectral overlap-free quantum dot-based determination of benzo[a]pyrene-induced cancer stem cells by concurrent monitoring of CD44, CD24 and aldehyde dehydrogenase 1.
Neoplasms
Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients.
Neoplasms
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.
Neoplasms
Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.
Neoplasms
Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancer.
Neoplasms
Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.
Neoplasms
Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer.
Neoplasms
Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel.
Neoplasms
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1?/VEGF signalling in MCF-7 breast cancer cells.
Neoplasms
Stromal CD10 expression in breast cancer correlates with tumor invasion and cancer stem cell phenotype.
Neoplasms
Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
Neoplasms
Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.
Neoplasms
Studies on expression of aldehyde dehydrogenase in normal and cancerous tissues of thyroids.
Neoplasms
Sulforaphane Suppresses the Growth of Triple-negative Breast Cancer Stem-like Cells In vitro and In vivo.
Neoplasms
Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction.
Neoplasms
SUMO-Activating Enzyme Subunit 1 (SAE1) Is a Promising Diagnostic Cancer Metabolism Biomarker of Hepatocellular Carcinoma.
Neoplasms
Surveillance of Cancer Stem Cell Plasticity Using an Isoform-Selective Fluorescent Probe for Aldehyde Dehydrogenase 1A1.
Neoplasms
Synergic effect of OP449 and FTY720 on oral squamous cell carcinoma.
Neoplasms
Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells.
Neoplasms
Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells.
Neoplasms
Tamoxifen induces a pluripotency signature in breast cancer cells and human tumors.
Neoplasms
TAp63 and ?Np63 (p40) in prostate adenocarcinomas: ?Np63 associates with a basal-like cancer stem cell population but not with metastasis.
Neoplasms
Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example.
Neoplasms
Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.
Neoplasms
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer.
Neoplasms
Targeting aldehyde dehydrogenase: a potential approach for cell labeling.
Neoplasms
Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma.
Neoplasms
Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
Neoplasms
Targeting ALDH2 with disulfiram/copper reverses the resistance of cancer cells to microtubule inhibitors.
Neoplasms
Targeting ALDHbright human carcinoma initiating cells with ALDH1A1- specific CD8+ T cells.
Neoplasms
Targeting c-kit inhibits gefitinib resistant NSCLC cell growth and invasion through attenuations of stemness, EMT and acquired resistance.
Neoplasms
Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC.
Neoplasms
Targets and pathways involved in the antitumor activity of citral and its stereo-isomers.
Neoplasms
TAZ induces lung cancer stem cell properties and tumorigenesis by up-regulating ALDH1A1.
Neoplasms
TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer.
Neoplasms
Telomere shortening in alcohol dependence: Roles of alcohol and acetaldehyde.
Neoplasms
Telomere Shortening in the Oral Epithelium in Relation to Alcohol Intake, Alcohol Dehydrogenase (ADH-1B) and Acetaldehyde Dehydrogenase (ALDH-2) Genotypes and Clinicopathologic Features.
Neoplasms
Tescalcin/c-Src/IGF1R?-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1.
Neoplasms
Tetrandrine inhibits glioma stem-like cells by repressing ?-catenin expression.
Neoplasms
The Clinical Significance of Cancer Stem Cell Markers ALDH1A1 and CD133 in Lung Adenocarcinoma.
Neoplasms
The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer.
Neoplasms
The different pathogeneses of sporadic adenoma and adenocarcinoma in non-ampullary lesions of the proximal and distal duodenum.
Neoplasms
The effect of genetic polymorphisms in the vinyl chloride metabolic pathway on mutagenic risk.
Neoplasms
The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study.
Neoplasms
The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.
Neoplasms
The expression of ALDH1 in cervical carcinoma.
Neoplasms
The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
Neoplasms
The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma.
Neoplasms
The functional role of the EZH2 gene in controlling breast cancer stem cells.
Neoplasms
The genetic basis of addictive disorders.
Neoplasms
The Heparan Sulfate Sulfotransferases HS2ST1 and HS3ST2 Are Novel Regulators of Breast Cancer Stem-Cell Properties.
Neoplasms
The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer.
Neoplasms
The impact of Aldehyde dehydrogenase 1 expression on prognosis for metastatic colon cancer.
Neoplasms
The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties.
Neoplasms
The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
Neoplasms
The long non-coding RNA MACC1-AS1 promotes nasopharyngeal carcinoma cell stemness via suppressing miR-145-mediated inhibition on SMAD2/MACC1-AS1 axis.
Neoplasms
The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype.
Neoplasms
The murine hepatic sequelae of long-term ethanol consumption are sex-specific and exacerbated by Aldh1b1 loss.
Neoplasms
The predominant expression of cancer stem cell marker ALDH1A3 in tumor infiltrative area is associated with shorter overall survival of human glioblastoma.
Neoplasms
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.
Neoplasms
The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures.
Neoplasms
The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
Neoplasms
The prognostic roles of ALDH1 isoenzymes in gastric cancer.
Neoplasms
The prognostic roles of circulating ALDH1+ tumor cell in the patients with non-small cell lung cancer.
Neoplasms
The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Neoplasms
The receptor tyrosine kinase Axl regulates cell-cell adhesion and stemness in cutaneous squamous cell carcinoma.
Neoplasms
The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer.
Neoplasms
The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population.
Neoplasms
The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment.
Neoplasms
The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
Neoplasms
The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer.
Neoplasms
The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.
Neoplasms
The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
Neoplasms
The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasms.
Neoplasms
Through the glass darkly: intraepithelial neoplasia, top-down differentiation and the road to ovarian cancer.
Neoplasms
Transcriptome analysis and prognosis of ALDH isoforms in human cancer.
Neoplasms
Transcriptomic Analysis of Breast Cancer Stem Cells and Development of a pALDH1A1:mNeptune Reporter System for Live Tracking.
Neoplasms
Treatment resistance in stem cells and breast cancer.
Neoplasms
Tumorigenesis of smoking carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is related to its ability to stimulate thromboxane synthase and enhance stemness of non-small cell lung cancer stem cells.
Neoplasms
Tumour budding and the expression of cancer stem cell marker aldehyde dehydrogenase 1 in nasopharyngeal carcinoma.
Neoplasms
Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality.
Neoplasms
Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Neoplasms
UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells.
Neoplasms
Upregulation of ALDH1B1 promotes tumor progression in osteosarcoma.
Neoplasms
Urokinase Plasminogen Activator System Targeted Delivery of Nanobins as a Novel Ovarian Cancer Therapeutics.
Neoplasms
Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain.
Neoplasms
Value of CagA, HER2, ALDH1, and KiSS-1 in predicting metastasis and prognosis for gastric adenocarcinoma.
Neoplasms
Vasculogenic mimicry and expression of ALDH1, Beclin1, and p16 correlate with metastasis and prognosis in oral squamous cell carcinoma.
Neoplasms
VEGFA activates an epigenetic pathway upregulating ovarian cancer-initiating cells.
Neoplasms
Verification of ALDH Activity as a Biomarker in Colon Cancer Stem Cells-Derived HT-29 Cell Line.
Neoplasms
Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
Neoplasms
Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells.
Neoplasms
WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer.
Neoplasms
Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules.
Neoplasms
Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors.
Neoplasms
Zinc-finger E-box-binding homeobox 1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib.
Neoplasms
[A coexistence of the Dupuytren's disease and malignant neoplasms: a review].
Neoplasms
[Abnormal expression of genes that regulate retinoid metabolism and signaling in non-small-cell lung cancer].
Neoplasms
[Advance in research on the association of ALDH2 gene polymorphisms with cancer susceptibility in drinkers].
Neoplasms
[Advancement of studies on ALDH1 as a universal marker of stem cells].
Neoplasms
[Alcohol and oropharyngolaryngeal and digestive tract cancer]
Neoplasms
[Anti-tumor mechanism of Artemisia annua based on bioinformatics].
Neoplasms
[Effect of aspirin on breast cancer stem cells and stemness of breast cancer].
Neoplasms
[Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
Neoplasms
[Expression and Clinical Significance of ALDH1 and Twist in Gastric Adenocarcinoma].
Neoplasms
[Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship with Ovarian Cancer Stem Cell Markers CD117, CD133, ALDH1.]
Neoplasms
[Expression of Acetaldehyde Dehydrogenase in Gefitinib-resistant Human Lung Adenocarcinoma HCC-827/GR Cells].
Neoplasms
[Expression of ALDH1, CXCR4 and E-cadherin in castric carcinoma and their roles in lymphatic metastasis].
Neoplasms
[Expressions and Significance of ALDH1, HIF-1? and VEGF in Laryngeal Squamous Cell Carcinoma].
Neoplasms
[Genetic polymorphisms of alcohol-metabolizing enzymes and cytokines in patients with alcohol induced pancreatitis and alcoholic liver cirrhosis]
Neoplasms
[High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma].
Neoplasms
[Lung non-terminal respiratory unit type adenocarcinoma: a clinicopathologic study].
Neoplasms, Second Primary
Clinical features and treatment outcomes of Japanese head and neck cancer patients with a second primary cancer.
Neoplasms, Squamous Cell
ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors.
Neoplasms, Squamous Cell
Esophageal melanosis, an endoscopic finding associated with squamous cell neoplasms of the upper aerodigestive tract, and inactive aldehyde dehydrogenase-2 in alcoholic Japanese men.
Neoplasms, Squamous Cell
In vitro and in vivo expression of aldehyde dehydrogenase 1 in oral squamous cell carcinoma.
Neoplastic Cells, Circulating
Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells.
Neoplastic Cells, Circulating
Identification of ALDH1A3 as a viable therapeutic target in breast cancer metastasis-initiating cells.
Neoplastic Cells, Circulating
Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients.
Nervous System Diseases
A Neurodegenerative Phenotype Associated With Sjögren-Larsson Syndrome.
Nervous System Diseases
Conserved missense variant in ALDH1A3 ortholog impairs fecundity in C. elegans.
Neural Tube Defects
Analysis of ALDH1A2, CYP26A1, CYP26B1, CRABP1, and CRABP2 in human neural tube defects suggests a possible association with alleles in ALDH1A2.
Neural Tube Defects
Replication and exploratory analysis of 24 candidate risk polymorphisms for neural tube defects.
Neuralgia
Dihydromyricetin attenuates neuropathic pain via enhancing the transition from M1 to M2 phenotype polarization by potentially elevating ALDH2 activity in vitro and vivo.
Neurilemmoma
ALDH1 - A new immunohistochemical diagnostic marker for Schwann cell-derived tumors.
Neuroblastoma
Involvement of aldehyde dehydrogenase 1A2 in the regulation of cancer stem cell properties in neuroblastoma.
Neuroblastoma
Overexpression of aldehyde dehydrogenase 1A1 reduces oxidation-induced toxicity in SH-SY5Y neuroblastoma cells.
Neurocutaneous Syndromes
Compound heterozygous mutations in the ALDH3A2 gene cause Sjögren-Larsson syndrome: a case report.
Neurocutaneous Syndromes
Impaired skin barrier function due to reduced ?-O-acylceramide levels in a mouse model of Sjögren-Larsson syndrome.
Neurocutaneous Syndromes
Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
Neurocutaneous Syndromes
Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
Neurocutaneous Syndromes
Sjögren-Larsson syndrome: phenotypic variability in two brothers with a neurocutaneous disorder.
Neurodegenerative Diseases
Age-dependent neurodegeneration accompanying memory loss in transgenic mice defective in mitochondrial aldehyde dehydrogenase 2 activity.
Neurodegenerative Diseases
Aldehyde dehydrogenase 2 in the spotlight: The link between mitochondria and neurodegeneration.
Neurodegenerative Diseases
Association between ALDH2 Gene Polymorphism and Late-onset Alzheimer Disease: An Up-to-date Meta-analysis.
Neurodegenerative Diseases
Functional significance of aldehyde dehydrogenase ALDH1A1 to the nigrostriatal dopamine system.
Neurodegenerative Diseases
Overexpression of Aldehyde Dehydrogenase-2 Attenuates Neurotoxicity Induced by 4-Hydroxynonenal in Cultured Primary Hippocampal Neurons.
Neurodegenerative Diseases
Oxadiazon affects the expression and activity of aldehyde dehydrogenase and acylphosphatase in human striatal precursor cells: A possible role in neurotoxicity.
Neurodegenerative Diseases
Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: An update.
Neurodegenerative Diseases
Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.
Neurodegenerative Diseases
The Role of Mitochondrial Aldehyde Dehydrogenase 2 (ALDH2) in Neuropathology and Neurodegeneration.
Neuroendocrine Tumors
ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.
Neurofibroma
ALDH1 - A new immunohistochemical diagnostic marker for Schwann cell-derived tumors.
Neurofibrosarcoma
ALDH1 - A new immunohistochemical diagnostic marker for Schwann cell-derived tumors.
Neuroinflammatory Diseases
Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer's disease related pathology.
Neuroinflammatory Diseases
Neuroprotective effects of Alda-1 mitigate spinal cord injury in mice: involvement of Alda-1-induced ALDH2 activation-mediated suppression of reactive aldehyde mechanisms.
Non-alcoholic Fatty Liver Disease
Differences in the genetic backgrounds of patients with alcoholic liver disease and non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseases.
Non-alcoholic Fatty Liver Disease
The Association and Interaction of Aldehyde Dehydrogenase 2 Polymorphisms with Food Group Intake and Probability of Having Non-Alcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Vinyl chloride-induced interaction of nonalcoholic and toxicant-associated steatohepatitis: Protection by the ALDH2 activator Alda-1.
Obesity
Aldehyde dehydrogenase 2 and beta3-adrenergic receptor gene polymorphisms: their association with elevated liver enzymes and metabolic syndrome.
Obesity
Aldehyde Dehydrogenases Genetic Polymorphism and Obesity: From Genomics to Behavior and Health.
Obesity
ALDH2 protects against high fat diet-induced obesity cardiomyopathy and defective autophagy: role of CaM kinase II, histone H3K9 methyltransferase SUV39H, Sirt1, and PGC-1? deacetylation.
Obesity
Characterization of Two Distinct Structural Classes of Selective Aldehyde Dehydrogenase 1A1 Inhibitors.
Obesity
Correction to: ALDH2 protects against high fat diet-induced obesity cardiomyopathy and defective autophagy: role of CaM kinase II, histone H3K9 methyltransferase SUV39H, Sirt1, and PGC-1? deacetylation.
Obesity
Development of new disulfiram analogues as ALDH1a1-selective inhibitors.
Obesity
Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors.
Obesity
Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity.
Obesity
Discovery of coumarin-based selective aldehyde dehydrogenase 1A1 inhibitors with glucose metabolism improving activity.
Obesity
Episodic ?-cell death and dedifferentiation during diet-induced obesity and dysglycemia in male mice.
Obesity
Investigation of an ALDH1A1-specific inhibitor for suppression of weight gain in a diet-induced mouse model of obesity.
Obesity
Moderate vitamin A supplementation in obese mice regulates tissue factor and cytokine production in a sex-specific manner.
Obesity
Obesity, Current Treatment and Future Horizons.
Obesity
Pharmacological inhibition of ALDH1A enzymes suppresses weight gain in a mouse model of diet-induced obesity.
Obesity
The prolonged survival of fibroblasts with forced lipid catabolism in visceral fat following encapsulation in alginate-poly-L-lysine.
Obesity, Abdominal
The contribution of vitamin A to autocrine regulation of fat depots.
Odontogenic Cysts
Can lower aldehyde dehydrogenase activity in saliva be a risk factor for oral cavity cancer?
Odontogenic Tumors
Can lower aldehyde dehydrogenase activity in saliva be a risk factor for oral cavity cancer?
Optic Nerve Injuries
Optic nerve injury upregulates retinoic acid signaling in the adult frog visual system.
Oropharyngeal Neoplasms
Alcohol-metabolizing Enzymes' Gene Polymorphisms and Susceptibility to Multiple Head and Neck Cancers.
Oropharyngeal Neoplasms
Heavy alcohol drinking downregulates ALDH2 gene expression but heavy smoking up-regulates SOD2 gene expression in head and neck squamous cell carcinoma.
Oropharyngeal Neoplasms
Local Acetaldehyde: Its Key Role in Alcohol-Related Oropharyngeal Cancer.
Oropharyngeal Neoplasms
Prognostic value of ALDH2 polymorphism for patients with oropharyngeal cancer in a Japanese population.
Osteoarthritis
Functional Characterization of the Osteoarthritis Genetic Risk Residing at ALDH1A2 Identifies rs12915901 as a Key Target Variant.
Osteoarthritis
Genetic contribution to osteoarthritis development: current state of evidence.
Osteoarthritis
Severe osteoarthritis of the hand associates with common variants within the ALDH1A2 gene and with rare variants at 1p31.
Osteoarthritis
The rs4238326 polymorphism in ALDH1A2 gene potentially associated with non-post traumatic knee osteoarthritis susceptibility: a two-stage population-based study.
Osteoarthritis, Knee
The rs4238326 polymorphism in ALDH1A2 gene potentially associated with non-post traumatic knee osteoarthritis susceptibility: a two-stage population-based study.
Osteonecrosis
A case-control study of association between life-style, alcohol dehydrogenase 2 and aldehyde dehydrogenase 2 genotype and idiopathic osteonecrosis of the femoral head.
Osteoporosis
A critical assessment of the potential of pharmacological modulation of aldehyde dehydrogenases to treat the diseases of bone loss.
Osteoporosis
Aldehyde-stress resulting from Aldh2 mutation promotes osteoporosis due to impaired osteoblastogenesis.
Osteoporosis
Astaxanthin improves osteopenia caused by aldehyde-stress resulting from Aldh2 mutation due to impaired osteoblastogenesis.
Osteoporosis
Disruption of aldehyde dehydrogenase 2 gene results in altered cortical bone structure and increased cortical bone mineral density in the femoral diaphysis of mice.
Osteoporosis
Disruption of the Aldehyde Dehydrogenase 2 Gene Results in No Increase in Trabecular Bone Mass Due to Skeletal Loading in Association with Impaired Cell Cycle Regulation Through p21 Expression in the Bone Marrow Cells of Mice.
Osteoporosis
Effects of "Essential AD2" Supplement on Blood Acetaldehyde Levels in Individuals Who Have Aldehyde Dehydrogenase (ALDH2) Deficiency.
Osteoporosis
Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol Ingestion.
Osteoporosis
Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.
Osteoporosis
The Role of Alcohol, LPS Toxicity, and ALDH2 in Dental Bony Defects.
Osteosarcoma
MicroRNA-761 suppresses tumor progression in osteosarcoma via negatively regulating ALDH1B1.
Osteosarcoma
MicroRNA?487b?3p inhibits osteosarcoma chemoresistance and metastasis by targeting ALDH1A3.
Osteosarcoma
Overexpression of FER1L4 promotes the apoptosis and suppresses epithelial-mesenchymal transition and stemness markers via activating PI3K/AKT signaling pathway in osteosarcoma cells.
Osteosarcoma
The expressions of CD133, ALDH1, and vasculogenic mimicry in osteosarcoma and their clinical significance.
Osteosarcoma
Upregulation of ALDH1B1 promotes tumor progression in osteosarcoma.
Ovarian Neoplasms
?-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids.
Ovarian Neoplasms
A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer.
Ovarian Neoplasms
ALDH1 expression correlates with favorable prognosis in ovarian cancers.
Ovarian Neoplasms
ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome.
Ovarian Neoplasms
ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.
Ovarian Neoplasms
ALDH1A1 contributes to PARP inhibitor resistance via enhancing DNA repair in BRCA2-/- ovarian cancer cells.
Ovarian Neoplasms
ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling.
Ovarian Neoplasms
ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer.
Ovarian Neoplasms
All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells.
Ovarian Neoplasms
Association of ALDH1A1-NEK-2 axis in cisplatin resistance in ovarian cancer cells.
Ovarian Neoplasms
BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer.
Ovarian Neoplasms
CD166 Promotes the Cancer Stem-like Properties of Primary Epithelial Ovarian Cancer Cells.
Ovarian Neoplasms
Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy.
Ovarian Neoplasms
Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis.
Ovarian Neoplasms
DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1.
Ovarian Neoplasms
Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy.
Ovarian Neoplasms
Discovery of microarray-identified genes associated with ovarian cancer progression.
Ovarian Neoplasms
Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.
Ovarian Neoplasms
DOXIL when combined with Withaferin A (WFA) targets ALDH1 positive cancer stem cells in ovarian cancer.
Ovarian Neoplasms
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells.
Ovarian Neoplasms
Early detection biomarkers for ovarian cancer.
Ovarian Neoplasms
Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine.
Ovarian Neoplasms
Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
Ovarian Neoplasms
Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines.
Ovarian Neoplasms
MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
Ovarian Neoplasms
Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development.
Ovarian Neoplasms
Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium.
Ovarian Neoplasms
Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.
Ovarian Neoplasms
Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer.
Ovarian Neoplasms
PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations.
Ovarian Neoplasms
Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles.
Ovarian Neoplasms
Solanum Incanum Extract Downregulates Aldehyde Dehydrogenase 1-Mediated Stemness and Inhibits Tumor Formation in Ovarian Cancer Cells.
Ovarian Neoplasms
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer.
Ovarian Neoplasms
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.
Ovarian Neoplasms
[Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship with Ovarian Cancer Stem Cell Markers CD117, CD133, ALDH1.]
Pancreatic Neoplasms
Acetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancers.
Pancreatic Neoplasms
Aldehyde dehydrogenase 1A1 and gelsolin identified as novel invasion-modulating factors in conditioned medium of pancreatic cancer cells.
Pancreatic Neoplasms
Aldehyde Dehydrogenase 1B1 as a Modulator of Pancreatic Adenocarcinoma.
Pancreatic Neoplasms
ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose Metabolism.
Pancreatic Neoplasms
Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer.
Pancreatic Neoplasms
Association of aldehyde dehydrogenase 2 gene polymorphism with pancreatic cancer but not colon cancer.
Pancreatic Neoplasms
Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine.
Pancreatic Neoplasms
Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.
Pancreatic Neoplasms
Correlations between polymorphisms of extracellular superoxide dismutase, aldehyde dehydrogenase-2 genes, as well as drinking behavior and pancreatic cancer.
Pancreatic Neoplasms
Fibulin-3 negatively regulates ALDH1 via c-MET suppression and increases ?-radiation-induced sensitivity in some pancreatic cancer cell lines.
Pancreatic Neoplasms
Formulation Comprising Arsenic Trioxide and Dimercaprol Enhances Radiosensitivity of Pancreatic Cancer Xenografts.
Pancreatic Neoplasms
Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells.
Pancreatic Neoplasms
Inactive aldehyde dehydrogenase-2 increased the risk of pancreatic cancer among smokers in a Japanese male population.
Pancreatic Neoplasms
Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.
Pancreatic Neoplasms
Nrf2 Depletion Sensitizes Pancreatic Cancer Cells to Gemcitabine via Aldehyde Dehydrogenase 3a1 Repression.
Pancreatic Neoplasms
Phosphorylation-dependent regulation of ALDH1A1 by Aurora kinase A: insights on their synergistic relationship in pancreatic cancer.
Pancreatic Neoplasms
Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells.
Pancreatic Neoplasms
Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1.
Pancreatic Pseudocyst
SPINK1 gene mutations and pancreatitis in Japan.
Pancreatitis
A small-molecule activator of mitochondrial aldehyde dehydrogenase 2 reduces the severity of cerulein-induced acute pancreatitis.
Pancreatitis
Alcohol-metabolizing enzyme gene polymorphisms and alcohol chronic pancreatitis among Polish individuals.
Pancreatitis
Alcoholism and alcoholic organ damage and genetic polymorphisms of alcohol metabolizing enzymes in Chinese patients.
Pancreatitis
Chinese alcoholic patients with esophageal cancer are genetically different from alcoholics with acute pancreatitis and liver cirrhosis.
Pancreatitis
Genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 and liver cirrhosis, chronic calcific pancreatitis, diabetes mellitus, and hypertension among Japanese alcoholic men.
Pancreatitis
Genotypes of alcohol-metabolizing enzymes in relation to alcoholic chronic pancreatitis in Japan.
Pancreatitis
Genotypes of Alcohol-Metabolizing Enzymes in Relation to Alcoholic Chronic Pancreatitis in Japan.
Pancreatitis
Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver.
Pancreatitis, Alcoholic
Alcohol and aldehyde dehydrogenase polymorphisms in Japanese patients with alcohol-induced chronic pancreatitis.
Pancreatitis, Alcoholic
Alcoholism and alcoholic organ damage and genetic polymorphisms of alcohol metabolizing enzymes in Chinese patients.
Pancreatitis, Alcoholic
CD14 promoter polymorphism in Chinese alcoholic patients with cirrhosis of liver and acute pancreatitis.
Pancreatitis, Alcoholic
Genotypes of alcohol-metabolizing enzymes in relation to alcoholic chronic pancreatitis in Japan.
Pancreatitis, Alcoholic
Genotypes of Alcohol-Metabolizing Enzymes in Relation to Alcoholic Chronic Pancreatitis in Japan.
Pancreatitis, Alcoholic
[Genetic polymorphisms of alcohol-metabolizing enzymes and cytokines in patients with alcohol induced pancreatitis and alcoholic liver cirrhosis]
Pancreatitis, Chronic
Alcohol dehydrogenase and aldehyde dehydrogenase gene polymorphism in alcohol liver cirrhosis and alcohol chronic pancreatitis among Polish individuals.
Pancreatitis, Chronic
Alcohol-metabolizing enzyme gene polymorphisms and alcohol chronic pancreatitis among Polish individuals.
Pancreatitis, Chronic
Genetic polymorphisms in alcohol dehydrogenase, aldehyde dehydrogenase and alcoholic chronic pancreatitis susceptibility: A meta-analysis.
Pancreatitis, Chronic
Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage.
Pancreatitis, Chronic
Microsatellite scan identifies new candidate genes for susceptibility to alcoholic chronic pancreatitis in Japanese patients.
Pancreatitis, Chronic
Polymorphism in alcohol-metabolizing enzymes, glutathione S-transferases and apolipoprotein E and susceptibility to alcohol-induced cirrhosis and chronic pancreatitis.
Pancreatitis, Chronic
SPINK1, ADH2, and ALDH2 gene variants and alcoholic chronic pancreatitis in Japan.
Papilloma
ALDH1 as a prognostic marker for lymph node metastasis in OSCC.
Papilloma
Heavy alcohol drinking downregulates ALDH2 gene expression but heavy smoking up-regulates SOD2 gene expression in head and neck squamous cell carcinoma.
Paraparesis, Spastic
Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
Parkinson Disease
Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease.
Parkinson Disease
Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's disease.
Parkinson Disease
Aldehyde dehydrogenase 1-positive nigrostriatal dopaminergic fibers exhibit distinct projection pattern and dopamine release dynamics at mouse dorsal striatum.
Parkinson Disease
Aldehyde dehydrogenase 2 genetic variations may increase susceptibility to Parkinson's disease in Han Chinese population.
Parkinson Disease
Aldehyde dehydrogenase 2 in sporadic Parkinson's disease.
Parkinson Disease
Aldehyde dehydrogenase 2 is associated with cognitive functions in patients with Parkinson's disease.
Parkinson Disease
ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia.
Parkinson Disease
ALDH1A1 Genetic Variations May Modulate Risk of Parkinson's Disease in Han Chinese Population.
Parkinson Disease
ALDH1A1 regulates postsynaptic ?-opioid receptor expression in dorsal striatal projection neurons and mitigates dyskinesia through transsynaptic retinoic acid signaling.
Parkinson Disease
Association Between Aldehyde dehydrogenase-2 Polymorphisms and Risk of Alzheimer's Disease and Parkinson's Disease: A Meta-Analysis Based on 5,315 Individuals.
Parkinson Disease
Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's disease.
Parkinson Disease
Characterization of Two Distinct Structural Classes of Selective Aldehyde Dehydrogenase 1A1 Inhibitors.
Parkinson Disease
Effect of ALDH2 on Sleep Disturbances in Patients with Parkinson's Disease.
Parkinson Disease
Functional significance of aldehyde dehydrogenase ALDH1A1 to the nigrostriatal dopamine system.
Parkinson Disease
Genetic Analysis of the ZNF512B, SLC41A1, and ALDH2 Polymorphisms in Parkinson's Disease in the Iranian Population.
Parkinson Disease
Identification of aldehyde dehydrogenase 1A1 modulators using virtual screening.
Parkinson Disease
Interactions of COMT and ALDH2 Genetic Polymorphisms on Symptoms of Parkinson's Disease.
Parkinson Disease
Neurorescue by a ROS Decomposition Catalyst.
Parkinson Disease
Oxadiazon affects the expression and activity of aldehyde dehydrogenase and acylphosphatase in human striatal precursor cells: A possible role in neurotoxicity.
Parkinson Disease
Psychotropics regulate Skp1a, Aldh1a1, and Hspa8 transcription--potential to delay Parkinson's disease.
Parkinson Disease
Role of ADH2 and ALDH2 gene polymorphisms in the development of Parkinson's disease in a Chinese population.
Parkinson Disease
Study on Parkinson's disease and alcohol drinking.
Parkinsonian Disorders
Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism.
Pentalogy of Cantrell
Duplication of the ALDH1A2 gene in association with pentalogy of Cantrell: a case report.
Periodontal Diseases
Association of ALDH2 genotypes with periodontitis progression.
Periodontitis
ALDH2 genotype is associated in the relation between alcohol intake and periodontitis.
Periodontitis
Association of ALDH2 genotypes with periodontitis progression.
Peripheral Nervous System Diseases
Influence of alcohol intake and aldehyde dehydrogenase 2 phenotype on peripheral neuropathy of diabetes.
Perivascular Epithelioid Cell Neoplasms
Expression of CD44 and CD29 by PEComa cells suggests their possible origin of mesenchymal stem cells.
Persistent Infection
High expression of aldehyde dehydrogenase 1 and tissue necrosis factor alpha may relate to chronic infection of buffalo mammary gland.
Pharyngeal Neoplasms
Folate, alcohol, and aldehyde dehydrogenase 2 polymorphism and the risk of oral and pharyngeal cancer in Japanese.
Pharyngeal Neoplasms
[Field cancerization and field therapy - the therapy of actinic keratosis by imiquimod].
Phyllodes Tumor
In phyllodes tumour of the breast expression of c-kit but not of ALDH1A1 is associated with adverse clinico-pathological features.
Pituitary Neoplasms
Reduction of retinaldehyde dehydrogenase 1 expression and production in estrogen-induced prolactinoma of rat.
Pleural Effusion, Malignant
ALDH1 and SALL4 Expression in Cell Block Samples from Patients with Lung Adenocarcinoma and Malignant Pleural Effusion.
Polycystic Ovary Syndrome
Expression Levels of the Oxidative Stress Response Gene ALDH3A2 in Granulosa-Lutein Cells Are Related to Female Age and Infertility Diagnosis.
Polyneuropathies
ALDH2/ADH2 polymorphism associated with vasculopathy and neuropathy in type 2 diabetes.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Oncorequisite role of an aldehyde dehydrogenase in the pathogenesis of T-cell acute lymphoblastic leukemia.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Aberrant expression of aldehyde dehydrogenase 1A (ALDH1A) subfamily genes in acute lymphoblastic leukaemia is a common feature of T-lineage tumours.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Oncorequisite role of an aldehyde dehydrogenase in the pathogenesis of T-cell acute lymphoblastic leukemia.
Prolactinoma
Reduction of retinaldehyde dehydrogenase 1 expression and production in estrogen-induced prolactinoma of rat.
Prostatic Intraepithelial Neoplasia
Increased Expression of ALDH1A1 in Prostate Cancer is Correlated With Tumor Aggressiveness: A Tissue Microarray Study of Iranian Patients.
Prostatic Neoplasms
Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis.
Prostatic Neoplasms
ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.
Prostatic Neoplasms
ALDH1A3 correlates with luminal phenotype in prostate cancer.
Prostatic Neoplasms
ALDH1A3 serves as a predictor for castration resistance in prostate cancer patients.
Prostatic Neoplasms
Androgen regulation of aldehyde dehydrogenase 1A3 (ALDH1A3) in the androgen-responsive human prostate cancer cell line LNCaP.
Prostatic Neoplasms
Association study between genetic variants in retinol metabolism pathway genes and prostate cancer risk.
Prostatic Neoplasms
Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.
Prostatic Neoplasms
Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2.
Prostatic Neoplasms
Increased Expression of ALDH1A1 in Prostate Cancer is Correlated With Tumor Aggressiveness: A Tissue Microarray Study of Iranian Patients.
Prostatic Neoplasms
MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer.
Prostatic Neoplasms
p63 Cytoplasmic Aberrance is Associated with High Prostate Cancer Stem Cell Expression.
Prostatic Neoplasms
Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model.
Prostatic Neoplasms
Shikonin enhances the antitumor effect of cabazitaxel in prostate cancer stem cells and reverses cabazitaxel resistance by inhibiting ABCG2 and ALDH3A1.
Prostatic Neoplasms
Silybin Prevents Prostate Cancer by Inhibited the ALDH1A1 Expression in the Retinol Metabolism Pathway.
Prostatic Neoplasms
Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.
Prostatic Neoplasms
Sulforaphane Inhibits c-Myc-Mediated Prostate Cancer Stem-Like Traits.
Prostatic Neoplasms
The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer.
Prostatic Neoplasms
Tissue Biomarkers for Prognosis of prostate cancer: A Systematic Review and Meta-analysis.
Protein Deficiency
Deficient expression of aldehyde dehydrogenase 1A1 is consistent with increased sensitivity of Gorlin syndrome patients to radiation carcinogenesis.
Proteinuria
ALDH2/ADH2 polymorphism associated with vasculopathy and neuropathy in type 2 diabetes.
Pterygium
Proteomic analysis in pterygium; upregulated protein expression of ALDH3A1, PDIA3, and PRDX2.
Pulmonary Arterial Hypertension
Aldehyde dehydrogenase 2 protects against oxidative stress associated with pulmonary arterial hypertension.
Pulmonary Arterial Hypertension
ALDH1A3 Coordinates Metabolism With Gene Regulation in Pulmonary Arterial Hypertension.
Pulmonary Arterial Hypertension
Influence of the aldehyde dehydrogenase 2 polymorphism on the vasodilatory effect of nitroglycerin in infants with congenital heart disease and pulmonary arterial hypertension.
Pulmonary Disease, Chronic Obstructive
Aldehyde dehydrogenase 2-a potential genetic risk factor for lung function among southern Chinese: evidence from the Guangzhou Biobank Cohort Study.
Pulmonary Disease, Chronic Obstructive
Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients.
Pulmonary Disease, Chronic Obstructive
Susceptibility to COPD: differential proteomic profiling after acute smoking.
Pulmonary Fibrosis
Multi?layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/??catenin signaling activation (Review).
Quadriplegia
Sjögren-Larsson syndrome: Novel mutations in the ALDH3A2 gene in a French cohort.
Rectal Neoplasms
A critical Analysis of the Relationship Between Aldehyde dehydrogenases-2 Glu487Lys Polymorphism and Colorectal Cancer Susceptibility.
Rectal Neoplasms
Aldehyde dehydrogenase 2 (ALDH2) genotype affects rectal cancer susceptibility due to alcohol consumption.
Rectal Neoplasms
ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer.
Rectal Neoplasms
ALDH1 is a prognostic factor for patients treated with neoadjuvant chemoradiotherapy and radical resection for stage III rectal cancer.
Rectal Neoplasms
ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.
Rectal Neoplasms
Expression Analysis of Aldehyde Dehydrogenase 1A1 (ALDH1A1) in Colon and Rectal Cancer in Association with Prognosis and Response to Chemotherapy.
Rectal Neoplasms
GAPDH and PUM1: Optimal Housekeeping Genes for Quantitative Polymerase Chain Reaction-Based Analysis of Cancer Stem Cells and Epithelial-Mesenchymal Transition Gene Expression in Rectal Tumors.
Rectal Neoplasms
Genotype difference of aldehyde dehydrogenase 2 gene in alcohol drinkers influences the incidence of Japanese colorectal cancer patients.
Renal Insufficiency
Aldehyde dehydrogenase 2 as a potential protective factor for renal insufficiency in Japanese subjects with heart failure: a pilot study.
Renal Insufficiency
Maternal inheritance of diabetes is associated with inactive ALDH2 genotype in diabetics with renal failure in Japanese.
Reperfusion Injury
A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: Role of AMPK-regulated autophagy.
Reperfusion Injury
Alda-1 Ameliorates Liver Ischemia-Reperfusion Injury by Activating Aldehyde Dehydrogenase 2 and Enhancing Autophagy in Mice.
Reperfusion Injury
Alda-1 Attenuates Lung Ischemia-Reperfusion Injury by Reducing 4-Hydroxy-2-Nonenal in Alveolar Epithelial Cells.
Reperfusion Injury
Alda-1, an aldehyde dehydrogenase-2 agonist, causes deterioration in renal functions following ischemia-reperfusion injury due to crystalline nephropathy.
Reperfusion Injury
Aldehyde Dehydrogenase 2 (ALDH2) in Rat Fatty Liver Cold Ischemia Injury.
Reperfusion Injury
Aldehyde dehydrogenase 2 regulates autophagy via the Akt-mTOR pathway to mitigate renal ischemia-reperfusion injury in hypothermic machine perfusion.
Reperfusion Injury
Aldehyde Dehydrogenase-2 Activation during Cardioplegic Arrest Enhances the Cardioprotection against Myocardial Ischemia-Reperfusion Injury.
Reperfusion Injury
Aldehyde dehydrogenase-2 acts as a potential genetic target for renal fibrosis.
Reperfusion Injury
Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation.
Reperfusion Injury
Isoflurane Preconditioning Confers Cardioprotection by Activation of ALDH2.
Reperfusion Injury
Mitochondrial aldehyde dehydrogenase in myocardial ischemia-reperfusion injury: from bench to bedside.
Reperfusion Injury
Mitochondrial Aldehyde Dehydrogenase in Myocardial Ischemic and Ischemia-Reperfusion Injury.
Reperfusion Injury
Poly(ADP-ribose) polymerase inhibition prevents reactive oxygen species induced inhibition of aldehyde dehydrogenase2 activity.
Reperfusion Injury
Precision Medicine Considerations for the Management of Heart Disease and Stroke in East Asians.
Reperfusion Injury
Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: An update.
Respiratory Insufficiency
Biallelic hypomorphic variants in ALDH1A2 cause a novel lethal human multiple congenital anomaly syndrome encompassing diaphragmatic, pulmonary, and cardiovascular defects.
Retinitis Pigmentosa
Protection of retinal function and morphology in MNU-induced retinitis pigmentosa rats by ALDH2: an in-vivo study.
Retinoblastoma
Cancer stem cell characteristics in retinoblastoma.
Rhabdomyosarcoma
Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma.
Rhabdomyosarcoma, Embryonal
Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma.
Rosacea
Hypothesis of demodicidosis rosacea flushing etiopathogenesis.
Sarcoma
Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma.
Sarcoma
Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.
Sarcoma
Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations.
Sarcoma
ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study.
Sarcoma
Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcoma.
Sarcoma
Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance.
Sarcoma
Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma.
Sarcoma
The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasms.
Sarcoma, Ewing
C/EBP?-1 promotes transformation and chemoresistance in Ewing sarcoma cells.
Sarcoma, Kaposi
Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors.
Sarcoma, Synovial
Evaluation of expression of cancer stem cell markers and fusion gene in synovial sarcoma: Insights into histogenesis and pathogenesis.
Scleroderma, Systemic
Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in scleroderma.
Sepsis
Inhibition of ALDH2 expression aggravates renal injury in a rat sepsis syndrome model.
Sepsis
Proteomic alteration of mitochondrial aldehyde dehydrogenase 2 in sepsis regulated by heat shock response.
Sepsis
The Role of ALDH2 in Sepsis and the To-Be-Discovered Mechanisms.
Sjogren-Larsson Syndrome
Bezafibrate induces FALDH in human fibroblasts; implications for Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Characterization of the human omega-oxidation pathway for omega-hydroxy-very-long-chain fatty acids.
Sjogren-Larsson Syndrome
Comprehensive in silico screening and molecular dynamics studies of missense mutations in Sjogren-Larsson syndrome associated with the ALDH3A2 gene.
Sjogren-Larsson Syndrome
Enzymatic diagnosis of Sjögren-Larsson syndrome using electrospray ionization mass spectrometry.
Sjogren-Larsson Syndrome
Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.
Sjogren-Larsson Syndrome
Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.
Sjogren-Larsson Syndrome
Neurodegeneration in an adolescent with Sjogren-Larsson syndrome: a decade-long follow-up case report.
Sjogren-Larsson Syndrome
Novel ALDH3A2 heterozygous mutations are associated with defective lamellar granule formation in a Japanese family of Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Novel ALDH3A2 heterozygous mutations in a Japanese family with Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Novel and recurrent ALDH3A2 mutations in Italian patients with Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease.
Sjogren-Larsson Syndrome
Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Sjögren-Larsson syndrome in Brazil is caused by a common c.1108-1G-->C splice-site mutation in the ALDH3A2 gene.
Sjogren-Larsson Syndrome
Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
Sjogren-Larsson Syndrome
Sjögren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2.
Sjogren-Larsson Syndrome
Sjogren-Larsson Syndrome: Mechanisms and Management.
Sjogren-Larsson Syndrome
Sjögren-Larsson syndrome: Novel mutations in the ALDH3A2 gene in a French cohort.
Skin Neoplasms
Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.
Small Cell Lung Carcinoma
ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells.
Small Cell Lung Carcinoma
ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors.
Solitary Fibrous Tumors
ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study.
Solitary Fibrous Tumors
Differential diagnosis of solitary fibrous tumors: A study of 454 soft tissue tumors indicating the diagnostic value of nuclear STAT6 relocation and ALDH1 expression combined with in situ proximity ligation assay.
Solitary Fibrous Tumors
Histopathological findings and immunohistochemical expression of the stem cell markers CD44, ALDH1, Bmi-1, and Nanog in oral solitary fibrous tumors.
Solitary Fibrous Tumors
The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasms.
Spasm
Association of East Asian Variant Aldehyde Dehydrogenase 2 Genotype (ALDH2*2*) with Coronary Spasm and Acute Myocardial Infarction.
Spasm
Risk and Protective Factors of Lifetime Cocaine-Associated Chest Pain.
Spasm
Variant Aldehyde Dehydrogenase 2 (ALDH2*2) Is a Risk Factor for Coronary Spasm and ST-Segment Elevation Myocardial Infarction.
Spinal Cord Injuries
GSNOR and ALDH2 alleviate traumatic spinal cord injury.
Spinal Cord Injuries
Neuroprotective effects of Alda-1 mitigate spinal cord injury in mice: involvement of Alda-1-induced ALDH2 activation-mediated suppression of reactive aldehyde mechanisms.
Spinal Dysraphism
Analysis of ALDH1A2, CYP26A1, CYP26B1, CRABP1, and CRABP2 in human neural tube defects suggests a possible association with alleles in ALDH1A2.
Spinal Dysraphism
Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during mouse development.
Spinocerebellar Ataxias
Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse.
Squamous Cell Carcinoma of Head and Neck
A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
Squamous Cell Carcinoma of Head and Neck
A novel orthotopic mouse model of head and neck cancer and lymph node metastasis.
Squamous Cell Carcinoma of Head and Neck
A perspective on challenges and opportunities in characterizing oral cancer stem cells.
Squamous Cell Carcinoma of Head and Neck
Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.
Squamous Cell Carcinoma of Head and Neck
ALDH1 as a prognostic marker for lymph node metastasis in OSCC.
Squamous Cell Carcinoma of Head and Neck
ALDH2 1510 G/A (Glu487Lys) polymorphism interaction with age in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
ALDH3A1 acts as a prognostic biomarker and inhibits the epithelial mesenchymal transition of oral squamous cell carcinoma through IL-6/STAT3 signaling pathway.
Squamous Cell Carcinoma of Head and Neck
Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
Squamous Cell Carcinoma of Head and Neck
Association of Genetic Polymorphisms of Aldehyde Dehydrogenase-2 and Cytochrome P450 2E1-RsaI and Alcohol Consumption with Oral Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer.
Squamous Cell Carcinoma of Head and Neck
Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3?-dependent cancer stem cell properties.
Squamous Cell Carcinoma of Head and Neck
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
Squamous Cell Carcinoma of Head and Neck
Discrimination of Cancer Stem Cell Markers ALDH1A1, BCL11B, BMI-1, and CD44 in Different Tissues of HNSCC Patients.
Squamous Cell Carcinoma of Head and Neck
Epigenetic therapy regulates the expression of ALDH1 and immunologic response: Relevance to the prognosis of oral cancer.
Squamous Cell Carcinoma of Head and Neck
Evaluation of the risk of metachronous multiple squamous cell carcinoma of the head and neck after transoral surgery based on the genetic polymorphisms of alcohol dehydrogenase 1B and aldehyde dehydrogenase 2.
Squamous Cell Carcinoma of Head and Neck
Expression and associations of TRAF1, BMI-1, ALDH1, and Lin28B in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Expression of ALDH1A1 and CD44 in primary head and neck squamous cell carcinoma and their value for carcinogenesis, tumor progression and cancer stem cell identification.
Squamous Cell Carcinoma of Head and Neck
Expression of CD44, CD44v9, ABCG2, CD24, Bmi-1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological factors.
Squamous Cell Carcinoma of Head and Neck
Heavy alcohol drinking downregulates ALDH2 gene expression but heavy smoking up-regulates SOD2 gene expression in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis.
Squamous Cell Carcinoma of Head and Neck
Immunolocalization of Cancer Stem Cells Marker ALDH1 and its Association with Tumor Budding in Oral Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Impact of alcohol dehydrogenase-aldehyde dehydrogenase polymorphism on clinical outcome in patients with hypopharyngeal cancer.
Squamous Cell Carcinoma of Head and Neck
Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
In vitro and in vivo expression of aldehyde dehydrogenase 1 in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Overexpression of ALDH1 and EMT marker profile are linked with unfavorable outcome in head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Predictive Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prognostic Implications of ALDH1 and Notch1 in Different Subtypes of Oral Cancer.
Squamous Cell Carcinoma of Head and Neck
Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prognostic Value of Drinking Status and Aldehyde Dehydrogenase 2 Polymorphism in Patients With Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Protein expression of CYP1A1, CYP1B1, ALDH1A1, and ALDH2 in young patients with oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC.
Squamous Cell Carcinoma of Head and Neck
SET overexpression decreases cell detoxification efficiency: ALDH2 and GSTP1 are downregulated, DDR is impaired and DNA damage accumulates.
Squamous Cell Carcinoma of Head and Neck
Spatial distribution of cancer stem cells in head and neck squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells.
Squamous Cell Carcinoma of Head and Neck
Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor.
Squamous Cell Carcinoma of Head and Neck
The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
Squamous Cell Carcinoma of Head and Neck
Vasculogenic mimicry and expression of ALDH1, Beclin1, and p16 correlate with metastasis and prognosis in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
[Correlation between drinking behavior and polymorphisms of extracellular superoxide dismutase, aldehyde dehydrogenase 2 genes, and oral squamous cell carcinoma].
ST Elevation Myocardial Infarction
Role of Aldehyde Dehydrogenase 2 Glu504Lys Polymorphism in Acute Coronary Syndrome.
ST Elevation Myocardial Infarction
Role of aldehyde dehydrogenase 2 Glu504lys polymorphism in acute coronary syndrome.
Starvation
Aldehyde dehydrogenase 2 activation in aged heart improves the autophagy by reducing the carbonyl modification on SIRT1.
Starvation
Stress responses of testicular development, inflammatory and apoptotic activities in male zebrafish (Danio rerio) under starvation.
Stomach Neoplasms
Alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes, alcohol drinking and the risk for stomach cancer in Chinese males.
Stomach Neoplasms
Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics.
Stomach Neoplasms
Aldehyde dehydrogenase 3A1 is robustly upregulated in gastric cancer stem-like cells and associated with tumorigenesis.
Stomach Neoplasms
ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer.
Stomach Neoplasms
ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer.
Stomach Neoplasms
ALDH2 and ADH1 Genetic Polymorphisms May Contribute to the Risk of Gastric Cancer: A Meta-Analysis.
Stomach Neoplasms
Analysis of ADH1B Arg47His, ALDH2 Glu487Lys, and CYP4502E1 polymorphisms in gastric cancer risk and interaction with environmental factors.
Stomach Neoplasms
Association between alcohol intake and risk for gastric cancer with regard to ALDH2 genotype in the Korean population.
Stomach Neoplasms
Association between ALDH2 and ADH1B polymorphisms, alcohol drinking and gastric cancer: a replication and mediation analysis.
Stomach Neoplasms
Association between ALDH2 Polymorphism and Gastric Cancer Risk in a Korean Population.
Stomach Neoplasms
Association Between ALDH2 Polymorphism and Gastric Cancer Risk in Terms of Alcohol Consumption: A Meta-Analysis.
Stomach Neoplasms
Association between ALDH2 rs671 G>A polymorphism and gastric cancer susceptibility in Eastern Asia.
Stomach Neoplasms
Bioinformatics analysis with graph-based clustering to detect gastric cancer-related pathways.
Stomach Neoplasms
BRD4 promotes the stemness of gastric cancer cells via attenuating miR-216a-3p-mediated inhibition of Wnt/?-catenin signaling.
Stomach Neoplasms
Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray.
Stomach Neoplasms
Chronic atrophic gastritis and metachronous gastric cancer in Japanese alcoholic men with esophageal squamous cell carcinoma.
Stomach Neoplasms
Effects of "Essential AD2" Supplement on Blood Acetaldehyde Levels in Individuals Who Have Aldehyde Dehydrogenase (ALDH2) Deficiency.
Stomach Neoplasms
Effects of alcohol consumption, ALDH2 rs671 polymorphism, and Helicobacter pylori infection on the gastric cancer risk in a Korean population.
Stomach Neoplasms
Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer.
Stomach Neoplasms
Expression of ALDH1A1 and CD133 is associated with the prognosis and effect of different chemotherapeutic regimens in gastric cancer.
Stomach Neoplasms
Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
Stomach Neoplasms
Expression of NUAK2 in gastric cancer tissue and its effects on the proliferation of gastric cancer cells.
Stomach Neoplasms
Faciogenital dysplasia 5 confers the cancer stem cell-like traits of gastric cancer cells through enhancing Sox2 protein stability.
Stomach Neoplasms
Gastric cancer depends on aldehyde dehydrogenase 3A1 for fatty acid oxidation.
Stomach Neoplasms
Genetic polymorphisms in alcohol metabolism, alcohol intake and the risk of stomach cancer in Warsaw, Poland.
Stomach Neoplasms
Genetic polymorphisms of ADH1B, ADH1C and ALDH2, alcohol consumption, and the risk of gastric cancer: the Japan Public Health Center-based prospective study.
Stomach Neoplasms
Helicobacter pylori, chronic atrophic gastritis, inactive aldehyde dehydrogenase-2, macrocytosis and multiple upper aerodigestive tract cancers and the risk for gastric cancer in alcoholic Japanese men.
Stomach Neoplasms
Increased formation of gastric N(2)-ethylidene-2'-deoxyguanosine DNA adducts in aldehyde dehydrogenase-2 knockout mice treated with ethanol.
Stomach Neoplasms
Kimchi and soybean pastes are risk factors of gastric cancer.
Stomach Neoplasms
Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer.
Stomach Neoplasms
miR-625 reverses multidrug resistance in gastric cancer cells by directly targeting ALDH1A1.
Stomach Neoplasms
Polymorphisms in ADH1B and ALDH2 genes associated with the increased risk of gastric cancer in West Bengal, India.
Stomach Neoplasms
Predictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage.
Stomach Neoplasms
The aldehyde dehydrogenase 2 (ALDH2) Glu504Lys polymorphism interacts with alcohol drinking in the risk of stomach cancer.
Stomach Neoplasms
The prognostic roles of ALDH1 isoenzymes in gastric cancer.
Stomach Ulcer
Lipoic acid protects gastric mucosa from ethanol-induced injury in rat through a mechanism involving aldehyde dehydrogenase 2 activation.
Stroke
Aldehyde dehydrogenase 2 activation and coevolution of its ?PKC-mediated phosphorylation sites.
Stroke
Aldehyde dehydrogenase 2 polymorphism as a protective factor for intracranial vascular stenosis in ischemic stroke in Han Chinese.
Stroke
Aldehyde Dehydrogenase Mutation Exacerbated High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease with Gut Microbiota Remodeling in Male Mice.
Stroke
ALDH 2 conferred neuroprotection on cerebral ischemic injury by alleviating mitochondria-related apoptosis through JNK/caspase-3 signing pathway.
Stroke
ALDH2 and Stroke: A Systematic Review of the Evidence.
Stroke
ALDH2 attenuates early-stage STZ-induced aged diabetic rats retinas damage via Sirt1/Nrf2 pathway.
Stroke
ALDH2 protects against stroke by clearing 4-HNE.
Stroke
ALDH2 rs671 polymorphisms and the risk of cerebral microbleeds in Chinese elderly: the Taizhou Imaging Study.
Stroke
ALDH2, a novel protector against stroke?
Stroke
APSH YI-02 THE POLYMORPHISM IN ALDEHYDE DEHYDROGENASE-2 (ALDH2) GENE IS ASSOCIATED WITH MYOCARDIAL INFARCTION AND STROKE IN A CHINESE POPULATION.
Stroke
Association of ADH1B polymorphism and alcohol consumption with increased risk of intracerebral hemorrhagic stroke.
Stroke
Associations of common variants at ALDH2 gene and the risk of stroke in patients with coronary artery diseases undergoing percutaneous coronary intervention.
Stroke
Homozygous ALDH2*2 Is an Independent Risk Factor for Ischemic Stroke in Taiwanese Men.
Stroke
Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study.
Stroke
Sex-specific differences in the association of a common aldehyde dehydrogenase 2 gene polymorphism and alcohol consumption with stroke risk in a Korean population: a prospective cohort study.
Stroke
Synergistic Effects of Aldehyde Dehydrogenase 2 Polymorphisms and Alcohol Consumption on Cognitive Impairment after Ischemic Stroke in Han Chinese.
Stroke
Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.
Stroke
The role of ALDH2 and ADH1B polymorphism in alcohol consumption and stroke in Han Chinese.
Stroke, Lacunar
A polymorphism of the aldehyde dehydrogenase 2 gene is a risk factor for multiple lacunar infarcts in Japanese men: the Takahata Study.
Tachycardia
Developing precision medicine for people of East Asian descent.
Tachycardia
Gene Therapy Correction of Aldehyde Dehydrogenase 2 Deficiency.
Tachycardia
Genetic polymorphism of enzymes of alcohol metabolism and susceptibility to alcoholic liver disease.
Tendinopathy
Alda-1, an activator of ALDH2, ameliorates Achilles tendinopathy in cellular and mouse models.
Teratocarcinoma
Enzymatic conversion of retinaldehyde to retinoic acid by cloned murine cytosolic and mitochondrial aldehyde dehydrogenases.
Thrombosis
Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice.
Thyroid Cancer, Papillary
Aldehyde dehydrogenase activity plays no functional role in stem cell-like properties in anaplastic thyroid cancer cell lines.
Thyroid Cancer, Papillary
High ALDH1A1 expression correlates with poor survival in papillary thyroid carcinoma.
Thyroid Cancer, Papillary
[High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma].
Thyroid Carcinoma, Anaplastic
Aldehyde dehydrogenase activity plays no functional role in stem cell-like properties in anaplastic thyroid cancer cell lines.
Thyroid Neoplasms
BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma.
Tics
ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
Tics
Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
Tics
Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer.
Tremor
Effect of tremorogenic and antitumor agents on enzymes regulating a minor metabolic pathway of biogenic amines: an hypothesis for the underlying mechanism.
Tremor
Interactions of COMT and ALDH2 Genetic Polymorphisms on Symptoms of Parkinson's Disease.
Triple Negative Breast Neoplasms
A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
Triple Negative Breast Neoplasms
A triple negative breast cancer: what it is not!
Triple Negative Breast Neoplasms
Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC).
Triple Negative Breast Neoplasms
Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.
Triple Negative Breast Neoplasms
Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
Triple Negative Breast Neoplasms
Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.
Triple Negative Breast Neoplasms
ALDH1 Cancer Stem Cell Marker as a Prognostic Factor in Triple-Negative Breast Cancer.
Triple Negative Breast Neoplasms
ALDH1 Expression and Vasculogenic Mimicry Are Positively Associated with Poor Prognosis in Patients with Breast Cancer.
Triple Negative Breast Neoplasms
ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer.
Triple Negative Breast Neoplasms
Characterizing Breast Cancer in a Population with Increased Prevalence of Triple-Negative Breast Cancer: Androgen Receptor and ALDH1 Expression in Ghanaian Women.
Triple Negative Breast Neoplasms
Cytokeratin 19 (KRT19) has a Role in the Reprogramming of Cancer Stem Cell-Like Cells to Less Aggressive and More Drug-Sensitive Cells.
Triple Negative Breast Neoplasms
Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype.
Triple Negative Breast Neoplasms
Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer.
Triple Negative Breast Neoplasms
Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancer.
Tuberculosis
Functional polymorphism in aldehyde dehydrogenase-2 gene associated with risk of tuberculosis.
Tuberculosis
Vitamin A Metabolism by Dendritic Cells Triggers an Antimicrobial Response against Mycobacterium tuberculosis.
Urinary Bladder Neoplasms
Alcohol drinking and bladder cancer risk from a pooled analysis of ten cohort studies in Japan.
Urinary Bladder Neoplasms
Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.
Urinary Bladder Neoplasms
Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.
Urinary Bladder Neoplasms
Aldehyde dehydrogenase 2 (ALDH2) and alcohol dehydrogenase 1B (ADH1B) polymorphisms exacerbate bladder cancer risk associated with alcohol drinking: Gene-environment interaction.
Urinary Bladder Neoplasms
ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
Urinary Bladder Neoplasms
HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: Array-based DNA methylation and expression profiling.
Urinary Bladder Neoplasms
Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2.
Urinary Bladder Neoplasms
Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer.
Urinary Bladder Neoplasms
YAP regulates ALDH1A1 expression and stem cell property of bladder cancer cells.
Urinary Bladder Neoplasms
[Effects of 5-Aza-2'-deoxycitydine and trichostatin A on expression and apoptosis of ALDH1a2 gene in human bladder cancer cell lines]
Uterine Cervical Neoplasms
Aldehyde dehydrogenase 1 (ALDH1) positivity correlates with poor prognosis in cervical cancer.
Uterine Cervical Neoplasms
Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
Uterine Cervical Neoplasms
Aldehyde dehydrogenase 1, a target of miR-222, is expressed at elevated levels in cervical cancer.
Uterine Cervical Neoplasms
Chemoradiation therapy reduces aldehyde dehydrogenase 1 expression in cervical cancer but does not improve patient survival.
Uterine Cervical Neoplasms
Evidence for epithelial-mesenchymal transition in cancer stem-like cells derived from carcinoma cell lines of the cervix uteri.
Uterine Cervical Neoplasms
Expression and functional role of ALDH1 in cervical carcinoma cells.
Uterine Cervical Neoplasms
Low P16INK4A Expression Associated with High Expression of Cancer Stem Cell Markers Predicts Poor Prognosis in Cervical Cancer after Radiotherapy.
Uterine Cervical Neoplasms
MiR-23b controls ALDH1A1 expression in cervical cancer stem cells.
Uterine Cervical Neoplasms
The expression of ALDH1 in cervical carcinoma.
Uterine Cervical Neoplasms
Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Virus Diseases
Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis.
Virus Diseases
Association between smoking, acetaldehyde dehydrogenase-2 1-1 status, and alcohol drinking among Taiwanese polyvinyl chloride workers.
Virus Diseases
Hepatitis B and C viruses infection, lifestyle and genetic polymorphisms as risk factors for hepatocellular carcinoma in Haimen, China.
Vitamin A Deficiency
A human ALDH1A2 gene variant is associated with increased newborn kidney size and serum retinoic acid.
Vitamin A Deficiency
Cellular expression of retinal dehydrogenase types 1 and 2: effects of vitamin A status on testis mRNA.
Vitamin A Deficiency
Differentiation-dependent regulation of retinal dehydrogenase gene expression in the trachea.
Vitamin A Deficiency
Localization of retinaldehyde dehydrogenases and retinoid binding proteins to sustentacular cells, glia, Bowman's gland cells, and stroma: Potential sites of retinoic acid synthesis in the postnatal rat olfactory organ.
Vitamin A Deficiency
Retinal dehydrogenase gene expression in stomach and small intestine of rats during postnatal development and in vitamin A deficiency.
Vitamin A Deficiency
Vitamin A deficiency induces congenital spinal deformities in rats.
Wilms Tumor
Inhibition of GSK3 Represses the Expression of Retinoic Acid Synthetic Enzyme ALDH1A2 via Wnt/?-Catenin Signaling in WiT49 Cells.
Xeroderma Pigmentosum
DNA polymorphism and risk of esophageal squamous cell carcinoma in a population of North Xinjiang, China.
Xerostomia
Aldehyde dehydrogenase 3A1 activation prevents radiation-induced xerostomia by protecting salivary stem cells from toxic aldehydes.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1.2.1.3 aldehyde dehydrogenase (NAD+)
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
